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I hereby declare that I alone have composed this thesis and that, 
except where stated the work in it is entirely my own. 
PRP2 protein of Saccharomyces cerevislae is a factor known to be 
required for pre-mRNA splicing. The aim of this work has been to examine 
the Involvement of PRP2 protein in pre-mRNA splicing, and its interactions 
with other splicing factors, using a mainly Immunological approach. 
Antibodies which react with PRP2 protein were raised In rabbits against 
fusions between different regions of PRP2 protein (which together cover the 
whole of the protein) and E. coli 3-galactosIdase. These different 
antisera recognised PRP2 protein with different affinities, under conditions 
of immunoprecipitation or on western blots. 	?RP2 protein was over- 
expressed in yeast using three different expression systems. 	It was also 
expressed in E. coli and by in vitro translation. 	An assay system for 
PRP2 protein activity in pre-mRNA splicing was developed (based upon the 
system described by Lustig et al, 1986), and the protein was partially 
purified by biochemical methods. 
Anti-PRP2 antibodies were used to investigate the Interactions of PRP2 
protein with small nuclear ribonucleoproteins (snRNPs) and with splicing 
complexes, by studying the RNA species co-precipitated during 
Immunoprecipitations. 	No association of PRP2 protein with snRNPs was 
detected. 	However, it was shown that PRP2 protein is associated with 
splicing complexes, while temperature sensitive prp2 protein did not 
associate with such complexes, following heat inactivation. These studies 
revealed that pre-mRNAs which contain a branchpoint sequence but less than 
approximately 32 nucleotides downstream of this sequence are preferentially 
co-precipitated by anti-PRP2 antibodies. Studies of the kinetics of 
interaction of PRP2 protein with splicing complexes revealed that PRP2 
protein associates with complexes at a specific transition between two 
complexes, and that It remains associated with spliceosomes throughout step 
1 of the splicing reaction. PRP2 protein dissociates from the spliceosome 
prior to step 2 of the splicing reaction, or immediately upon completion of 
this step. Evidence was obtained that PRP2 protein, in spliceosomes, is 
associated, either directly or indirectly, with the region of the transcript 
containing the 5' splice site. 
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1.1. RNA Splicing 
It was discovered in the mid 1970s that the coding regions of many 
genes are interrupted by stretches of DNA which do not code for RNA 
sequences found In the mature transcript (Witkowski, 1978). In 1977 It 
was proposed that these regions (called introns) are transcribed, but are 
removed from the primary transcript by a process termed RNA splicing. 
Introns have subsequently been found in eukaryotic genes encoding mRNA, 
tRNA, rRNA and snRNA, in eubacterial phage genes encoding mRNA and in 
archaebacterial tRNA genes. Introns are divided into four classes 
according to the conserved sequences which they contain: for each class of 
intron a different mechanism of splicing operates. 
The different classes of intron are: 
(I) 	Introns in nuclear tRNA genes (Abelson, 1979); 
group I introns, in Tetrahymena rRNA, fungal mitochondrial, 
chloroplast and bacteriophage T4 genes (Cech and Bass, 1986); 
group II introns, in fungal mitochondrial and chioroplast genes 
(Cech and Bass, (1986); 
pre-mRNA and snRNA introns (Green, 1986; Padgett et p1, 1986; 
Sharp, 1987) 
This thesis is concerned with splicing of pre-mRNA introns and the 
introduction will therefore concentrate on this class of introns. The 
relationship between different classes of splicing reaction will be 
discussed in section 1.10. 
1 
1 2 Structure and Occurrence of Introns 
Most higher eukaryotic genes contain introns, and the number of introns 
in a gene may be as high as 50 (Wozney et Al, 1981). These vary in size 
between 31bp (Ghosh et p1, 1978) and approximately 60kbp (Garber et al, 
1983; Scott et al 1983), with little conservation of size between analogous 
introns in related species. By contrast, exon sizes appear to cluster, 
around means of 52, 140, 223 and 229 base pairs (Naora and Deacon, 1982). 
In Saccharoniyces cerevisiae (henceforth referred to as yeast) few genes 
have introns, although most ribosomal protein genes do possess one. The 
largest intron so far discovered in yeast is 513 bp (Leer et p1, 1983). 
Yeast introns are generally found close to the 5' ends of genes. 
Comparison of the sequences of yeast and mammalian introns revealed the 
conserved sequences shown in figure 1. The 5' and 3' splice site 
consensus sequences are similar in yeast and higher eukaryotes, although 
yeast introns lack the conserved nucleotides in exon 1 and the 
polypyrimidine sequence at the 3' splice site. An Internal sequence 
UACUAAC is found In yeast introns at the site of formation of the branch 
structure in step 1 of the splicing reaction (see section 1.3). This 
sequence is not found in metazoa, although a less stringently conserved 
version of the sequence is present in most introns (Keller and Noon, 1984; 
Keller and Noon, 1985). 	The sequences at the splice junctions are also 
more strongly conserved in S. cerevisiae than in metazoa. 	The 
introduction of point mutations, and deletion of the conserved sequences 
have demonstrated that these elements are essential for accurate and 
efficient splicing (see section 1.4). 
M-e 	 W4 
In order to investigate the details of the splicing reaction pathway It 
was necessary to develop a system in which a single well defined substrate 
was spliced, and the products and intermediates easily analysed, i.e. an ia 
vitro system. The systems currently used have two main components: a 
Hela cell nuclear extract, or yeast whole cell extract, and a radioactively- 
2 
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labelled pre-mRNA, produced by transcription in vitro, using a bacterial RNA 
polymerase (Hernandez and Keller, 1983; Hardy et al, 1984; Kramer et al, 
1984; Lin et al, 1985). These extracts splice pre-mRNA with an efficiency 
such that the products and intermediates can be clearly visualised by 
autoradiography, following polyacrylamide gel electrophoresis. 
Development of in vitro systems led to the formulation of the two step 
pathway for pre-mRNA splicing, which is shown in figure 1 (Grabowski et p1, 
1984; Padgett et al, 1984; Ruskin et p1, 1984; Konarska et p1, 1985a). In 
the first step of the splicing reaction the pre-mRNA is cleaved at the 5' 
splice site, leaving a 3' hydroxyl group on exon 1. The first residue of 
the intron forms an unusual 2'-5' phosphodiester bond with an adenosine 
residue near the 3' end of the intron, creating a branched or 'lariat' 
structure. In yeast this adenosine is the most 3' adenosine of the 
UACUAAC sequence (Domdey et p1, 1984; Rodriguez et p1, 1984). 
These intermediates are converted into products in the second step of 
the reaction, In this step the lariat intermediate is cleaved at the 3' 
splice site and the exons ligated, resulting in two products: the spliced 
mRNA and the excised intron, (which remains in the form of a lariat), with 
a 3' hydroxyl group. 
Although ATP is necessary for in vitro splicing, the number of 
phosphodiester bonds is conserved in the products and therefore the 
reaction could theoretically proceed without any energy imput. It is 
believed that both steps of the reaction proceed by trans- ester if ication 
reactions (e.g. in step 1 by direct nucleophilic attack by the 2' hydroxyl 
of the branchpoint adenosine upon the phosphate at the 5' splice site), 
since it has been impossible to detect cleavage of the RNA in either step 
of the reaction in the absence of the concomitant ligation (2 1-5' or exon 1-
exon 2). One of the requirements for ATP in in vitro splicing is in the 
assembly of a large complex in which the reaction takes place (see section 
1.7). 
The requirements of the in vitro splicing reaction for ions and 
cofactors appear to be similar in yeast and mammalian systems. 	In both, 
3 
monovalent cation (Na+, K) concentrations of 50-100 mM are optimal (Mn et 
j, 1985; Hernandez and Keller, 1983; Kramer et al, 1984). There is a 
requirement for low levels of Mg, while high levels inhibit splicing. 
ATP is also necessary, and analogues In which either the a-A or A-Y bond Is 
non-hydrolysable do not support splicing (Kramer et al, 1984; Lin et al, 
1985). In neither the mammalian nor yeast system Is It necessary for the 
RNA to be 5'-capped, although this does improve splicing efficiency in the 
former (Kramer et p1, 1984; Inoue et p1, 1989). The temperature optimum, 
in vitro, is 30C for the mammalian system and 25C for yeast. 
That the same reaction pathway occurs in vivo as in vitro has been 
confirmed by detection of branched molecules in HeLa cell heterogeneous 
nuclear RNA (hnRNA) (Wallace and Edmonds, 1983) and by the identification 
of lariats in in vivo 3-globIn transcripts, some of which were identical to 
those produced during In vitro splicing of the -globIn transcript (Zeitlin 
and Efstratiadis, 1984; Ruskin et al, 1984). Similar experiments with & 
cerevisiae have confirmed that the pathway is the same In vivo and in vitro 
(Domdey et al, 1984; Rodriguez et Al, 1984; Lin et Al, 1985). 
1.4.1 Mammalian pre-mRNA 
As indicated In section 1.2, the only conserved sequences in mammalian 
introns are at the 5' and 3' splice sites and at the weakly conserved 
branch point sequence, suggesting that It is only these sequences which are 
required for splicing. Deletion studies have shown that within the Intron, 
only 6 nucleotides at the 5' splice site and 24 nucleotides at the 3' splice 
site are essential for splicing, provided a minimum Intron size of 80 
nucleotides is maintained (Wieringa et p1, 1984; Van Santen and Spritz, 
1985). There is no apparent upper limit on intron size. Removal of all 
but 20 nucleotides of exon 1 and 4 nucleotides; of exon 2 permits splicing 
(Parent et p1, 1987; Turnbull-Ross et p1, 1988); exon 2 is not absolutely 
required for step 1 of the reaction (Frendewey and Keller, 1985). However, 
4 
the severity of the effect of truncating exon sequences may vary in 
different genes. 
At the 5' splice site in -globin genes, naturally occurring mutations 
inactivate the splice site, causing activation of cryptic 5' splice sites. 
This produces abberrant, or truncated, -g1obins and therefore results in 
thalassemias (Treisman et Al, 1983). The cryptic 5' splice sites which are 
used generally have strong homology to the 5' splice site consensus 
sequence (Kramer et Al, 1984). Mutation of GI or U2 inhibits cleavage to 
varying degrees, and may permit step 1 of the reaction, but not step 2 
(Aebi et p1, 1987). Purine transitions at intron positions 3 and 4 have 
little effect on splicing (Treisman et p1, 1983), while changes at position 
5 often lead to the utilization of cryptic 5' splice sites (Vieringa at p1, 
1983). 
Due to the lack of strong conservation of mammalian branchpolnt 
sequences, and the finding that deletion of authentic branchpoints led to 
activation of cryptic branchpoints, with little effect upon the efficiency 
of in vitro splicing (Ruskin et al, 1985), it was believed that the sequence 
surrounding the branchpoirit nucleotide was relatively unimportant. 
Branches can form at G and U nucleotides, but these are blocked for step 2 
of the reaction (Aebi et p1, 1987). However, two recent studies, using 
similar cis-competition assays have revealed that branchpomnt sequence 
mutants can strongly affect splicing efficiency, both in. vitro and in vivo 
(Zhuang and Weiner, 1989a; Reed and Maniatis, 1988). It was also shown 
that when two branchpoint sites within the same intron are in competition, 
the match of the branchpomnt sequences to the mammalian consensus sequence 
YURAC is an important determinant of the efficiency of utilization of a 
particular branchpoint. These competition assays demonstrated that the 
yeast consensus sequence tJACUAAC is the most efficiently utilized mammalian 
branchpoint sequence (Zhuang et al, 1989a). In general, the severity of 
effect of mutations In the mammalian branchpoint sequence parallels the 
effect of analogous mutations in the yeast branchpoint sequences (Reed and 
Maniatis, 1988). 
5 
The branchpoint nucleotide is usually 18-40 nucleotides upstream of the 
3' splice site (Ruskin et p1, 1984; Keller and Noon, 1984; Reed and Naniatis, 
1985), and it was assumed until recently that there is a strong distance 
constraint upon the position of the branchpoint. While the polypyrimidine 
tract has been shown to be essential for step 1 of the reaction (Frendewey 
and Keller, 1985; Reed and Maniatis, 1985; Ruskin and Green, 1985; Reed, 
1989), mutations in the AG dinucleotide have effects varying from nil to 
almost complete abolition of step 1, in different genes (Reed and Maniatis, 
1985; Ruskin and Green, 1985; Aebi et p1, 1986; Smith et al 1985). Recent 
studies (Reed, 1989; Smith et p1, 1989) have shown that branchpoints up to 
177 nucleotides upstream of the 3' splice site can be active In splicing, 
provided that they are adjacent to a long polypyrimidine tract. However, 
in most genes the short polypyrimidine tract results in a requirement for 
the AG dinucleotide for efficient lariat formation (Reed, 1989). The AG 
dinucleotide is essential for the second step of splicing (Reed and 
Maniatls, 1985; Ruskin and Green, 1985; Aebi et p1, 1986). It appears that 
the 3' splice site is the first AG downstream of the branchpoint (Reed and 
Naniatis, 1985; Smith et p1, 1989). 
1.4.2 Yeast pre-mRNA 
The yeast splice site and branchpoint consensus sequences are more 
strongly conserved than those in metazoa, and deletion of 5' splice site and 
branchpoint sequences does not, in general, lead to utilization of cryptic 
sites in yeast. 	This may reflect a greater degree of sequence specificity 
of the yeast splicing machinery. 	Since metazoan introns do not contain 
the UACUAAC consensus sequence, they are not spliced, or abberrantly 
spliced in yeast (Watts et p1, 1984). The yeast RP51A pre-niRNA can be 
spliced in a HeLa extract, although a different branchpoint is used (Ruskin 
et al, 1986). 
As with mammalian introns, the bulk of yeast intron sequences, with the 
exception of the consensus sequences is not required for splicing. The 
two smallest naturally occurring introns, in the MATa1 gene have 42 and 43 
nucleotides separating the 5' splice site and branch point (Miller, 1984), 
which is close to the minimum, (44 nucleotides) determined by deletion 
studies 'Thomson-Jager and Domdey, 1987). 	The average size of yeast 
introns is 300-500 nucleotides and large insertions decrease the efficiency 
of splicing (Kllnz and Gallwitz, 1985). Most introns are positioned near 
the 5' end of transcripts and moving an intron downstream resulted in a 
decrease in splicing efficiency (Kllnz and Gallwitz, 1985). A first exon 
as small as 12 nucleotides permits splicing, while one consisting of 1 
nucleotide permits step 1 of the reaction (Duchene et al, 1988). Exon 2 is 
dispensible for step 1 of the reaction, and a second exon of 10 nucleotides 
is sufficient for splicing (Rymond and Rosbash, 1985). 
In contrast to the situation in metazoa, deletion of the 5' splice site 
blocks splicing (Gallwitz, 1982). Point mutations at position 1 and 2 of 
the intron completely inhibit step 2 of the splicing reaction and with the 
exception of G1-A1 also inhibit step 1 (Newman et p1, 1985; Fouser and 
Friesen, 1986; Vifayraghavan et al, 1986). The 0 residue at position 5 
appears to be Important for selection of the cleavage site in step 1, since 
mutation to A or C permits a low level of cleavage at cryptic sites, which, 
Interestingly, bear no sequence resemblance to the 5' splice site consensus 
(Fouser and Friesen, 1986; Vijayraghavan et p1, 1986; Parker and Guthrie, 
1985). This suggests that the 5' splice site cleavage activity In step 1 
of splicing may not be strictly dependent on RNA sequence. 
Deletion of the branch point sequence abolishes splicing in all cases 
tested, except that of actin, where a cryptic branch site, close to the 
normal branchpoint is used (Langford and Gallwitz, 1983; Langford et p1, 
1984; Pikielny et p1, 1983; CellinI et p1, 1986). Point mutations in the 
branchpoint sequence have variable effects upon the two steps of splicing, 
sometimes depending on the nucleotide introduced, and possibly also on 
different genes and detection methods employed (Newman at p1, 1985; Fouser 
and Friesen, 1986; Vljayraghavan et p1, 1986; Langford et p1, 1984; Jacquler 
and Rosbash, 1986; Jacquier et p1, 1985). The branchpolnt nucleotide is 
always at position 6 in the sequence, but the presence of an adenosine at 
this position is more important for step 2 of the reaction than step 1. 
Branches can form when other nucleotides are present at this position, but 
these strongly inhibit step 2 of the reaction, It has been suggested that 
the stricter dependence of step 2 than step 1 on the 5' splice site Gi and 
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branchpoint A6, (the two nucleotides joined at the branch), may constitute a 
proof-reading step in splicing. While mutations at some branchpoint 
sequence nucleotides can have drastic effects on splicing, mutants at other 
positions e.g. J1 and A2 seem to have little effect (Fouser and Friesen, 
1986; Langford et Al, 1984; Jacquler et al, 1985). This seems paradoxical 
given the absolute conservation of these nucleotides in yeast Introns, but 
may reflect laboratory growth conditions which may not be suitable for 
testing the phenotypes of these mutations. 
If the 3' splice site AG is deleted in yeast, the first AG downstream of 
the branchpoint is utilized (Langford and Gallwltz, 1983), Transcripts 
which lack any AG undergo step 1 of the splicing reaction efficiently, 
provided that they contain more than 29 nucleotides 3' to the branchpoint 
sequence (Rymond et al, 1987). Mutation of AG to AC strongly inhibits 
step 2 of the reaction (Vijayraghavan et p1, 1986). 
In addition to conserved sequences, studies of individual genes have 
revealed non-conserved sequences which affect the efficiency of splicing of 
particular pre-mRNAs. Newman (1987) identified a region upstream of the 
TACTAAC sequence in the CYH2 gene which was required for efficient 
splicing. In genes in which this sequence was deleted, efficient splicing 
could be restored by deletion of another element, close to the 5' splice 
site, suggesting the presence of an inhibitory sequence in this region. 
Another study identified a region near the 5' splice site in the RP51A 
intron, which was responsible for increasing the efficiency of splicing of 
this pre-mRNA (Pikielny and Rosbash, 1985). 
The second main focus of research on pre-mRNA splicing has been the 
identification of the trans-acting factors which comprise the splicing 
machinery and investigation of the role of these factors in splicing. 
These factors may be divided into two main categories: (a) small nuclear 
ribonucleoprotein particles (snRNPs) and (b) other protein factors. 
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15 1(ammalian snRNPs 
1.5.1 Mammalian suRNAs 
Small nuclear ribonucleoprotein particles are found in the nuclei of 
eukaryotic cells and consist of small RNA species, stably associated with 
proteins (Steitz, 1988). 	The snRNAs which are Involved In RNA splicing 
are J1, U2, U4, US and tJ6 RNAs. 	These are uridine rich, and are the most 
highly abundant small nuclear RNAs (2x10-1x106 copies/cell), 	They range 
In size from 106 to 189 nucleotides and with the exception of U6, the cap 
structure of which is unknown, possess a trimethyl guanosine (mG) cap at 
their 5' end. Certain nucleotides are modified In U snRNAs but the 
functional role of these modificiations is uncertain. The Ui, U2 and US 
RNAs are each contained within a separate paricle, while U4 and U6 RNAs are 
base paired to each other in a single snRNP (Hashimoto and Steitz, 1984; 
Bringmann et p1, 1984; Rinke et p1, 1985). 
The U1-6 snRNAs all contain extensive secondary structure, although In 
different species some of these features may be deleted or severely reduced, 
tJ6 RNA is the most strongly conserved RNA, although different regions of 
the RNAs are conserved to different degrees, and this has provided valuable 
evidence on the importance of these regions in snENA function (see Guthrie 
and Patterson, 1988 for a review). Extensive Intermolecular base pairing 
between U4 and U6 has been confirmed by the consistent finding of 
complementary base substitutions in different species. Ul, U2, U4 and US 
all contain a motif which contains the sequence PuAU,GPu (n>3), flanked by 
double stranded stems (Branlant et al, 1982). This conserved sequence is 
a binding site for Sm antigens (see section 1.5.1.2). 
15.1.2 Mammalian snRNP proteins 
There are several autoimmune disorders in humans, In which snRNPs act 
as autoantigens, and sera from patients with these disorders react with all 
the snRNPs (anti-Sm), with a subset (anti-(U1,U2)-RNP) or with Individual 
snRNPs (anti-U1-RNP, anti-U2-RNP) (Van Venrooij, 1987). SnRNPs have been 
immunopurified using these sera and anti-m 3G antibodies (Hinterberger at 
1983; Kinlaw et al, 1983; Bringmann and Luhrmann, 198(5), 	The U snRNPs 
all contain a common set of 7 proteins (B, B', D, D', E, F and G). 	cDNAs 
encoding D and E proteins have been cloned (Rokeach et p1, 1988; Wieben at 
j, 1985). The B and B' proteins show immunological cross-reactivity and 
similarity in their peptide maps (Reuter et al, 1987). 
Evidence from in vivo pulse labelling experiments suggests that the D, 
E, F and G 'core' proteins form a 65 cytoplasmic complex prior to binding 
to snRNAs (Fisher et p1, 1985). These proteins are tightly bound to the 
Sm binding site after prolonged micrococcal nuclease digestion of snRNPs 
(Liautard et p1, 1982), although only F can be UV cross-linked to the snRNA 
(Woppmann et Al, 1988). The B and B' proteins have recently been shown to 
have a nuclease activity which is not sequence specific, and is inactive in 
native snRNPs (Temsamanl et p1, 1989). The function of this activity and 
its role in RNA splicing is uncertain. 
The Ui snR!P contains 3 specific proteins, A, 70K and C. cDNAs encoding 
these proteins have been cloned (Thiessen et p1, 1986; Slllekens et p1, 
1987, 1988; Sprltz et p1, 1988) . The sequence of the cDNAs encoding A and 
70K reveals that they, like the U2 specific protein B" (Habets et p1, 1987) 
both contain an 80 amino acid domain which is common to a number of RNA 
binding proteins (Dreyfuss et p1, 1988), In the case of the 70K protein, 
this has been shown to be part of a 110 amino acid RNA-binding domain 
(Query et al, 1989). In vitro reconstitution studies of Ui snRNP have 
shown that after the DEF and G proteins have bound to the Sm site, 70K and 
A both bind to stem-loop 1 of Ui RNA, and this binding is stabilized by the 
binding of the DEF and G 'core' proteins (Patton et p1, 1987; Patton and 
Pederson, 1988; Hamm et p1, 1988). C protein appears to be required for 
stabilization of the base pairing interaction between the 5' splice site and 
Ui RNA (Heinriche et al, 1990) (see section 1.5.3.1). 
The tJ2 snRRP contains 2 specific proteins, A' and B", and cDNAs encoding 
these proteins have been cloned (Sillekens et p1, 1989; Habets et p1, 1987). 
These proteins require the 3' terminal stem loop of U2 RNA in order to bind 
Mattaj and De Robertis, 1985). However it appears that they are not 
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required for the activity of 152 snRNP in splicing (Pan and Prives, 1989; 
Hamm et al, 1989). 
Recently, it has been shown that a fraction of U5 snRNPs contain, in 
addition to the 7 common proteins, up to 7 unique proteins (Bach et al, 
1989). Two independent studies have identified a protein of 70K or lOOK 
(Tazi et p1, 1986; Gerke and Steitz, 1986) which is an Sm antigen, 
associated with US snRNP. This protein is known as intron binding 
protein (IBP), since it binds to the polypyrimidine tract at the 3' end of 
introns, independently of US snRNP, at 0C and in the absence of ATP. US 
snRNP also contains a >200kD protein which appears to be the mammalian 
homologue of the yeast PRP8 protein (Anderson et p1; 1989 Pinto and Steitz, 
1989) 
1.5,2 Yeast snRNPs 
1.5.2,1 Yeast snRNAs 
In yeast, snRNAs are much less abundant than the IJ1-6 RNAs of mammals, 
and are present at less than 200 copies per cell (Vise et al, 1983; Riedel 
et p1, 1986). This may reflect the infrequency of introns in yeast genes. 
They have the same biochemical properties, of stability, possession of a 5' 
mG cap and modified nucleotides. Initial studies identified 24 such 
snRNAs, of which 5 of the first 6 cloned were dispensible for cell growth 
(Parker et p1, 1988; Tollervey et p1, 1983; Tollervey and Guthrie, 1985). 
The homologues of the mammalian Ui, 2, 4, 5 and 6 RNAs (previously SNR 19, 
20, 14, 7 and 6, respectively) have now been identified (Ares, 1986; 
Kretzner et p1, 1987; Slliciano et p1, 1987a, b; 	Patterson and Guthrie, 
1987). 	They all contain the Sm binding consensus sequence, with the 
exception of US. 
Yeast Ui snRNA is 568 nucleotides in length and contains several large 
insertions, relative to the mammalian Ui RNA (Kretzner et p1, 1987; 
Siliciano et p1, 1987b). It lacks stem-loops 2 and 3 in the consensus Ui-
RNA structure, but is identical to mammalian U1-RNA over its first ten 
nucleotides. Yeast U2 RNA is even larger at 1175 nucleotides, but contains 
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a 950 nucleotide region which may be deleted without apparent effect on 
cell viability (Igel and Ares, 1988; Shuster and Guthrie, 1988), It also 
contains a sequence GUAGUA which is complementary to the yeast intron 
branchpoint sequence. tJ4 and U6 RNAs are more similar in size to their 
mammalian counterparts, but US is far more strongly conserved (Brow and 
Guthrie, 1988), They have been shown to be base paired to each other in 
the same snRNP (Brow and Guthrie, 1988), although the melting temperature 
of the U4/U6 hybrid is anomalously high, 
Yeast U5 RNA exists in two forms which are present in equal amounts. 
These differ by the presence of an extra 35 nucleotides at the 3' end of 
the larger form, The predicted secondary structure of this RNA is similar 
to the mammalian species, and a 9 nucleotide sequence, which is predicted 
to be in a single stranded loop is absolutely conserved. 
1.5,2.2 Yeast snRffP proteins 
Using a genetic approach to the identification of splicing factors 
(section 1.6.2), it has been possible to identify yeast snRNP proteins. 
Thus, the PRP8 protein is associated with US snRNP (Lossky et p1, 1987) 
while PRP4 protein is associated with U416 snRNP (Banroques and Abelson, 
1989; Peterson-Bjorn et al, 1989). In addition to these, yeast Ui, 2, 4, 5 
and 6 RNAs are associated with homologues of the mammalian Sm antigens, 
since they can be precipitated from in vitro splicing extracts using these 
sera (Tollervey and Xattaj, 1987), or following injection of the RNAs into 
Xenopus oocytes (Tollervey and Xattaj, 1987; Riedel et p1, 1987), 
1.53.1 Mammalian systems 
The initial suggestion of a role for snRNPs in RNA splicing was based 
on the complementarity of the first 10 nucleotides at the 5' end of Ui RNA 
to the 5' splice site consensus sequence (Lerner et p1, 1980; Rogers and 
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Wall, 1960), 	Subsequent studies showing that anti-Sm and anti-U1-RIP 
antibodies (Yang et p1, 1981; Padgett et p1, 1983) and oligonucleotide-
directed cleavage of the 5' end of Ui RNA (Kramer and Kaniatis, 1985) both 
inhibited splicing, confirmed this hypothesis with respect to Ui RNA. It 
was also shown that Ui snRNP, but not the RNA alone, protects the 5' 
splice site region of pre-mRNA from digestion with Ti RNase (Mount et al, 
1983). Ui snRNP also binds to cryptic 5' splice sites (Chabot and Steitz, 
1987a) and to synthetic 5' splice sites, which have been inserted into a 
pre-mRJA (Nelson and Green, 1988). 
It has been directly demonstrated, by suppression of 5 splice mutations 
by the complementary mutation in Ui RNA, that Ui RNA does interact with 
the 5' splice site through Watson-Crick base pairing (Zhuang and Weiner, 
1986). This base pairing interaction seems to determine the exact site of 
5' cleavages, since it was possible to predict the site of cleavage in 
different mutants on the basis of the strength of base pairing interactions 
with Ui RNA (Aebi et p1, 1987; Weber and Aebi, 1988), Comparison of 
several thousand splice site sequences suggested that although the 
hybridizing region of the pre-mRNA is composed of two domains, (one of 
which is dispensible provided the overall stability of the hybrid is 
maintained), cleavage always occurs opposite the bond between residues 9 
and 10 of Ui RNA (Jacob and Gallinaro, 1989) 
Oligonucleotide directed cleavage of U2 RNA demonstrated the involvement 
of U2 snRNP in splicing (Black et p1, 1985; Kramer and Maniatis, 1985). 
Precipitation of protected Ti RNase fragments from the branchpomnt region 
with anti-U2-RNP indicated that U2 snRffP was bound to this region during 
splicing (Black et p1, 1985). It has recently been shown that the effects 
of branchpomnt sequence mutations can be suppressed by the complementary 
mutations In the GUAGUA sequence in U2 RNA (Wu and Manley, 1989; Zhuang 
and Weiner, 1989b). Thus, U2 snRNP interacts with the branchpomnt 
sequence through Watson-Crick base pairing at some stage of the reaction. 
In order to accomodate the observed variability of branchpoint sequences, 
it has been proposed that overlapping domains of U2 RNA base pair with the 
branchpoint sequence (Hartmuth and Barta, 1988). It has been suggested 
that in this base pairing scheme, the branchpoint adenosine may be 
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unpaired, or 'bulged', in a comparable way to the proposed mechanism for 
splicing of group II introns (Cech and Bass, 1986). This arrangement may 
facilitate nucleophilic attack by the 2' hydroxyl group of the branchpoint 
adenosine upon the phosphate group at the 5' splice site. 
The Involvement of US RA in splicing has not been demonstrated by 
oligonucleotide directed cleavage, due to the resistance of U5 snRNP to 
cleavage using this approach. However, as noted above (section 1.5.1.2), tJ5 
Is associated with a protein which binds to the 3' splice site region. 
The 3' splice site region was shown, in a separate study (Chabot et p1, 
1985), to be protected by an mG precipitable, but micrococcal nuclease 
resistant factor. 	Of the major snRNPs only US shows this degree of 
resistance to micrococcal nuclease. 	Recently, it has been shown that 
extracts depleted of U5 snRNP are able to undergo step 1 of the splicing 
reaction but not step 2, although the efficiency of step 1 was also 
inhibited (Wlnkelmann et p1, 1989). Thus US may only be absolutely 
required for the second step of pre-xnRNA splicing. 
Although U4/6 Is required for splicing, as shown by oligonucleotide-
directed cleavage experiments (Berget and Robberson, 1986; Black and Steitz, 
1986), no direct binding of the U4/6 snRNP to the RNA has been 
demonstrated. 
1.5.3,2 Yeast systems 
Disruption of the genes encoding the yeast U snRNA homologues has shown 
that they are all required for cell viability (Ares, 1986; Kretzner et p1, 
1987; Slliciano et p1, 1987a, b; Brow and Guthrie, 1988; Patterson and 
Guthrie, 1987). A yeast strain containing a conditional null allele of 
SNR7 was constructed by placing this gene under the control of the glucose-
repressible GALl promoter (Patterson and Guthrie, 1987). After growth on 
glucose for a number of generations, the level of US snRNA was reduced to 
less than 0.5% of the normal level, and this resulted in Inhibition of pre-
mRNA splicing. Interestingly, and in parallel with the finding in a 
mammalian system (WInkelmann et al, 1989), for some transcripts tested, US 
depletion resulted in the accumulation of lariat intermediates. This 
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result suggests that normal levels of 1J5 snRNP are only absolutely required 
for the second step of splicing. 
Similar genetic experiments to those performed on mammalian Ui RNA 
showed that yeast Ui RNA interacts with the ' splice site through Watson-
Crick base pairing (Seraphin et p1, 1988; Siliciano and Guthrie, 1988). By 
the same technique (Parker et al, 1987) it was demonstrated that base 
pairing occurs between a GUAGUA sequence in U2 RNA and the TJACUAAC 
sequence in yeast introns. 
Both in vitro and in viva, pre-mRA is complexed with heterogeneous 
nuclear ribonucleoprotein (hnRNP) proteins (Dreyfuss et Al, 1988). It was 
Initially thought that these proteins had no sequence specificity of RNA 
binding, but recent work has shown that the hnRNP proteins C, Al and D 
bind specifically to sequences near the 3' end of introns, Including the 
polypyrimidine tract and branch point sequences (Swanson and Dreyfuss, 
1988a,b). 	Depletion of the hnRNP C protein from extracts showed that It 
is required for splicing (Choi et al, 1986). 	It has been suggested that a 
relatively high non-specific RNA binding affinity in these proteins allows 
them to find their target sequences rapidly, presumably while the RNA is 
being transcribed, by binding to the RNA and diffusing in one dimension 
only. 
A variety of soluble protein factors have been identified by 
fractionation of HeLa cell extracts (Kramer and Keller, 1985; Kramer et p1, 
1987). Some of these factors are required only for the second step of 
splicing. 
A factor that is necessary for U2 binding to pre-mRNA, but which binds 
independently from it, was identified (Ruskin et p1, 1988). This protein, 
U2AF, requires both the 3' splice site dinucleotide and the polypyrmidine 
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tract in order to bind efficiently, and was shown to be distinct from hriRJP 
C protein and the U5-associated intron binding protein. 
Another protein, of molecular weight 62kD, which also binds to the 
polypyrimidine tract, has recently been purified (Garcia-Blanco et p1, 
1989). 
There is evidence for the existence of a factor which collaborates with 
Ui snRNP binding to 5' splice site sequences, using a filter binding 
assay Mayeda et al (1986) detected an activity in the flowthrough from a 
Ui snRNP purification column which stimulated Ui binding to an RNA 
substrate containing only a 5' splice site. Recently, by simply pelleting 
snRNPs by ultracentrifugation a factor was detected which allowed Ui to 
protect the 5' splice site (Zapp and Berget, 1989), Complexes containing 
Ui and U2 snRNP and pre-n1RNA formed in the absence of this factor, but the 
5' splice site was not protected in such complexes. 
1.6.2 Yeast splicing factors 
In yeast, the ability to isolate splicing mutants has allowed the 
identification of a number of genes encoding putative splicing factors, An 
early study by Hartwell (1967) isolated 400 temperative sensitive mutants 
which were defective in macromolecule synthesis. 	Of these, 23, falling 
into 9 complementation groups (prp2 to prp 10/11, formerly rna2 to 
10/11) ceased synthesis of RNA at the restrictive temperature. 	These 
have subsequently been shown to primarily affect RNA splicing (Rosbash el 
1, 1981). 	Since most ribosomal protein genes contain introns, a block in 
RNA splicing inhibits synthesis of these proteins, which in turn rapidly 
inhibits the synthesis of rRNA. 	rRNA comprises the majority of cellular 
RNA, so an Indirect effect of the block in pre-mRNA splicing is a rapid 
cessation of synthesis of the majority of cellular RNA. 	In a recent study 
11 further complementation groups were Isolated (Vijayraghavan et p1, 1989). 
Among these were mutants in which only the second step of splicing was 
Inhibited. 	It has been shown that in vitro splicing extracts made from 
all the pra strains, with the exception of prp6 and prp9, are temperature 
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sensitive in vitro, suggesting that these gene products are directly 
involved in splicing (Lustig et al, 1986). 
Several of the ERF. genes have been cloned by complementation of the 
temperature sensitive phenotype (Lee et p1, 1984; Last et al, 1984; Soltyk at 
j, 1984; Jackson at p1, 1988). The gene products (Chang et p1, 1988; 
Banroques and Abelson, 1989) or fusion proteins derived from these genes 
(Lee et p1, 1986; Last and Woolford, 1986; Peterson-Bjorn et p1, 1989; 
Jackson et p1, 1988; this thesis) have been expressed in E coil and used to 
raise antisera to the proteins. This has in turn allowed Identification of 
the gene products in yeast, and partial elucidation of their role in RNA 
splicing. Thus, PRP8 protein has been shown to be associated with the U5 
snRNP (Lossky et p1, 1987) and also to bind directly to the pre-mRNA 
during RNA splicing (E. Whittaker, personal communication). PRP4 protein 
is associated with the U4/6 snRNP (Peterson-Bjorn et p1, 1989; Banroques 
and Abelson, 1989), By synthesising radio-labelled PR?11 protein in an I. 
vitro translation system, it was shown that this protein is associated with 
splicing complexes (see section 1.7.2), but not with any individual snRNP 
(Chang et p1, 1988). 
The PRP2 gene has been cloned (Lee et al, 1984; Last et p1, 1984) and 
its sequence determined (J. Beggs, unpublished). 	This sequence has 
revealed two interesting homologies. 	The first is the presence of the 
consensus sequence for the 'zinc finger' structure which is present in a 
number of nucleic acid binding proteins . The other major homology is to 
the enzyme adenylate kinase, which binds AT?, although the sequence found 
in PRP2 protein contains only the part of the AT? binding site which is 
responsible for phosphate group binding. The significance of these 
homologies for the function of PRP2 protein is uncertain. 
PRP2 protein has been identified by immunological methods and has a 
molecular weight of approximately lOOkD, by SDS-PAGE (Lee et p1, 1986; Last 
and Woolford, 1986). Immunofluoresence studies using anti-PRP2 antibodies 
have shown that the protein is localized in the cell nucleus (Last and 
Woolford, 1986). ?RP2 protein appears to be distinct from the other EE 
gene products in that when prp2 splicing extracts are heat inactivated, 
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splicing complexes form (Lin et p1, 1987). 	In this study another factor, 
b,,, which appears to be required for the activity of PRP2 protein, was 
detected. 
Two other factors which are required for step 2 of the splicing reaction 
have been identified by biochemical fractionation (Cheng and Abelson, 198). 
Another approach to the identification of trans-acting factors is the 
isolation of extragenic suppressors of already existing mutations, of either 
the pre-tnRNA or of the pr4. genes. Using the first approach, prp16 a gene 
encoding a protein which suppresses the branchpoint sequence mutation 
UACUA.0 was isolated (Couto et Al, 1987) . This gene is distinct from the 
U2 snR!A gene. 
Using the second approach, cold sensitive suppressors of prp2 and prp8 
have been isolated in this laboratory (D.Jamieson, unpublished). A 
suppressor of pr92 was isolated, which itself is required for splicing 
(Last at p1, 1987) this protein might be the b.- factor (Lin et p1, 1987). 
It has also been shown that high levels of PRP3 protein suppress the pr44 
defect and that two pr44 suppressors also suppress pr43 (Last et p1, 1987). 
Given that PRP4 protein is associated with tJ4/6 snRNP, it is probable that 
PRP3 protein is also associated, either directly or indirectly, with this 
snRNP. 
Introns are more common in Schizosaccharomyces pombe than in 
cerevisipe, and the SV40 large T intron is spliced in this organism (Kaufer 
et Al, 1985), although other mammalian introns tested are not spliced. 
Three temperature sensitive pre-mRNA splicing mutant strains were recently 
isolated (Potashkin et al, 1989), but as yet no in vitro splicing system has 
been described for this organism. 
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1.7 Splicing Complexes 
1.7.1 Mammalian splicing complexes 
As might be expected from the fact that pre-mRNA splicing requires the 
binding of four snRNP particles, as well as a number of other factors, to 
the RNA, pre-mRNA splicing takes place in a large complex. This complex, 
termed the spliceosome was first observed on sucrose gradients as a 50-608 
peak of radioactivity (Frendewey and Keller, 1985; Grabowski et al, 1965). 
It was shown that this peak contained splicing intermediates, in addition 
to pre-mRNA. When pooled peak fractions were mixed with splicing extract, 
the pre-mRNA was converted to intermediates and products without the time 
lag which normally occurs before initiation of in vitro splicing (Grabowski 
et p1, 1985). Spliceosomes have now been observed and purified by non-
denaturing gel electrophoresis (Konarska and Sharp, 1986; Lamond et p1, 
1987), affinity chromatography (Grabowski and Sharp, 1986; Bindereif and 
Green, 1987) and gel filtration followed by electron microscopy (Reed et p1, 
1988). 
The initial experiments with sucrose gradients showed that in the lag 
period before splicing commences, a 35-40S complex forms, which then is 
converted to the full size 50S-60S spliceosome (Frendewey and Keller, 1985; 
Grabowski et p1, 1985). At the same early times a complex appears on 
non-denaturing gels, which is referred to as complex A; at later time 
points a more slowly migrating complex, B, forms, which contains splicing 
intermediates (Konarska and Sharp, 1986). It is assumed that complex A 
corresponds to the 35-408 peak and complex B to the 50-603 peak. 
Formation of complex A requires ATP (Konarska and Sharp, 1986) and the 
presence of a polypyrimidine tract in the substrate RNA (Frendewey and 
Keller, 1985; Bindereif and Green, 1986) . In the absence of a 5' splice 
site, a complex forms which has the same apparent sedimentation coefficient 
as the 35-403 complex on sucrose gradients (Frendewey and Keller, 1985; 
Konarska and Sharp, 1986), but under appropriate conditions this complex 
can be distinguished from the authentic complex A on non-denaturing gels 
(Zillmann et p1, 1988). Initially, it was not possible to detect Ui snRNP 
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In spliceosomes (Konarska and Sharp, 198; Lamond et p1, 1987; Grabowski 
and Sharp, 1986), which was unexpected, given its established role in 5' 
splice site binding, and the fact that anti-TJ1-RNP antibodies co-precipitate 
splicing intermediates (Grabowski et p1, 1985). This was later shown to 
be due to the treatment of splicing reactions with heparin and high salt, 
In order to remove non-specific RA binding proteins from the pre-mRNA by 
competition. Under less stringent conditions it was possible to detect Ui 
in spllceosomes (Bindereif and Green, 1987; Reed et al, 1988; Zillmann et p1, 
1988), 
Analysis of the kinetics of snRNP binding suggests that Ui snRNP binds 
to the substrate first, followed by U2 snRNP (Bindereif and Green, 1987). 
Several pieces of data suggest that the Initial binding of Ui snRNP is not 
to the 5' splice site, but requires the presence of 3' splice site sequences. 
Thus, Ui snRNP is required for formation of the A-like complex on 
substrates lacking a 5' splice site (Zillmann et p1, 1987). Furthermore, 
cleavage of the 5' end of Ui RNA with oligonucleot ides plus RN'ase H 
inhibits, but does not abolish co-precipitation of substrate RNA with anti-
Ui-RNP antibodies, and this binding depends on the presence of 3 splice 
sequences, but not on 5' splice site sequences (Zillmann et p1, 1987). As 
mentione din section 1.6.1, in the absence of a specific factor Ui snRNP 
binds to the pre-mRNA, but does not protect the 5' splice site (Zapp and 
Berget, 1989). However, immunodep let ion or oligonucleotide-d irected 
cleavage of Ui snRNP inhibits the binding of the other snRNPs, suggesting a 
'hierarchic' role of Ui snRNP in splicing complex assembly (Zillmann et al, 
1987), 
Cleavage of the 5' end of U2 RNA inhibits formation of complex A 
(Zillmann et p1, 1988; Frendewey et p1, 1987; Chabot and Steitz, 1987a), 
while cleavage of the U2 RNA sequence which is capable of base pairing with 
the branchpoint sequence, did not inhibit complex A formation (Zlllmann at 
1, 1988). Another study showed that branchpoint mutations which decrease 
the degree of complementarity to U2 RNA did not inhibit spliceosome 
formation (Reed and Manlatis, 1988). These results suggest that although 
U2 snRNP protects the branchpoint region from digestion with Ti RNase, at 
early stages in complex assembly, it is not base paired to this sequence. 
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However, other data (Lamond et al, 1989) have suggested that 112 snRNP is 
base paired to the branchpoint region at early stages of spliceosome 
assembly. At later stages it is clear that base pairing between 112 RNA and 
branchpoint sequences is important (see section 1.5.3.1). The association 
of U2 snRNP with the RNA requires ATP and 3' splice site sequences, which 
are bound by the 112 snRNP activating factor (U2AF, section 1.6.1). 
In the transition to complex B, the 114/6 and US snRNPs bind 
simultaneously (Konarska and Sharp, 1986). The formation of an ATP-
dependent complex between US and 114/6 snRNPs, prior to incorporation into 
spliceosomes has been detected (Konarska and Sharp, 1987). Under 
conditions in which complex B could be resolved into two complexes, U4 RNA 
was found to be absent from the more slowly migrating complex, which 
contained the splicing intermediates (Lamond et p1, 1988). However, it is 
possible that this result Is due to Instability of the Interaction of 114 
snRNP with the spliceosome under gel electrophoresis conditions. It has 
recently been demonstrated, using an ollgonucleotide complementary to 114 
that It is possible to detect 134 snRNP in complexes containing the lariat 
intron product (Blencowe et p1, 1989), suggesting that 114 snRNP is present 
in spliceosomal complexes throughout the reaction. There must, however, be 
a weakening of the interactions between U4 snRNP and the spllceosome, 
immediately prior to formation of the active spliceosome. 
In the 50-60S spliceosome the size of the 5' splice site fragments 
protected by Ui snRNP increases (Chabot and Steitz, 1987b). Following 
step 1 of the reaction, the U2 snRNP appears to move slightly downstream 
(Kramer, 1987), while fragments of exon 1 become protected from RNase Ti 
digestion by Ui snRNP (Chabot and Steitz, 1987b). In this study, 
protection of both 5' splice site and branchpoint fragments by both Ui 
snRNP and 1J2 snRNP was observed, Indicating that some interactions between 
these snRNPs must occur. 
When the splicing reaction is completed, spliceosomes dissociate. 	The 
lariat Intron product is released in a complex with at least the U2, 5 and 
6 snRNPs (Konarska and Sharp, 1987), while mRIIA Is found in complexes 
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similar to those which form on pre-mRNAs prior to assembly into 
spi iceosomes. 
1.7.2 Yeast splicing complexes 
Yeast spliceosonies were initially observed as 40S peaks on glycerol 
gradients (Brody and Abelson, 1985). As in the mammalian case, they 
contained splicing intermediates and required ATP for their formation, 
In general, mutations which block step 1 of the yeast splicing reaction 
strongly inhibit spliceosome formation. A study of chemical modification 
of pre-niRNAs revealed the dependence of different steps of spliceosome 
assembly, and of the splicing reaction, upon different nucleotides, 
(including those immediately adjacent to the consensus sequences) (Rymond 
and Rosbash, 1988) 
The first event detected in yeast spliceosome assembly is the binding of 
Ui snRNP to form a complex which is 'committed' to splicing (Seraphin and 
Rosbash, 1989). 	Efficient formation of this complex requires both an 
intact 5' splice site and branchpolnt sequence. 	Cleavage of Ui RNA 
inhibits association of other snRNPs with the pre-inRNA (Ruby and Abelson, 
1988). The second complex to form contains Ui and U2 snRNPs and has 
been referred to as complex B (Cheng and Abelson, 1987), or complex III 
(Pikielny et p1, 1986). As noted in section 1,5,32., the 5' terminal region 
of Ui RNA interacts with the 5' splice site through Watson-Crick base 
pairing in spliceosomes (Seraphin et p1, 1988; Siliciano and Guthrie, 1988). 
The binding of U2 snRNP to the pre-mRNA requires the presence of tJl snRNP 
at the 5' splice site, but may also depend to some degree on the 5' splice 
site sequences themselves (Ruby and Abelson, 1988). It has been shown 
that U2 RNA is base paired to the UACUAAC sequence (Parker et p1, 1987), in 
spliceosomes. 
Following the formation of complex B (III) there exists a difference 
between the observed patterns of spliceosome formation. Cheng and Abelson 
(1987) observed three further, more slowly migrating complexes, which 
appeared in the order A2-1, Al, A2-2. A2-1 and A2-2 co-migrate in the gel 
system used by these investigators while Al migrates more slowly than 
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these two and appears only transiently. 	Only A2-2 contained splicing 
intermediates, and was therefore defined as the active spliceosome. 
Pikielny et al (1986) observed two complexes, I and II (numbered In order 
of increasing electrophoretic mobility), migrating more slowly than complex 
III . 	The order of appearance of complexes was III, I, II, with II being 
the active spliceosome. 	Investigation of the snRNP composition of these 
complexes revealed that complex A2-1 contained 1J2, 154, 155 and 156 RNAs (Ui 
was not detected in these experiments, cf section 1.7.1), while Al and A2-2 
contained only U2, U5 and U6 RNAs. 	Complex I contained U2, 154, 155 and U6 
RNAs while complex II contained tJ2, US and 156. 	Whatever the relationship 
between complex A2-1 , Al and I, as in mammalian systems, 154 RNA appears 
to dissociate from spliceosomal complexes immediately prior to formation of 
the active spliceosome. (It should be noted, however, that this may only 
reflect a change in 154 association with spliceosomes, which makes It 
unstable to gel electrophoresis conditions, cf. section 1.7.1). 
The 3' splice site Is not required for step 1 of the reaction, and as 
expected, active spliceosomes form upon substates lacking a 3' splice site 
(Rymond et p1, 1987). However, for the RP51A gene, approximately 29 
nucleotides downstream of the TJACUAAC sequences are necessary for step 1, 
and pre-mRNAs with less than this length of RNA sequence 3' to the UACUAAC 
sequence do not undergo the transition from complex I to complex II. It 
is interesting to note that complexes formed on such substrates do contain 
155 RNA despite the fact that, in mammalian systems, US snRNP is thought to 
be associated with the 3' splice site region (section 1,5.2), 
During the transition from complex III to complexes I and II, the degree 
of protection of the 5' splice site from oligonucleotide- directed RNaseH 
cleavage increases (Rymond and Rosbash, 1986). 	This finding is similar to 
results in mammalian systems (Chabot and Steitz, 1987b). 	In yeast 
spliceosomes, only the 5' splice site and UACUAAC sequence are protected 
from oligonucleotide-directed RNaseH cleavage. 
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In mammalian systems, pre-mRNA5 generally contain sequences which have 
a good match to the splice site consensus sequences, but which are not used 
in splicing. Studies in which competition between 5' splice sites was 
examined (Eperon et al 1986, Nelson and Green 1988) indicated that the 
consensus 5' splice site is the most effective competitor, and in general, 
the 5' splice which Is used has greater complementarity to Ui RNA than any 
possible cryptic splice site. It was also shown that increasing the 
complementarity of the SV40 large T 5 splice site to Ui RNA improved its 
efficiency of usage (Yuan et al 1987). However Nelson and Green (1988), 
demonstrated that the sequence context of splice sites also has complex 
effects on efficiency of 5' splice site usage. Their data suggested that 
regions in the proximity of the authentic 5' splice site are more 
'permissive' for splicing than other regions of the transcript. Reed and 
Maniatis (1986) and Cooper and Ordahi (1989) also found effects of exon 
sequences on 5' splice site usage. Where a number of 5' splice sites 
compete for a single 3' splice site, the most upstream site is often 
preferred (Kedes and Steitz, 1986). 
Although earlier studies indicated that mutation of branchpoint 
sequences had little effect on splicing efficiency, recent Investigations, 
using cis-competition assays have revealed that splicing efficiency can be 
affected by the match of the sequence around the branchpoint to the 
consensus, (and thereby, complementarity to U2 snRNP; Zhuang et al 1989; 
Reed and Maniatls, 1988). In the case of the 5V40 Tft intron, branch site 
mutations can effect the relative efficiency of usage of the two 5' splice 
sites in vivo (Noble et p1, 1988). 
As these results make clear, no simple scanning mechanism (5' to 3' or 
3' to 5') can account for the choice of pairs of splice sites, although some 
element of scanning cannot be excluded. The mechanism may differ for 
different pre-mRNAs, and probably depends upon non-conserved sequence 
elements, in addition to high order pre-mRNA structure effects. 
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An increasing number of cases are being discovered of alternative 
patterns of splicing of a single primary transcript (reviewed in Breitbart 
et p1, 1987). This phenomenon underlies the production of different 
isoforms of many proteins, often in a cell type or developmental stage-
specific pattern. There are several types of alternative splicing: (i) 
omission or retention of a single exon; (Ii) the retention or omission of a 
single Intron; (ill) mutually exclusive splicing of two exons; (iv) use of 
alternative 5' splice sites with a single 3' splice site, or vice versa. 
An example of the first of these types is the rat fast skeletal troponin 
T gene, in which any of exons 4 to 8 may be retained or omitted from the 
mRNA, Independently of each other, to give 32 possible Isoforms (Breitbart 
et p1, 1985). This process Is regulated In a tissue and developmental 
stage specific manner. 
Two examples of retention/omission of an intron occur in D.melanogaster: 
the auto regulated splicing of the su(w) pre-mRNA (Zachar et al 1987; Chou 
et p1, 1987), and the retention of the third Intron in the P-element primary 
transcript in somatic cells, but not in the germ line (Laski et al, 1986). 
In the former case, as might be expected, the retained introns contain 
translation termination codons, resulting in the production of non-
functional mRNAs. In the rat -fibrinogen gene, on the other hand, the 
open reading frame is maintained throughout the retained intron (Crabtree 
and Kant, 1982; Chung and Davie, 1984). 
The mutually exclusive Inclusion of two exons in an niRNA has been 
studied in the rat a-tropomyosin gene (Wieczorek et al, 1988) In which the 
choice between three pairs of exons determines whether the smooth, striated 
muscle, or noninuecle Isoforms of the protein Is produced. Where mutually 
exclusive exons are present In a pre-mRNA, the intron between them is a 
'pseudo intron', since It is never spliced. An example is the intron 
between a-tropomyosin exons three and four, which Is not spliced due to the 
short distance between the 5' splice site and branchpoint sequence (Smith 
et p1, 1989), 
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The earliest discovered examples of alternative splicing, the T/t splice 
in SV40, involves use of alternative 5' splice sites and a common 3' splice 
site (Reddy et al, 1978). 
One of the best understood example of regulated splicing is the cascade 
of alternative splicing events in D. melanogaster somatic sex determination 
(Baker, 1989). The initial signal, the ratio of X chromosomes to 
autosomes, gives rise to the activity of the 5zi gene in females only, due 
to autoregulation of axi splicing (ommission of an exon which contains a 
stop codon) by the sxl protein. In females, the sxl protein also partially 
blocks the (default) male-specific splicing of the tta pre-mRNA, resulting 
in production of active tx& mRNA, which also lacks an exon containing a 
stop codon. In females, the tra protein, in concert with the tra-2 
protein, directs female specific splicing (inclusion of exon 4, rather than 
exons 5 and 6) of the dax pre-mRNA. The male and female specific forms 
of the dsx protein control expression of genes which cause male or female 
somatic differentiation. 
In yeast, the only case of regulated splicing so far discovered is the 
auto-inhibition of splicing of the RPL32 gene (Dabeva et p1, 1986). Other 
ribosomal protein genes which were tested do not exhibit a similar auto-
regulation. 
Clues to the mechanism of regulation of alternative splicing by the sxl, 
tra and tra-2 proteins are the presence in all these proteins of the 80 
amino acid consensus sequence common to a number of RNA binding proteins 
(Dreyfuss, 1989), In addition, tra and tra-2, possess an rk iy,%Iand serine 
rich domain, also found in Ui 70K protein and in the su(w) protein, which 
also regulates the splicing of its own pre-mRNA (Bandziulis et p1, 1989). 
Other candidate trans-acting factors, which may be responsible for 
tissue and developmental stage specific regulation of splicing, include the 
different forms of Ui and U4 RNA (Forbes et al, 1984; Lund et al, 1985; 
Lund et p1; 1987, Lund and Dahlberg, 1987; Korf et p1, 1988). Expression 
of in different tissues of N , a protein related to the B and B' 5nRNP 
proteins, appears to be correlated with the ability of cells of that tissue 
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to perform the splice which produces CGRP (calcitonin-gene related peptide) 
instead of calcitonin (MacAllister et al, 1988, 1989). As yet, in vitro 
systems which reproduce the patterns of alternative splicing found in viva 
have not been described. 
1.9 Trans-splicin g  
All the results discussed above concern splicing of exans which are 
encoded within a single pre-mRNA. It has recently been discovered, 
however, that splicing of exons on different pre-mRNAs can also occur. 
The initial finding was that all pre-mRNAs in Trypanosoma brucel contained 
a common 35 nucleotide leader sequence at their 5' ends (van der Ploeg, 
1986). 	This segment of RNA derives from a 137 nucleotide RNA, which is 
transcribed from multiple clusters of repeated DNA sequences. 	The 35 
nucleotide leader is found at the 5' end of the 137 nucleotide RNA, and is 
followed by a consensus 5' splice site, while the bodies of T. brucel mRNAs 
have a 3' splice site consensus sequence near their 5' ends. It was shown 
thatthe 5' leader Is joined to the body of the pre-mRNA by a process of 
trans-splicing (Murphy et al, 1986; Sutton and Boothroyd, 1986). Trans-
splicing has also been found in Caenorhabditls elegans (Blumenthal and 
Thomas, 1988) and In other nematodes (Bektesh et p1, 1988). 
The 5' and 3' splice sites sequences In trans-splicing conform to the 
consensus sequences, and branched intermediates have been detected (Murphy 
et al 1986; Sutton and Boothroyd, 1986). The branchpoint residues are 
adenosines, located 44 and 56 nucleotides upstream from the 3' splice site 
in the T. brucei a- and J3-tubulin genes, but the branchpoint sequences have 
no homology to the mammalian branchpoint consensus sequence (Patzelt et al 
1989). However, there is a sequence In T. brucei U2 RNA, from nucleotides 
48-58, which can potentially base pair with all the observed branchpoint 
sequences. 
It appears that the 137 nucleotide RNA performs the function of Ui 
snRNP in trans-splicing: it has an mG cap structure, a 'domain A' Sm-
binding site and Is Sm-precipitable (Thomas et p1, 1988; van Doren and 
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Hirsch, 1988; Bruzik At al, 1988). 	In fact, T. brucei has no detectable Ui 
homologue (Mottram et p1, 1988). 
There is no homology between the 137 nucleotide RNA and the bodies of 
T. brucel mRNAs, so it is likely that the two halves of the trans-
spliceosome form independently and then recognise each other. Such a 
mechanism has been observed in mammalian in vitro splicing extracts 
(Konarska et al 1985b). 
The main question that arises with reference to the evolution of RNA 
splicing is that of the antiquity of introns. With a number of exceptions, 
prokaryotic genes do not contain introns, whereas they are widespread in 
eukaryotic genes (S. cerevisiae being an intermediate case). It is 
possible to envisage either that introns pre-date the divergence of 
prokaryotes and eukaryotes and have been subsequently eliminated from the 
former (Doolittle, 1978; Gilbert, 1978, 1985), or that they were absent in 
ancestral genes, and have become inserted into eukaryotic genes at a later 
stage (Orgel and Crick, 1980). 
A number of observations favour the former hypothesis. 	Firstly, the 
existence of introns in some prokaryotic genes (Schmidt, 1985) and in 
chioroplasts (Shih et al, 1988) suggest that these introns were present in 
the genes of the common ancestor of prokaryotes and eukaryotes. Secondly, 
the structure of many intron-containing genes suggests that during 
evolution they have lost introns by precise excision (Perler et p1, 1980; 
Shah et p1, 1982; Cooper and Cram, 1982). An extension of this hypothesis 
is the idea of 'genes-in-pieces', i.e. that exons code for domains, or 
modules (Go, 1981; 1983) of protein structure, which can be assembled in 
different combinations to form different proteins, The separation of 
exons by introns would allow recombination within the introns, resulting in 
'exon shuffling', which would generate evolutionary diversity more rapidly 
than point mutation within exons. The structure of many genes, in 
particular the immunoglobulin/histocomp-atability antigen/T cell receptor 
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family (Honjo, 1963) supports the idea that exons correspond to protein 
domains. The correspondence of exons with protein structure modules Is 
evident In the glycolytic enzymes pyruvate kinase (Lonberg and Gilbert, 
1985) and triosephosphate isomerase (Straus and Gilbert, 1986). Analysis 
of the structure of the LDL receptor gene (Sudhof et al, 1985a, b) suggests 
strongly that it has arisen by processes of intron loss and exori shuffling. 
It is, however, also clear that certain Introns In eukaryotes and 
prokaryotes are mobile, and capable of inserting by DNA recombination Into 
genes which contain the correct target sequence (Lambowltz, 1989). It 
therefore appears that processes of both intron insertion and elimination 
have contributed to the pattern of Introns In present day genes. 
In prokaryotes the vast majority of genes do not contain introns, The 
hypothesis of Doolittle (1978) suggests that in these organisms there has 
been a higher selective pressure In favour of Intron loss, due to the need 
to minimize genome size, in order to allow rapid DNA replication. 
One problem with the idea of Introns In ancestral genes is the necessity 
for a machinery for accurate and efficient RNA splicing. However, the 
discovery that some group I and group II introns can catalyse their own 
excision in vitro (Cech and Bass, 1986), in the absence of proteins, has 
provided a possible resolution to this problem. 
The mechanism of the splicing reaction for group I, II and pre-mRNA 
Introns Is similar, having two steps. In the first step, the 5' splice 
site is cleaved by a nucleophilic attack, of a free guanosine nucleotide for 
group I introns, or of a 2' hydroxyl group of a residue near the 3' end of 
the intron, for group II and pre-mRNA Introns. In the second step of the 
reactions, the 3' hydroxyl group of exon 1 makes a nucleophllic attack on 
the phosphodiester bond at the 3' splice site, producing spliced RNA and 
the excised intron. These similarities in mechanism suggest that the 
three different groups of Introns have a common ancestor, which was 
probably a self-splicing intron. Thus, the RNA molecules in the common 
ancestor may have played both informational and enzymatic roles (Gilbert, 
1986): the Tetrahymena thermophila rRNA group I intron is also an ollgo-C 
polymerase (Zaug and Cech, 1986), suggesting that RNA could catalyse its 
own replication (Cech, 1987). 	At later stages of evolution, most of the 
catalytic functions of RNA have been taken over by proteins, whereas the 
long term information storage role has been taken over by D!A. In the 
case of group I and II RNA splicing, the RNA catalytic role has been 
retained, although, in vivo, proteins are required to stabilize the conserved 
RNA secondary structures in the Intron, which are necessary for splicing. 
This suggests that the catalytic molecules in nuclear pre-mRNA splicing may 
be the U snRNAs, which may have evolved to replace the conserved secondary 
structure elements of group I and II introns, It is, however, possible 
that the catalytic molecule in pre-mRNA splicing is a protein. 
1.11 This Thesis 
In this thesis I present the following: 
production and characterization of antibodies to 3 -galactosidase-PRP2 
fusion proteins; 
construction of systems for over-expression of PRP2 protein, in s.,. 
cerevisiae, E. coli and in vitro; 
development of an assay system for PRP2 protein activity, based on a 
system described by (Lustig et al, 1986); 
partial purification of PRP2 protein; 
analysis of Interactions between PRP2 proteins and yeast spliceosomes, 
including (a) demonstration of direct association of PR?2 protein with 
spliceosomes, and (b) failure of heat-inactivated prp2 protein to associate 
with spliceosomes, (c) analysis ofinteraction of PRP2 protein with specific 
spliceosoinal complexes and (d) mapping of the PRP2 protein binding site 
relative to pre-mRNA, in spliceosomes. 
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2.1 Materials 
Restriction enzymes and other DNA modifying enzymes: Amersharn Inter-
national, Bethesda Research Laboratories, Boehringer Mannheim, New England 
Biolabs and Pharmacia. 
Radiochemicals: Amershani International, New England Nuclear. 
Deoxyr ibonuc leot ides and dideoxyribonuc leotides: Pharmacia. 
Ribonucleotides: Sigma and Pharmacia. 
Acrylamide and NN'-methylene bisacrylamide: BDH Chemicals, "Electran" grade. 
Agarose, Ultra-Pure Agarose and Low Melting-Point Agarose: Sea-Kern and BRL. 
Media reagents: Difco Labs. 
Standard laboratory reagents (analytical grade, or better): BDH, Fisons, 
Sigma, May and Baker, Koch-Light, Bio-Rad and Serva. 
2.1.2 Growth media 
All quantities listed are for 1 litre, unless otherwise stated. 
Solutions were autoclaved (see section 2.2.2) and stored at room 
temperature. Antibiotic and amino acid stock solutions were added to 
media immediately before use. 
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2.1.2.1 E. coil media 
Luria broth (LB): 	log Bacto-Tryptone 
5g yeast extract , lOg NaCl, adjusted to 
pH7.2 with NaOH. 
Luria-agar (LB-agar): 	LB plus 15g agar. 
LB/ampicillin: 	 LB plus 0.1mg/mi ampicillin. 
M9+CA medium: 	 6g Na2HPOH20, 3g KH2PO, 0.5g NaCl, ig IiH4C1, 
5g casamino acids , 2g glucose, 10mg 
vitamin Bi, 0.25g Mg2SOd.7H20, 22mg CaC12.7H20. 
M9+CA+W medium: 	 M9+CA medium plus 20mg tryptophan. 
Ampicillin stock: 	O.lg/mi, stored at -20C, 
2.1.2.2 Yeast media 
YPDA: 	 log Bacto-Tryptone, 20g Bacto-Peptone, 
20g glucose, 20mg adenine sulphate. 
YPDA-agar: 	 YPDA plus 20g agar 
YPDAS: 	 YPDA plus 218g sorbitol. 
YIIX: 	 6.7g yeast nitrogen base (without amino acids), 
20g glucose (supplemented with amino 
acids to 40jtg/ml as required). 
Y]O(-agar: Y1O( plus 20g agar 
YKMS: YMX plus 218g sorbitol 
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ThMS bottom .gar: 
YKMS top agar: 
Amino acid stocks: 
Tjracil: 
Y?V3 plus 20g Eact.o-Agar. 
Y1O!S plus 30g Bacto-Agar. 
4mg/nil in dH20; filter sterilised and stored 
at 4C. 
2mg/nil in dH20; filter sterilised and stored 
at 4C. 
2.1.3 Bacterial strains 
All strains were derivatives of E. coil K-12. 
TABLE 2.1 Bacterial Strains 
Strain 	Genotype 






DH5 	 F, 
recAl, endAl 
gyrA96, thil, hsdR17 










tIiL supE, 	 et al 
F', (lacI, lacZ4M15, 	 (1977) 
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2.1.4 Yeast strains 
TABLE 2.2 Yeast Strains 
Strain 	Genotype 	 Source 




KY117 	 , his3-t200, lys2-801', 	K. StruM (Harvard) 
ade2-1O1, trp1-1, ura3-52, 
KY118 	 QL, his3-e200, 1ys2_801m, 	K. StruM (Harvard) 
ade2-1O1, trpl-M, ura3-52, 
QAL 
DBY747 	 , hi --3- A l 	 D. Botstein (MIT) 
1eu2-3 leu2-112 
trp1-289 ura3-52, g1 
DJY40 	 , his7, 	 D. Jamieson 
ura3, lys2, 1eu2 	 (this lab) 
JBY27 	 , prp2-1, leu2-3 	 J.Beggs 
leu2-112, his3-A200, trpl, 	(this lab) 
ura3, 1ys2_801m, 
adel/2, gL 
DJY39 	 oL, prp2-4, ura3-52 	 D.Jamieson 
his3, h1s7, leu2 (this lab) 
tyrl, adel/2, &&I- 
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TABLE 2.2 (cont.) Yeast train 
Strain 	Genotype 	 Source 
DJY85 	 &&, prp2-1/prp2--1, 	 D. Jamieson 





215 P1smld vectors and constructs 
Plasmid Description Source Reference 
pUR278 E. 	coil piasmids; D. 	Lane Ruther 
piJR288 multiple cloning sites (ICRF, 	Glare and 
pUR289 in 3' 	end of iacZ gene, Hail) Muller- 
pUR290 For synthesis of Hill 
pUR291 IPTG-inducible 	3-gaiact-- (1983) 
pUR292 osidase fusion proteins, 
in strain BME71-18. 
pATH-i E. 	coil plasmid; D. 	Finnegan Dieckmann 
pATH-2 multiple cloning sites in (Edinburgh) and 
pATH-3 3' end of trpE Tzagaloff 
gene, aW.  (1985) 
For synthesis of IAA- 
inducible trpE fusion 
proteins. 
pDR540 E. 	coil plasmid; Pharmacia 
tac promoter followed by 
iI site, aW.  
For IPTG-inducible 
expression of proteins. 
pSPT18 E. 	coli plasmid; Pharniacia 
multiple cloning site 
flanked by bacteriophage T7, 
SF6 promoters, aW. 	For 
in vitro RNA synthesis. 
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Table 2.3 (continued) 
Plasmid 	Description 	 Source 	 Reference 
pFP2. 1 	 pUR290 with 460bp E=U 	M. Lee 	 Lee 
fragment of PRP2 gene. (this lab) 	et p1, 
1986 
pJDB207 	Yeast E,coli shuttle 	J. Beggs 	Beggs 
plasmid; high copy (this lab.) (1981) 
number, LEU2; 
pBM125 	 Yeast E.coll shuttle 	M. Johnston, 
plasmid, low copy number, 	R. Davis 
URA3, GIIV. 	 (Stanford) 
Contains yeast GALl VAS 
and promoter. &W 
pKV49 	 Yeast E.coll shuttle 	D . Cousins 
plasmid; high copy number, 	(Oxford) 
PGK promoter 3' to GALl UAS, 
LEU2. B&II cloning 
site at 3' end of 
promoter. 
pY2000 	 YEp24 with 7.7kb Sa3A 	M. Lee 
insert containing 	 (this lab) 
PRP2 gene. 
pY2519+ 	YCp50 with PRP2 	 X. Lee 
gene and HIS3 gene (this lab) 
inserted at BAzHI site, 
3' to PRP2. 
Lee et al 
(1984) 
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Table 2.3 (continued) 
Plasmid Description Source Reference 
pY2076 pJDB207 with 3.2kb 	RI- M. 	Lee Lee et al 
AmRI insert containing (this lab) (1984) 
PRP2 gene. 
pSPRP51ApA pSP62 with yeast RP51A C. 	Pikielny Pikielny 
gene (with region (Brandeis) et al 
encoding polyA tail), (1986) 
downstream of SF6 promoter. 
pSPRF51A62 Derivative of pSPRP51ApA, C. 	Pikielny Pikielny 
with 263nt deletion from (Brandeis) et al 
RP51A intron. (1986) 
pSPRP51AA3B Derivative of pSPRP51ApA C. 	Pikielny Pikielny 
37nt deletion from RP51A in (Brandeis) et al 
intron, covering TACTAAC. (1986) 
sequence. 
pSPTactfalu pSPT19 carrying 544 bp Alul M. 	Lossky- Jackson 
fragment of ACT1 Elias et al 
gene. (this lab) (1988) 
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2.1.6.1 Antisera 
Antibodies (purified by ammonium sulphate precipitation) against the m3G 
cap structure were a gift from R. Luhrmann (Marburg). 
Human Sm antiserum (Kung) was provided by I. Mattaj (Heidelberg). 
Rabbit anti-PRP8 antiserum (aFF8.4, rabbit 58) was provided by G. Anderson 
(this lab). 
Wre 
Yeast RP51A 5' - TAAAAAGTTTGTAAATGCAA - 3' 
Yeast RP51A/C : 	5' 	- AAATGACGAAAAGCAATACA - 3' 
Yeast RP51A : 5' 	- AATATCGTCATATGTTTTCT - 3' 
Yeast Ui 5' - CTTAAGGTAAGTAT - 3' 
Yeast U2 5' - CTACACTTGATCTAAGCAAAAGGC - 3' 
Yeast tJ4 5' - TTTCAACCACGAAA - 3' 
Yeast U5 5' - AATATGGCAAGCCC - 3' 
Yeast U6 5' - TC(T/A)TCTCTGTATTG - 3' 
DNA ol igonuc leot ides were custom synthesised by the OSWEL DNA service 
(Dept. of Chemistry, Edinburgh University), except the oligonucleotide 
complementary to yeast U6 RNA which was a gift from D. Brow (UCSF), and 
that complementary to yeast U2 RNA, which was a gift from D.Field (Toronto) 
2.1.6.3 Others 
A11.III was a gift from N. Brown (Birmingham). 	Control RNA for in vitro 
translation (a mouse DHFR transcript made by in vitro transcription) was 
kindly provided by G. Reid. 
39 
22 General Methods 
Unless stated otherwise, all procedures involving liquid volumes of less 
than 1.5ml were carried out in sterile, capped, 1.5ml polypropylene tubes. 
Larger scale procedures were performed in lOmi or 50ml sterile Falcon 
tubes, In washed, non-sterile, 15ml or 30m1 glass Corex tubes and in other 
unsterilized laboratory glassware (conical flasks, beakers, etc.). Liquids 
were dispensed using Gilson Pipetman P-20, P-200 and P-1000 automatic 
pipettors and sterile plastic tips for volumes less than lml, and with 
sterile glass pipettes for volumes greater than lml. All procedures were 
performed at room temperatures, unless otherwise stated. 
Centrifugation of volumes less than 1 .5m1 was performed in an Eppendorf 
microcentrifuge at 13,000 rpm (13,800g). Volumes of up to 50m1 were 
centrifuged in an lED Centra-4X bench top centrifuge with a swing-out 
rotor, an MSE Xinor'S' bench top centrifuge with a fixed angle rotor, or a 
Sorvall RC-5B centrifuge with HB-4 swing out rotor or S334 fixed angle 
rotor. 	Larger volumes were centrifuged in a Sorvall RC-5B centrifuge, 
using GSA and GS-3 rotors. 	Ultracentrifugation was performed In Sorvall 
OTD50B or OTD55B ultracentrifuges, using T150 rotors. 
All solutions were prepared using distilled or double-distilled water. 
Solutions were stored at room temperature unless otherwise stated. 
Enzymes, nucleotide solutions and reaction buffers were stored at -20'C or 
-70C. 
Stock solutions were sterilized by autoclaving at 15psi, at 120C for 20 
minutes, or by filtration through Acrodisc filters (0.45m pore size; Gelman 
Sciences) in the case of solutions which were unstable on heating. 
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2.2,4 DeionizatIon of solutions 
Solutions were deionized where necessary by stirring, for 30 minutes at 
room temperature with approximately 0.1 volume of mixed-bed ion-exchange 
resin (20-50 mesh, Bic-Rad laboratories). The resin was removed by 
filtration through Whatman no.1 filter paper. 
"P-labelled nucleic acids, in gels or on filters, were detected by 
exposure of X-ray film (Du Pont Cronex, or Amersham Hyperfilm-XP) in 
light-proof, lead-shielded cassettes. 	The method of exposure depended 
upon the sensitivity desired. 	In order of increasing sensitivity, these 
were: (i) at room temperature; (ii) at -70C with a calcium-tungstate 
intensifying screen; (iii) at -70C with a pre-flashed film and calcium-
tungetate intensifying screen (Laskey, 1984). 
S-labelled proteins, in a gel soaked in Amplify (Amersham) were 
detected by exposure of pre-flashed X-ray film (Du Pont Cronex) at -70C. 
'2S 1-labelled proteins on filters, were detected using pre -flashed X-ray 
film (Du Pont Cronex) at -70C. 
2.2.6 Dialysis 
Dialysis tubing (Nedicell International Ltd.) was prepared by boiling for 
10 minutes In a large volume of 2% (w/v) sodium bicarbonate, 1mM EDTA, 
followed by rinsing thoroughly with dH 20, The tubing was stored at 4C in 
50% (vAr) ethanol and was rinsed with dH20 before use. The tubing was 
sealed with plastic clips and dialysis carried out at 4C with stirring and 
several changes of buffer. 
2.2.6 Buffers 
TE buffer: 	10mM Trls-HC1 (pH7.5), 1mM EDTA; autoclaved, 
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10 x TBE buffer; 	0,9M Tris-borate (pH8.3), 20mM EDTA; unsterilised. 
10 x TAE: 	 0.4M Tris-acetate (pH7.5), 20mM EDTA; unsterilised. 
20 x SSC: 	 3M NaCl, 0.3M N&citrate, adjusted to pH7.0 with 
NaOH; unsterilized. 
10 C PBS: 	 15mM KHZPOd, 1,5M NaCl, 
pH7.2; autoclaved. 
10 x TBS: 	 0.5M Tris-HC1, 1.5X NaCl, pH7.5; autoclaved. 
All procedures were performed under conditions of "Good Microbiological 
Practice" as recommended by the U.K. Genetic Manipulation Advisory Group. 
E.coli cells were grown at 37*C, on inverted agar plates or with 
continuous shaking for liquid cultures. 	The growth of liquid cultures was 
monitored by measurement of O.D.orm. Strains of E.coli which did not 
carry plasmids were grown on LB-agar plates or In liquid LB. 	Strains 
carrying plasmids which conferred ampicillin resistance were grown on 
LB/ampicillin agar plates or in liquid LB/ampicillin. Agar plates and 
starter cultures were stored at 4C and were viable for up to one month. 
E,coli cells were stored in the long term in 15% (v/v) glycerol, 85% (v/v) 
LB at -70C. 
Yeast cells were propagated as described in Sherman et al (1983). Wild 
type strains were grown at 30C, and rna2-1 and rna2-4 strains at 23C, on 
inverted agar plates or with continuous shaking in liquid culture. The 
growth of liquid cultures was monitored by measurement of 
OD600-,. 
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Strains not carrying plasmids were grown on YPDA-agar plates and in YPDA 
liquid medium. Strains transformed with plasmids were grown on YXM agar 
and in YMN liquid culture, supplemented with the appropriate amino acids 
and uracil 1 in order to select for the presence of the plasmid. Permanent 
yeast stocks were stored at -70C in 15% (vfv) glycerol, 85% (v/v) YPDA. 
Plasmid DNA was stored at 4C in dH20 or TE . 	DNA oligonucleotides 
and RNA (tRNA, total yeast RNA, in vitro synthesised RNA) were stored at - 
20 C. 
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Accurate estimation of concentrations of nucleic acids in solution were 
obtained by measuring OD2so,m using a Perkin-Elmer 320 spectrophotometer. 
Rough estimates of nucleic acid concentration were obtained by 
electrophoresing samples on an ethidium bromide-containing agarose gel 
(section 2.4,6) and comparing the fluorescence of the sample, when 
Illuminated by UV light, with a concentration standard. 
Nucleic acids were precipitated from aqueous solutions by addition of 
sodium acetate, pl'I5.2, to a final concentration of 300mM, followed by 2-5ig 
of carrier tRNA where necessary, and 2.5 volumes of ice cold ethanol, 
Precipitates were allowed to form for at least ten minutes on Ice (in 1.5inl 
tubes) or for at least one hour at -20C (for larger volumes). The 
precipitated nucleic acid was collected by centrifugation at 13,800 g at 4C 
for fifteen minutes in a mlcrocentrifuge (volumes less than 1.5ml) or at 
16,000g at 4C for thirty minutes in a Sorvall HB-4 rotor. Pellets were 
washed by resuspension in 70% ethanol and were recovered by centrifugation 
as above. The pellet was dried by allowing ethanol to drain from the 
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inverted tube, followed by brief incubation in a 65' C incubator, or under 
vacuum. 
Aqueous nucleic acid solutions were deproteinized by addition of an 
equal volume of a 25:24:1 mixture of phenol, chloroform and isoamyl alcohol 
followed by vortexing. The aqueous and organic phases were separated by 
centrifugation, (in a microcentrifuge or at 3,000rpm in a bench top 
centrifuge with swing-out rotor), for one to ten minutes at room 
temperature. 	The aqueous phase was recovered and re-extracted until no 
further material was visible at the interface after centrifugation. 	If 
necessary, residual phenol and chloroform in the aqueous phase were removed 
by ethanol precipitation of the nucleic acid. 	Phenol was redistilled and 
stored under dH20 at -20C. 	Phenol used for DNA extractions was 
equilibrated with 0.51( Tris pH7.5 and then mixed with chloroform and 
isoamyl alcohol and stored under TE (section 2.2.6) at VC. Phenol-
chloroform-isoamyl alcohol for RNA extractions was equilibrated with dH20 
and stored at VC, 
DNA was incubated with a greater than 2-fold excess of restriction 
endonuclease in the buffer recommended by the manufacturer of the enzyme. 
AjjIII was Incubated with DNA in a buffer containing 50mM NaCl, 10mM MgC12, 
10mM 0-mercapto ethanol, 10mM Tris-HC1 pH7.5. 	Incubations were at 37C 
for at least one hour. 	The progress of digestion was examined by agarose 
gel 	electrophoresis 	(section 2.4.6) 	and reactions stopped by freezing or 
phenol-chloroform extraction. 
Horizontal slab gels contained 0.8-1,5% agarose in TAE (section 2.2.6) 
buffer. The agarose was dissolved by boiling, and the solution was 
allowed to cool to 50C before addition of ethidium bromide to 0.5tg/ml, 
immediately prior to pouring. Preparative gels and most analytical gels 
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were 20x20x0.7cm, while 13x9x0.4cm gels, with paper wicks were used for 
rapid screening purposes. Before loading samples, 0.2 sample volumes of 
loading buffer (50% glycerol, 0.25% bromophenol blue) was added to each 
sample. Gels were elecrophoresed at 5-15 V/cm in TAE. Preparative gels 
were shielded from light in order to prevent light-induced nicking of DNA 
in the presence of ethidium bromide, or were run without ethidium bromide, 
and stained subsequently in the dark. Nucleic acids were visualised by 
illumination from below with short wavelength (254nm) UV light. Gels were 
photographed though a red filter using Ilford HP5 5x4 inch negative or 
Polaroid 667 positive film. 
2.4.7.1 Ground glass procedure 
DNA was recovered from agarose gels by addition of sodium iodide to 
excised gel pieces, to dissolve the agarose, followed by addition of ground 
glass to precipitate DNA, using the 'GENECLEAN' kit (BlO 101 Inc), according 
to the manufacturer's instructions. 
This procedure is based on a method described in Xaniatis et al (1982). 
Following electrophoresis DNA bands were visualised by illumination with 
long wavelength UV light in order to minimise damage to the DNA in the 
presence of ethidium bromide. A trough was cut in the gel directly ahead 
of the desired band (in the direction of electrophoresis), and dialysis 
tubing inserted into the trough to form the floor and far wall to the 
trough. The gel was then replaced in the electrophoresis tank, and the 
electrophoresis buffer removed until the surface of the buffer was level 
with, but not above, the top of the gel. 	The trough was filled with TAE 
(section 2.2,6) and electrophoresis resumed for two minutes. 	The polarity 
was briefly reversed to release DNA from the dialysis tubing and the buffer 
recovered from the trough. 	The gel was then illuminated with UV light to 
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check that the band of interest had migrated into the trough. 	DNA was 
recovered from the buffer in the trough by extraction with phenol-
chloroform and precipitation with ethanol. 
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Following electrophoresis the DNA band of interest was visualised under 
UV light and excised from the gel with a scalpel. It was then inserted 
into a dialysis bag and the minimum volume of TAE necessary to cover the 
gel slice was added. 	The bag was placed in a small horizontal gel 
electrophoresis tank and submerged in TAE. 	The current was then switched 
on, and electroelution of the DNA from the gel slice allowed to continue for 
thirty minutes. 	The current polarity was then briefly reversed and the 
liquid in the bag recovered. 	Small pieces of agarose were removed by 
microcentrifugation for one minute, and DNA recovered by extraction with 
phenol-chloroform and precipitation with ethanol. 
Denaturing acrylainide gels contained 6-20% acrylamide (19:1 acrylamide: 
bis acrylamide), 8 X urea and 1xTBE (section 2.2.6), final concentrations. 
Gel stocks containing acrylamide and urea were made up at 1.lx final 
concentration and were deionized and stored at 4C. 	Gels were prepared by 
mixing 45m1 of the stock solution with 5m1 of 1OxTBE. 10% (w/v) ammonium 
persulphate (freshly prepared; 0.3m1) and TENED (30l) were added as 
polymerization catalysts. The gels were poured between two clean glass 
plates (42 x 23 cm) which were separated along the two long edges with 1cm 
wide strips of 0.4mm thick Plastikard (Slater's Piastikard) and sealed with 
PVC tape. 	Veils of width 0.5-1 cm were formed by inserting a Plastikard 
comb into the top of the gel after pouring. 	Polymerisation was allowed to 
proceed at room temperature for at least one hour, following which the gel 
was run, or stored overnight at 4C. 
To run the gel, the PVC tape sealing the bottom of the gel was removed, 
the comb withdrawn and the gel placed in a vertical gel electrophoresis 
tank which contained 1xTBE. To remove any small pieces of acrylanilde the 
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wells were flushed out with a syringe. 	The gel was pre-electrophoresed 
for 30-60 minutes at 35W. 	Prior to loading samples two volumes of gel 
loading buffer (lOX urea, 1xTBE, 0.1% (w/v), 0.1% (w/v) xylene cyanol) were 
added to each sample, which was then incubated at 65C for three minutes. 
Samples were loaded using a drawn out glass capillary. Electrophoresis 
was at 35W and was continued until the dyes had migrated the desired 
distance. 
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32P-labelled RNA was electrophoresed on 42 x 23cm or on 16 x 16cm 
denaturing polyacrylamide gels. A brief exposure of the gel, which was 
labelled with radioactive ink of the appropriate specific activity was made, 
and the band of interest excised from the X-ray film. The X-ray film was 
aligned with the gel and the band beneath the hole in the film excised, cut 
into several pieces and placed in a 1.5m1 polypropylene tube. Elution 
buffer (0.5X ammonium acetate, 1mM EDTA, 0.5% SDS; 0.3m1) was added to the 
gel pieces and the tube incubated on a rotating wheel for thirty minutes at 
37C. The gel pieces were removed by centrifugation for fifteen seconds 
in a microcentrifuge and the supernate removed and re-centrifuged for two 
minutes to remove any small pieces of polyacrylamide. RNA was recovered 
from the eluate by extraction with phenol-chloroform and precipitation with 
ethanol, without added salt. 
2.4.10 Ligation of DNA fragments 
Ligations of linearized vectors to DNA fragments with cohesive ends were 
performed with a vector: insert molar ratio of 1:3 and with a final vector 
concentration of 20pg/ml. The DNAs, in dH20 were added to a 20ktl final 
reaction volume, containing 50mM TrlsHCl pH7.5, 10mM MgCl2, 10mM DTT, 
50mg/mi BSA (fraction V), 1mM AT? and two units T4 DNA ligase. Reactions 
were incubated overnight at 14C. 
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Recessed 3' ends of DNA, generated by restriction endonuclease cleavage 
were filled in using the large fragment of E.coli polymerase 1 (the Kienow 
fragment). The DNA fragment (0.1-2pg) was Incubated for one hour at 37C 
with two units of this enzyme and 0.1mM each of dATP, dCTP, dGTP and dTTP, 
in a buffer which contained 50mM Tris-HC1 pH7.5, 10mM XgC12 5mM DTT. The 
reaction was stopped by extraction with phenol-chloroform, or heating to 
65C for fifteen minutes. 
2.4.12 Transformation of E,colI 
2.4.12.1 Preparation of competent cells 
The method of preparation of E.coli cells which are competent for 
transformation with DNA is a modification of the method of Hanahan (1983). 
A single colony was picked and grown overnight In lOml of LB. The 
starter culture (5m1) was inoculated Into lOOmi of LB and incubated with 
shaking at 37C until an OD600 of 0.5 was reached. The culture was 
chilled on ice water and then transferred to pre-chilled 50ml centrifuge 
tubes. Cells were sedlmented by centrifugation at 1000xg for five minutes 
at 4C and were resuspended in 50ml of cold TFB1 (100mM RbC1, 50mM MnC12, 
35mM sodium acetate pH5.8, 10mM CaCl, 15% (v/v) glycerol; 	filter 
sterilized ) and incubated on ice for thirty minutes. 	The cells were re- 
centrifuged, as above, resuspended in 4ml of cold TFB2 (10mM MOPS pH6.8, 
10mM RbCl, 75mM CaC12, 15% (v/v) glycerol; filter sterilized) and incubated 
on ice for twenty minutes. They were then used directly for 
transformation, or snap-frozen in liquid nitrogen and stored at -70C in 
0.4inl aliquots. 
Competent cells (200ul) were mixed with aliquots of ligation reactions 
or bOng of plasmid DNA and incubated on ice for thirty minutes. The 
suspension was transferred to a small glass test tube and shaken in a 42C 
water bath for two minutes. 	It was then diluted with 0.8ml LB and 
incubated at 37C on a rotating wheel for at least one hour. 	Cells were 
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plated out on LB-agarfampicillin plates and incubated overnight at 37C, to 
allow colony formation. 
2.4.13 Transformation of yeast 
2.4,13.1 Transformation of yeast spheroplasts 
This method is based on that used by Beggs (1978). 	A 50m1 culture of 
cells was grown in YPDA, overnight, to late log phase and cells harvested 
by centrifugation (3,000 rpm in the bench top centrifuge for five minutes). 
Cells were washed with dH0 by resuspension and centrifugation, as above, 
and were resuspended in 20inl of 1K sorbitol, 25mM EDTA pH8.0, 50mM DTT. 
This suspension was incubated with gentle shaking at the growth 
temperature of the culture for fifteen minutes and cells harvested by 
centrifugation as above. The cell pellet was washed with 1.2K sorbitol by 
resuspension and centrifugation and resuspended in 20m1 of 1.2K sorbitol, 
10mM EDTA, 100mM sodium citrate pH5.8, to which fr-glucuronidase (Sigma; 
filter sterilized) was added to 1% (v/v). The suspension was incubated at 
the growth temperature of the culture with very gentle shaking for sixty to 
one hundred minutes. Spheroplast formation was monitored by diluting 
aliquots of cells In dH20 and observing lysis under the light microscope. 
Spheroplasts were harvested by centrifugation at 2,000rpm in the bench top 
centrifuge and were washed three times with 1.2K sorbitol by resuspension 
and centrifugation at 2,000rpm. 
Spheroplasts were resuspended in 0.5ml of 1.2K sorbitol, 10mM CaC12 and 
50ji1 aliquots incubated with 1-10kg of DNA (up to lSjil), at room 
temperature for fifteen minutes. The mixture was diluted with 0.5ml of 
20% PEG 4000, 10mM CaC12, 10mM Tris-HC1 pH7.5 and incubated for five 
minutes, followed by brief centrifugation in the microcentrifuge. The 
spheroplast pellet was resuspended in 100il of YPDAS and Incubated at the 
growth temperature of the yeast strain for several hours. 	Dilutions of 
the suspension were made in 1.2K sorbitol. 	The dilutions were added to 
7ml YKMS top agar (cooled to 45 *C immediately before use), containing the 
appropriate amino acids and uracil and immediately spread onto the surface 
of YMKS agar plates which contained the same amino acids. 	The top agar 
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was allowed to solidify and the plates incubated at the growth temperature 
of the strain, until transformant colonies were visible (usually four to 
five days). 
2.4.13.2 Transformation of yeast cells 
This procedure is the same as that of Ito et al (1983). 	A culture was 
grown overnight to stationary phase in YPDA at 30C and cells harvested by 
centrifugation at 3,000 rpm in the bench top centrifuge for five minutes. 
The cell pellet was washed by suspension in TE and centrifugation as above, 
resuspended in TE, and LiCl (2.5)! stock) added to give a final 
concentration of 0,1)!. The cells were incubated at 30C for one hour with 
gentle shaking and Spg  of plasmid DNA was then added to 200j.ti of the cell 
suspension. 	The mixture was incubated without shaking for thirty minutes 
at 30C and 0.7m1 of 50% (w/v) PEG4000 added. 	This suspension was 
incubated for one hour at 30C and then heated at 42C for five minutes. 
The cells were harvested by centrifugation for twenty seconds in the 
microcentrifuge, washed with dH20 by resuspension and centrifugation. 
They were then either resuspended in 0.1ml dH20 and plated directly into 
YXM-agar plates, supplemented with the appropriate amino acids and uracil 
to select transformants or were resuspended in lmi YPDA and grown for 
several hours at 30C prior to plating in dH20 as above. The plates were 
incubated at 30C and transformant colonies were usually visible after 
three to four days. 
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This procedure is based on that of Birnbolm and Daly (1980). 	Cultures 
(3m1) of E,coli transformants were grown overnight on LB/ampicillin, and 
1 .Sinl of the culture centrifuged In the microcentrifuge for thirty seconds 
to sediment the cells. The pellet of cells was resuspended in lOOj.il of 
lysls solution (10% w/v glucose, 25mM Tris-HC1 pH 8.0, lOs)! EDTA, 4mg/mi 
lysozyme; freshly prepared) and incubated on ice for thirty minutes. 
200d of 1% (w/v) SDS, 0.2)! NaOH (freshly prepared) was then added and 
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incubation on ice continued for five minutes, followed by addition of iSOp.i 
of 3M sodium acetate, pH5.2, and further incubation on ice for at least 
sixty minutes. Cell debris and chromosomal DNA were removed by spinning 
in the microcentrifuge for ten minutes and 400,ul of supernate was carefully 
removed. This supernate was extracted with phenol-chloroform and plasinid 
DNA precipitated with ethanol, without addition of further sodium acetate. 
The pellet from the ethanol precipitation was resuspended in SOpl of dH20 
and RNase A (10mg/mi stock solution prepared by boiling for fifteen minutes 
to inactivate DNases; 	stored at -20C) added to 100g/ml final 
concentration. 	The digestion of RNA was allowed to proceed for thirty 
minutes at 37C, prior to digestion of the plasmid DNA with restriction 
endonucleases. 
This method is a modified form of that used by Guerry et al (1973). 
a 500m1 culture of E.coli transformants picked from a single colony was 
grown overnight to stationary phase in LB/axnpiciilin. 	The cells were 
harvested at 5000rpm for ten minutes (Sorvall GS-3 rotor) at 4 C and 
resuspended in 6ml of 25% (w/v) sucrose, 50mM Tris-HC1 pH8.0, 62.5mM EDTA 
and transferred to 30ml polycarbonate centrifuge tubes. 	Lysozyme 
solution (imi, 10mg/mi lysozyme, in the same buffer) was added and the 
tubes incubated at room temperature for five minutes, after which lml of 
0.5M EDTA, pH8.0, was added and incubation continued for a further ten 
minutes at room temperature. 	The tubes were then transferred to ice, and 
14m1 of cold 'Triton mix' (0.1% (v/v) Triton X-100, 50mM Tris-HC1 pH8.0, 
10mM EDTA, 10% (wfv) glucose) was added, and the suspension gently mixed. 
After ten minutes on Ice, or when the cell lysate had become viscous due to 
release of chromosomal DNA from cells, the lysate was centrifuged at 17,000 
rpm for forty minutes at 4C In an SS34 rotor. 	The supernate was removed 
and 0.95g CsC1 and SOpl 10mg/mi ethidium bromide added for each ml of 
supernate. 	The supernate was then transferred to two 12nd polyallomer 
tubes which were sealed. 	The tubes were centrifuged In a TiSO rotor at 
37,000 rpm and 18C for at least forty hours. 	DNA was visualised under 
long-wavelength UV light and recovered by piercing the tube with a 19-guage 




buthn-1-ol (equilibrted with CsCI-saturated TE buffer) 	CsC1 was removed 
by dialysis for several hours against TEN buffer (TE plus lOOmX NaCl), 
followed by overnight dialysis against TE buffer, The DNA was 
deproteinized by extraction with phenol-chloroform, precipitated with 
ethanol and redissolved in TE or dH0. 
2.4.15 Measurement of radioactivity in nucleic acids 
This method Is a rapid and simplified version of that in Maniatis et al 
(1982).'-'P-labelled nucleic acids were spotted onto GF/C filters and the 
number of counts on the filters determined by Cerenkov counting, or 
estimated with a hand-held Geiger counter. The filters were then placed 
onto a vacuum filtration apparatus and SOmi of 10% TCA, followed by 50m1 
of 5% TCA, 50mX sodium pyrosphate passed through the filter. 	The amount 
of radioactivity on the filter was then determined as above. The ratio of 
the two different figures, before and after TCA precipitation, gave the 
percentage incorporation of radioactivity into nucleic acids. 
Oligonucleotides of less than twenty nucleotides in length are not 
efficiently retained on GF/C filters using this procedure. 
This method is based on that of Feinberg and Vogeistein (1983). 	The 
random priming reaction mix was prepared by adding reagents In the 
following order: dH20 (to give a final volume of 50M1,  lOj.tl oligo-
labelling buffer (see below), 1il of 20mg/ml BSA, up to 32.5il DNA solution 
(denatured by boiling for four minutes followed by rapid cooling on Ice-
water; 50-10ng DNA), 20J.LCi c-P-dCTP, two units of Klenow enzyme. The 
reaction mix was Incubated at room temperature for 4-6 hours and the 
reaction terminated by boiling prior to hybridization (see section 2.4.20). 
Incorporation of 2P-CTP into DNA was assayed by TCA precipitation. 
Oligo-labelling buffer was prepared as follows. 	Solutions A, B and C 
were mixed in the ratio 1:2.5:1.5 
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Solution 0: 1.25)! Trls-HC1 pH8.0, 125mM XgC1; stored at 4C 
Solution A: imi solution 0 + lB.il 3-mercaptoethanol + 5il each dAT?, 
dCTP, dOT? (each 0.1)! in 3m)! Tris-HC1 pH 7.0, 0.2mM 
EDTA); stored at -20C). 
Solution B: 2)! HEPES-NaOH pH6.6; stored at 4'C 
Solution C: Random sequence hexadeoxynucleotides in TE buffer, 
90 ODoT,n units/ml; stored at -20C. 
This procedure is modified from the procedure of Naxam and Gilbert 
(1980). The labelling reaction contained 20 pmol of oligonucleotide, 20iCi 
of '-32P-ATP, two units of T4 nucleotide kinase and lpl of 10 x kinase 
buffer (700mM Tris-HC1 pH7.5, lOOni)! MgCl2, 1mM KC1, 50mM DTT) in a final 
volume of 10jl. The reaction was incubated at 37C for thirty minutes. 
It was then added directly to hybridization solution or, when necessary, 
unincorporated '-?-ATP removed by gel filtration, using a Sephadex G-25 
column (Pharmacia, NAP10), according to the manufacturer's instructions. 
DNA was transferred from agarose gels to nitrocellulose filters 
according to the method of Southern (1975), Following electrophoresis and 
photography of the gel, the gel was soaked in SOOmi of Southern 
denaturation buffer (1.5m NaCl, 0.5)! NaOH) for one hour at room temperature, 
with gentle shaking. The gel was then neutralised by a further one hour 
incubation, with gentle shaking, in Southern neutralization buffer (15)! 
Tris-HC1 pH8.0, 1.5)! NaCl). A double sheet of Whatman 310! paper was 
wetted in a reservoir containing 10 x SSG buffer and draped over a glass 
plate with both ends dipping into the reservoir. The gel was then placed 
onto the 3M)! paper on the glass plate with its underside facing upwards, 
and any regions of the gel from which DNA was not to be transferred were 
covered with Saran wrap. The exposed portion of the gel was then covered 
with a piece of nitrocellulose membrane (BA85, Schleicher and Schuell) 
which had been pre-wetted in 2xSSC, taking care to remove any air bubbles 
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between the gel and filter. 	Two pieces of Whatman 3MH paper, pre-wetted 
in 2xSSC were placed on top of the nitrocellulose membrane, and on top of 
these a 5-10cm high stack of paper towels. A glass plate, weighted down 
with a 500g weight was placed on top of the paper towels, and transfer was 
allowed to proceed overnight, after which the nitrocellulose was removed, 
rinsed in 6xSSC for two minutes and baked at 85C under vacuum. 
This procedure, for screening E.coli colonies to Identify those carrying 
recombinant plasmids derives from Grunstein and Hogness (1975), Duplicate 
plates, carrying colonies streaked in a grid pattern were grown overnight. 
Routinely, 200 colonies were screened at one time. A circular 
nitrocellulose filter (BA85, Schleicher and Schuell), with orientation marks 
on one side, was placed gently on one plate of each pair, while the other 
was saved, as a master plate. The filter was removed and placed, colony 
side upwards upon a piece of filter paper, pre-soaked In Southern 
denaturation buffer (section 2.4.18) for 5 minutes, and then transferred to 
a similar filter, pre-soaked in Southern neutralization buffer (section 
2.4.18) for a further 5-10 minutes. The filter was washed briefly in 
2xSSC, dried on filter paper at 37'C for ten minutes and then baked for two 
hours at 80C under vacuum. 
Filters carrying DNA transferred from an agarose gel or from E.coli 
colonies were sealed Into plastic bags or placed in plastic airtight boxes 
with 10-30m1 of prehybridization buffer (2xSSC, 10xDenhardts solution [0,27. 
Ficoll, 0.2% (w/v)BSA, 0.2%(w/v) polyvinylpyrollldone], 2% SDS, 0.1mg/ml 
single-stranded salmon sperm DNA; pre-heated to 65C) and Incubated at 65C 
for greater than two hours. The probe (section 2.4.16) was denatured by 
boiling for four minutes, followed by rapid cooling on ice-water and was 
added to the liquid in the bag or box. Hybridization was allowed to 
continue overnight at 65C, and the filter then removed from the 
hybridization solution and washed three times for five minutes with SOOml 
of 2xSSC at room temperature. If necesary two further washes at 65C in 
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2xSSC, 0.5% SINS were performed and the filter air-dried on filter paper and 
exposed to X-ray film. 
Following electrophoresis (section 2.4.9) the gel plates were separated 
leaving the gel on one plate, and regions of the gel which did not contain 
samples to be transferred were removed. The gel was lifted off the glass 
plate using dry filter paper, which was then wetted by placing on filter 
paper which had been soaked in 0.5xTBE buffer. Three further pieces of 
filter paper, of the same dimensions, two Scotchbrite pads and a piece of 
nylon membrane (Hybond-L Amersham) cut to dimensions slightly larger than 
those of the gel, were all soaked in 0.5xTBE. A 'sandwich' was then 
constructed which consisted of one Scotchbrite pad on top of which was 
placed a piece of filter paper, followed by the gel on its piece of filter 
paper, the nylon membrane, two further pieces of filter paper and the 
second Scotchbrite pad, Care was taken to ensure that there were no air 
bubbles between any of the layers of the 'sandwich', which was then 
inserted into the plastic cassette of a Trans-Blot apparatus (Blo-Rad). 
The cassette was placed in the electrophoresis tank of the Trans-Blot 
apparatus with the gel side oriented towards the anode, and transfer 
performed in 0.xTBE for one hour at 200mA. The buffer in the tank was 
cooled by metal or plastic coils through which tap water flowed. 
Following transfer, the nylon filter was removed and dried for ten minutes 
at 37C on filter paper with the RNA side upwards. The filter was then 
covered with Saran Wrap and placed RNA side downwards on a UV 
trans illuminator for five minutes, in order to covalently link the nucleic 
acid to the filter. 
This method is adapted from that of Church and Gilbert (1984). 	The 
nylon membrane (prepared as in section 2.4.21) was wetted in dH20, and 
placed in a plastic airtight box containing 20-30ml of hybridization 
solution (0.5X sodium phosphate, pH7.0, 77. SDS, 1mM EDTA). The membrane 
was incubated in this solution at 28-37C for at least one hour and was 
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then transferred to a heat sealable plastic bag. 	The oligonucleotide probe 
(section 2,4.17) in 1.5m1 of lOmX sodium phosphate buffer was added 
directly to 10-20m1 of hybridization buffer (pre-warmed to 28-37°C) and the 
hybridization buffer containing the probe was added to the plastic bag 
containing the filter. The bag was sealed and placed in a water bath at 
28-37°C (depending on the melting temperature of the DNA-RNA hybrid) 
overnight, with continuous shaking. The membrane was then removed from 
the bag and washed twice at 28-37°C for ten minutes in 0.5X sodium 
phosphate pH7.0, 5% SDS, 1mM EDTA. The membrane was exposed, without 
drying, between two sheets of Saran Wrap. 
2.4.23 In vitro transcription reactions 
In vitro transcription of DNA using SP6 polymerase (Melton et p1, 1984) 
or T7 polymerase (Davanloo et al, 1984) was performed on DNA which was 
linearised with restriction enzymes. The reaction mixture contained 0.1-
0.2j.ig DNA, 0.5mM AT?, CT? and GTP, 25iM UTP, 20-40jiCi c-P-UTP, 10 units 
RNasin (Promega Biotech), 5 units of the appropriate RNA polymerase and imi 
of loxtranscription buffer (400mM Trls-HC1 pH7.5, 60mM MgC1 2 , 100mM DTT 
[plus 100mM NaC1 for T7 polymerase]). The reactions were performed in a 
final reaction volume of 5 or 10il for 15-30 minutes and were stopped on 
ice. Incorporation of radioactive label into RNA was measured by TCA 
precipitation (see section 2.4.15) and the transcripts stored at -20C. 
2.4.24 RNase H digestions 
SF6 or T7 transcribed RNA (section 2.4.23) was hybridized to 0.2 nmol of 
oligonucleotide in the manufacturers' recommended RNase H digestion buffer 
by incubation at 65C for three minutes, followed by incubation at 25°C for 
thirty minutes, in a volume of 10)Al. 	One unit of E. coli RNase H was 
added and incubation continued at 37°C for 30-60 minutes. 	The reaction 
was stopped by placing on ice. 
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2.5 In vitro Splicing 
This procedure is slightly modified from that of Lin et al (1985). A 1L 
or 1.5L culture of yeast cells was grown at 30C (wild type strains) or 
23C (temperature sensitive strains) to an 0D6001,m of 0.4 to 0.6 and 
harvested by centrifugation (5,000rpm for ten minutes at room temperature 
in a Sorvall GS-3 rotor). The cells were washed In 50m1 of 50mX 
potassium phosphate pH7 .5, by resuspension and centrifugation (In the bench 
top centrifuge, 3,000rpm for five minutes) and then resuspended in 50m1 of 
lyticase buffer (50mM potassium phosphate, 1.2)! sorbltol, 30mM DTT), to 
which 1 to 1.5ml of lyticase (Sigma) was added. Digestion of cell walls 
was allowed to proceed for up to 45 minutes at the growth temperature of 
the strain, with very gentle shaking. Spheroplast formation was monitored 
by observing lysis upon dilution of small aliquots of cells into dH20, and 
when greater than 80% of cells were clearly sensitive to lysis, the 
spheroplasts were sedlmented (2,000rpm, five minutes in the bench top 
centrifuge at room temperature). They were then washed twice with 50mM 
potassium phosphate p117.5, 1.2)! Sorbitol by resuspension and centrifugation 
(2,000rpm, five minutes In the bench top centrifuge at room temperature), 
resuspended in 200ml of YPDAS, and incubated with very gentle shaking at 
the appropriate growth temperature for 1.5 to 2 hours. The spheroplasts 
were harvested by centrifugation (3,000rpm for ten minutes at room 
temperature In a Sorvall GSA rotor), washed In 50mM sodium phosphate pH7.5, 
1.2)! sorbitol by resuspension and centrifugation and resuspended in cold 
buffer A (10mM HEPES-KOH pH7.0, 10mM KC1, 1,5mM MgCl, 0.5mM DTT, 1mM 
PXSF; lml per gram of spheroplasts). The suspension was transferred to a 
cold Dounce homogenizer and Incubated on ice for five minutes to allow 
osmotic swelling. Subsequent steps were performed in the cold room. The 
spheroplasts were lysed with twelve strokes of a tight fitting Teflon 
pestle, on ice, and transferred to a small glass beaker. Cold KC1 was 
added slowly, to a final concentration of 200mM and the mixture stirred on 
ice for thirty minutes. The lysate was then cleared by centrifugation 
(17,000rpm for thirty minutes at 4C In a Sorvall SS34 rotor) and the 
supernate subjected to a further centrifugation (37,000 rpm for 1 hour at 
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VC in a T150 rotor). 	The supernate from the second centrifugation was 
then either dialysed against two litres of D buffer (50mM KC1, 20mM 
HEPES-KOH pH7.0, 0.2mM EDTA, 0.5mM DTT, 20% (vfv) glycerol) or treated with 
ammonium sulphate (section 25.2). Following dialysis the protein extract 
was removed from the dialysis bag and centrifuged for ten minutes at VC 
in the microcentrifuge. The supernate was divided into 50p1 aliquots, snap 
frozen in liquid nitrogen and stored at -70C. 
In some cases the supernate of the 37,000rpm spin was treated with 
ammonium sulphate according to the procedure of Vijayraghavan et al (1986). 
Ammonium sulphate powder (enzyme grade, ground with a mortar and pestle 
0.246g1m1 of supernate) was added slowly to the supernate, with continuous 
stirring, on ice. The stirring was allowed to continue for a further 
thirty minutes on ice, and the extract was then centrifuged at 15,000rpm 
for twenty minutes at 4 C in a Sorvall 5534 rotor. The protein 
precipitate was redissolved in one tenth of the original extract volume of 
splicing extract dialysis buffer (section 25.1), on ice, and dialysed, 
centrifuged and frozen in the same way as untreated splicing extract. 
This fraction of splicing extract is referred to as 35P1. 
25,3 In vitro splicing 
In vitro splicing was performed according to the procedure of Lin et al 
(1985), with slight modifications. Reactions were set up as follows: 5il 
of splicing extract, or 25tl each of splicing extract and 35P1, were 
allowed to warm to room temperature. A mix (3pi) containing 10% PEG, 25.67. 
IgG buffer (250mM potassium phosphate, 67mM sodium citrate, 17% (v/v) 
glycerol, pH7.0), 200mM potassium phosphate, pH7S, 8.3mM MgC12, was then 
added. 	In the case of prp2 extracts to be heat inactivated, the mixture 
was then incubated for up to one hour at 32C. 	1l of dH20 (or PRP2 
protein preparation to be assayed for PRP2 activity, section 4.4), followed 
by 1)Al of a 1:5 to 1:20 dilution of SP6 or T7 RNA transcript, in 2mM ATP, 
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was then added, and the reaction incubated at 25 *C for up to one hour. 
The reaction was stopped by dilution with 175jil of 50m1( sodium acetate 
pH5.2, lmK EDTA, 0.1% SDS, 20).Lg/ml tRNA, followed by extraction with 
phenol/chloroform and precipitation of RNA with ethanol. The precipitated 
RNA was analysed by denaturing polyacrylamide gel electrophoresis <section 
2,4.9). 
Non-denaturing gel electrophoresis was performed by a slight 
modification of the method of Pikielny et al (1986). The gel mixture for 
non-denaturing gels contained 3% (w/v) acrylamide (60:1 acrylamlde 
bisacrylamide), 0.5% (w/v) agarose, 1xTBE. This was prepared by 
dissolving the agarose in TBE by boiling, and allowing the gel to cool to 
approximately 65C. The gel was then degassed, acrylamide/bisacrylamide 
stock solution and polymerising agents (see below) were addedand the gel 
was immediately poured between 16cnixl6cm glass plates separated by 1.5mm 
thick spacers. The polymerising agents used were APS and 3-dimethyl-
amino-propionitril (Fluka Chemie A.G.; 0.05% and 0.4% final concentration, 
respectively). The gel was allowed to polymerize for one hour at room 
temperature, and was then transferred to the cold room and pre-
electrophoresed for one hour at 150V. 
Samples were placed on ice and an equal volume of cold Q buffer (400mM 
KC1, 2mM magnesium acetate, 20mM EDTA, 64mM Tris-}IC1 pH 7.5), plus 6ig of 
yeast total RNA per 10jl sample, was added. The mixture was incubated on 
ice for ten minutes, 0.25 volumes of Sxloading buffer (50% (v/v) glycerol, 
2.5xTBE, 0.05% (w/v) each xylene cyanol and bromophenol blue) added, and 
the sample loaded on the gel. Electrophoresis was for four to sixteen 
hours at 50-200V, with recirculation of buffer. 
Following electrophoresis, gels were autoradiographed at 4C with pre-
flashed film, with markers of radioactive ink. The X-ray film was then 
aligned with the gel and the band of interest excised, cut into several 
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small pieces and placed in a dialysis bag with 0.5-0.7ml TEE. The bag was 
placed in a horizontal gel electrophoresis tank containing pre-cooled (to 
40 TEE, and electroelution performed for two hours at 150V and 4C. The 
current polarity was reversed for one minute, and the liquid withdrawn from 
the dialysis bag. 
To estimate protein concentration, 2jl of dilutions of the sample in 
dH0 were spotted onto Whatman no. 1 paper, alongside BSA concentration 
standards. The filter was dried at 65C for five minutes, and briefly 
immersed in 25% (v/v) propan-2-ol, 10% (v/v) acetic acid, 0.1% Coomassle 
Brilliant Blue R250 (Bio Rad). The filter was washed with tap water until 
background staining of the filter was low, and the protein concentration 
estimated by comparing the intensity of staining of the protein spots with 
the standards. 
Proteins were separated by SDS-discontinuous polyacrylamide gel 
electrophoresis, as described by Laemmli (1970). An 8,5% or 15% (wfv) 
acrylamide separating gel mix (see below, Table 2.4) was poured between two 
16xl6cm glass plates, which were separated by 1.5mm thick spacers and 
sealed with rubber tubing, until the liquid level was approximately 5 cm 
below the top of the notched plate. dH2O was carefully layered onto the 
surface of the separating gel in order to form a straight interface, and the 
gel allowed to polymerise for thirty minutes. The dH20 was then removed 
and stacking gel mix (Table 2.4) was poured between the plates upto the top 
of the notched plate, and a Teflon comb (with 12 0.5cm or 20 0.3cm wells) 
was inserted. The stacking gel was allowed to polymerise for at least 
thirty minutes, the comb and rubber tubing removed and the gel placed in a 
vertical gel electrophoresis tank containing SDS-PAGE running buffer (25mM 
Tris, 192 mX glycine pH8.3, 0.1% SDS). Samples were mixed with an equal 
W I- 
volume of SDS-gel loading buffer (125m1( Tris-HQ pH6, 200mM DTT, 4% 
(w/v) SDS, 40% glycerol, 0.02% bromophenol blue; stored at 4C), heated to 
100C for five minutes and loaded onto the gel. Electrophoresis was 
performed at 40-220V for 3-16 hours. 
Table 2.4 	Coposition 
Stock Solutions 
of SDS-polyacrylamlde gel mixes 




30% (w/v) acrylainide 8.5ml 15m1 1.67m1 
2,5% (w/v) bis-acrylamide 2.Oml imi 0.65m1 
iN Trls-HC1 pH 8.8 11.2m1 11.2mJ. - 
iN Tris-HC1 pH 6.8 - 
- 1.25ml 
dH20 8.4m1 2.9ml 6.4ml 
10% SDS 300il 300l lOOjil 
10% (w/v) APS 200il 200jil 100p1 
TEND 20ul 20pl lOpl 
2.6.3 C 
Following electrophoresis, the gel was transferred to a plastic container 
and Incubated for thirty minutes at 37C In Coomassie Blue staining 
solution (25% (v/v) propan-2-ol, 10% (v/v) acetic acid, 0.05% (wfv) 
Coomassie Brilliant Blue R250) with gentle agitation. The staining 
solution was removed, the gel rinsed very briefly in dHzO to remove excess 
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staining solution and then Immersed in destaining solution (25% (v/v) 
methanol, 20% (v/v) acetic acid) at room temperature, with gentle agitation. 
Small pieces of polyurethane foam were added to the destaining solution to 
adsorb Coomassie Blue, and destaining was continued until the background 
was low enough to clearly visualize the protein bands. The gel was dried 
at 80C under vacuum. 
Cells were harvested by centrifugation, (centrifugation conditions 
depending upon volume of culture) and were resuspended in dH20. They were 
lysed by addition of an equal volume of SDS-polyacrylamide gel loading 
buffer (section 2.6.2) and heating to 100C for five minutes. The lysate 
was centrifuged for three minutes at room temperature to remove insoluble 
material and the supernate loaded onto an SDS-polyacrylamide gel with wells 
for analysis of the protein, or onto a preparative SDS-polyacrylamide gel 
(without wells) for purification of fusion proteins (see section 2.6.8.1). 
Yeast cultures were grown overnight in supplemented YMX until the 
ODGoonm was approximately 0.4 and cells were harvested by centrifugation 
(centrifugation conditions depending upon culture volume). The cells were 
washed in PBS (section 2.2.6), by resuspension and centrifugation (3,000rpm, 
for five minutes at room temperature in the bench top centrifuge) and 
resuspended in at least 0.4ml of lysis buffer (PBS, 0.1% NP40, linX PXSF). 
The cells were lysed by sonication on ice, at full power, for three periods 
of thirty seconds (with thirty seconds on ice between each period of 
sonication). The lysate was centrifuged in a microcentrifuge for thirty 
seconds at room temperature, and the supernate centrifuged for a further 
ten minutes at 4C in a microcentrifuge. The supernate from this second 
spin was either used directly for immunoprecipi tat ions, or analysed by SDS-
PAGE (section 2.62). 
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in E.coli with IPTG 
Starter cultures (lOxnl) of E.coli carrying pTJR fusion constructs, parent 
vector or pDR-PRP2 (section 4.2) were grown overnight at 37C in 
LB/ampicillin. This starter culture was diluted 1:100 in fresh 
LB/ampicillin medium (up to 1L for preparative purposes), and incubated at 
37 *C until the 01)60o. had reached 0.4. IPTG was then added to give a 
final concentration of 0.5mM and the incubation continued for a further 
thirty minutes to one hour. 
Induction of trpE fusion protein synthesis in E.coli cells (strain HB101) 
carrying pATH fusion constructs was performed by the method of Spindler et 
J.. (1984), 	Cells were grown overnight in X9+CA+trpfampiclllin medium at 
37C. 	This starter culture was then diluted 1:10 into M9+CA/ampicillin 
medium and incubated with vigorous shaking for one hour at 37C. 	IAA 
(1mg/mi In EtOH) was added to a final concentration of 5ug/ml and 
Incubation continued for a further two hours with vigorous shaking at 37C. 
04W-4.40) - MMMUMOT2,49M 	 MT 
Yeast cell extracts containing high levels of PRP2 protein were produced 
from KY117 cells carrying pBM-PRP2 (section 41,2), or DJY40 cells carrying 
pKV-PRP2 (section 4.1.2). These plasmids contain the whole of the PRP2 
gene under the control of the yeast GALl promoter. In order to induce 
over-expression of FRP2 protein, lOml starter cultures of cells carrying 
these constructs, or parent vectors, were grown to stationary phase on 
yeast minimal medium, (supplemented with the appropriate amino acids to 
select for the plasmids), with 2% glucose as carbon source. Cells were 
then pelleted by centrifugation (4,000rpm, for 5 minutes in the bench top 
centrifuge), washed once with yeast minimal medium, containing 2% raffinose 
plus 2% galactose, and resuspended in lOml of this medium. The cell 
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suspension was diluted 1 100 In the same medium (supplemented with the 
appropriate amino acids), and grown overnight at 30C, until the 
was 0.4, whereupon they were harvested. 
VAROMUNIM 
A 200m1 culture of E.coli was induced for fusion protein synthesis 
(section 2.6.6 or 2.6,7), a lysate prepared (section 2.6.4) and 
electrophoresed on a 1.5 mm thick, 8.5% SDS-polyacrylamide gel without 
slots. 	Following electrophoresis, vertical strips were cut from the centre 
and each edge of the gel, and stained with Coomassie Blue . 	The stained 
strips were then realigned with the main portion of the gel, and a 
horizontal strip of gel containing the fusion protein excised. This strip 
was cut into several pieces and placed in a dialysis bag with 3-5mi of 
SDS-PAGE running buffer. The dialysis bag was placed in a horizontal gel 
electrophoresis tank and submerged in SDS-PAGE running buffer. The fusion 
protein was eluted for four hours at 150V, followed by brief reversal of 
the current polarity to remove the protein from the dialysis tubing, The 
liquid In the bag was withdrawn and the fusion protein concentrated by 
centrifugation at 3,000rpm (benchtop centrifuge with fixed angle rotor) in a 
Centricon 30 microconcentrator (Amicon Corporation). When the volume of 
the eluted fusion protein solution was less than 1.5ml, the solution was 
snap frozen and stored at -70C. 
3-galactosidase fusion proteins were purified by the procedure of Hall 
et al (1984). A lOOml culture of E.coli cells, carrying pUR fusion 
constructs was grown to an ODeoo,,n of 0.4 and fusion protein expression 
induced with IPTG (section 2.6.6). The cells were then harvested by 
centrifugation (3,000rpm, five minutes at 4C in fixed angle bench-top 
centrifuge) and resuspended in 2m1 of 15% sucrose, 50mM Tris pH8.0, 50mM 
EDTA. 	The cell suspension was transferred to a 30ml polycarbonate tube 
and 200jil of 10mg/nil lysozyme (freshly prepared) was added. 	The mixture 
64 
was incubated for forty minutes on ice, with intermittent gentle agitation, 
and 0.1% Triton X-100 In TE buffer (2.8ml) added. After a further five 
minute Incubation on ice the cell lysate was centrifuged at 17,000rpm for 
fifteen minutes at 4C (Sorvall SS-34 rotor). The pellet was resuspended 
in 2inl of 2X urea by sonication (in ten second bursts, with ten seconds on 
Ice between each burst, continued until the pellet had dispersed) and 
centrifuged, as above. 	The pellet from this centrifugation was resuspended 
in 2m1 of 6M urea, by sonication, and centrifuged, as above. 	The resulting 
supernatant was dialysed against 2L of PBS, and concentrated using a 
Centricon microconcentrator (section 2,6.9,1). 
4m. _9293 
All experiments on live animals were performed in compliance with the 
Cruelty to Animals Act (1986) under licence number 61400. Rabbits were 
females of the half-lop variety and were obtained from Froxfield Rabbits. 
50-200j.tg of fusion proteins were used for the first injection into 
rabbits, and 30-50,g for subsequence injections. 	1-2 volumes of adjuvant 
(Freunds complete adjuvant for the first Injection, 	Freunds incomplete 
adjuvant for subsequent injections) was added to the fusion protein 
preparation, and the mixture vortexed until a stable emulsion was formed. 
The emulsion was injected subcutaneously at several sites on the first 
injection, and at a mixture of intra-muscular and subcutaneous sites for 
subsequent injections. Blood was collected from the ear vein prior to the 
first injection and 12-14 days after the second and subsequent Injections. 
12-14 days after the final injection the rabbit was anaesthized with 
Sagatal (May and Baker Ltd.), and blood (100-150m1) withdrawn directly from 
the heart, using a 19-gauge needle and syringe. The rabbit was then 
killed with a further injection of Sagatal. 
Blood collected as described (section 2.6.10) was allowed to clot at 
room temperature and the clot released from the sides of the container 
using a glass rod. The clot was allowed to contract overnight at 4C, the 
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serum transferred to a lQml or SOmi Falcon tube and centrifuged at 
3,000rpm for five minutes in the bench-top centrifuge at room temperature, 
to remove red blood cells. The serum was then snap-frozen in liquid 
nitrogen in several small, and one large, aliquots and stored at -70C. 
Serum aliquots were thawed at room temperature when required and kept on 
ice until they were snap frozen again, prior to storage at -70C. 
2.6.12 Western blotting 
Proteins were electrophoret ical ly transferred from SDS-polyacry lamide 
gels to nitro-cellulose membranes using a modification of the method of 
Towbin et al (1979). Following SDS-PAGE (section 2.6.2) the gel was 
soaked in Western transfer buffer (20mM Tris, 192mM glycine, pH8.3) for 
thirty minutes at room temperature, together with four pieces of Whatnian 
3MM paper, two Scotchbrite pads and a piece of nitrocellulose membrane 
(BA85, Schleicher and Schuell; cut to dimensions slightly larger than the 
gel). These were placed In the cassette of a BioRad TransBlot apparatus 
in the following order: one Scotchbrite pad, two pieces of 3MM paper, the 
gel, the nitrocellulose membrane, two pieces of 3MM paper and finally the 
second Scotchbrite pad. 	Care was taken to remove any air bubbles between 
the different layers. The cassette was inserted into the TransBlot 
electrophoresis tank (with the gel oriented towards the anode), which 
contained Western transfer buffer. 	Cooling was supplied by a water 
cooling system. 	Following transfer (at 0.1A overnight or 0.3A for four 
hours), the proteins bound to the membrane were stained for one minute in 
Ponceau-S staining solution (Sigma) and the blot destained by washing the 
membrane with dH2:0. The membrane was then cut into strips, if necessary, 
and incubated at 37C for one hour with gentle agitation in 30nil blocking 
solution (table 2.5), It was then transferred to a plastic heat-sealable 
bag and incubated with 5-20m1 of primary antibody solution (1:500 to 1:1000 
dilution of antiserum In the appropriate buffer, Table 2.5) at 4C, overnight 
or at room temperature for two hours, with agitation. The membrane was 
washed in three changes of wash buffer (table 2.5), at room temperature for 
fifteen minutes each, with agitation, and was then incubated with either 
125Iprotein A at 37C or alkaline phosphatase-conjugated goat anti-rabbit 
IgG antibodies (table 2.5). It was then washed, as above, and exposed to 
M. 
X-ray film (for 1 I-labelled protein A), or developed by placing in Smi of 
freshly prepared alkaline phoshatase developer solution (NBT and BCIP 
supplied by Promega), and incubated until the bands reached the desired 
intensity. Development was stopped by washing the membrane in dH20, and 
the membrane was then dried in air, on filter paper and stored at room 
temperature in the dark. 
Table 2.5: Solutions for Western blotting 
Detection System 
125 1-protein A 
	






PBS, 5% (w/v)BSA 
PBS 1% (wlv) BSA 
lQuCi 12I protein A, 
PBS, 1% (w/v) BSA 
TBS 5% (w/v) BSA 
TBS 1% (w/v) BSA 
0. lXTris-HC1 pH9. 5, 
0.125M NaCl, lOmX 
MgCl, 0.33mg/mi BCIP, 




Antibodies were purified using a modification of the method of Robinson 
et al (1988). A crude lysate of E.coli cells in which fusion protein 
synthesis had been induced was subjected to preparative SDS-PAGE and 
transferred to a nitrocellulose membrane (section 2.6.12). The membrane 
was stained with Ponceau-S solution (Sigma), and a horizontal strip of the 
membrane containing the fusion protein band was excised and blocked for 
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one hour at 37C in TBS, 5% wlv BSA. 	The strip was then incubated with 
15m1 of a 1:300 dilution of antiserum in TBS, 1% (w/v) BSA, overnight at 
4C, or for two hours at room temperature, with agitation. The membrane 
strip was washed in 3 changes of TBS, at room temperature, for 15 minutes. 
Antibodies were eluted by incubating the strip at 4C for four minutes in 
1.5m1 glycine elution buffer (0.1w glycine-HC1 pH2.2, 50% (vfv) glycerol). 
The eluate was immediately neutralized with 75il 1M Tris base, snap-frozen 
in liquid nitrogen and stored at -70C. 
Immunoprecipitation of '3 -,S-labelled proteins from yeast extracts was 
performed by a modification of the procedure of Lee et al (1986). 
Proteins were radioactively labelled In vivo by adding 300-500Ci of L-
5S-methionine to 400m1 cultures of yeast cells (starting O.D. 0.025 to 
0.05) in YMM (supplemented according to strain and plasmid selection 
requirements) and Incubated overnight at 30C. When the O.D. of the 
culture had reached approximately 0.4,, the cells were harvested and lysed 
by sonication (section 2.6.5), 
The crude extract was diluted to 4ml with 1xPBS, 1% (v/v)NP40, 10% 
foetal calf serum, lml( PMSF, and divided into 6-12 aliquots of equal volume. 
Polyclonal serum (Spl) was added to each aliquot and the tubes were 
incubated at 4C overnight, with mixing. A 1:1 slurry (30l)of swollen 
Protein A separose (PAS, Sigma) beads NET buffer (50mM Tris-HC1 pH7.5, 
0.15)1 NaCl, 5mM EDTA) was then added, The mixture was incubated for 
one hour at 4C with mixing and the PAS beads sedimented by centrifugation 
(ten seconds In the mlcrocentrifuge at 4C), The supernatant was removed 
and the PAS beads subjected to the following series of washes at room 
temperature, with mixing: 2x30 minutes in HEN buffer (0,1)1 HEPES-NaOH 
pH7.9, 1)1 NaCl, 1% (v/v)NP40, 10mM EDTA, 1mM PMSF); 2x30 minutes in LT 
buffer (0.5)1 Lid, 0.1)1 Tris-HC1 pH8.8, 0.1% (w/v) SDS, 1% (v/v) NP40); ten 
minutes in HEN buffer, 	After the final wash the beads were resuspended in 
15il of NET buffer, 20jl of SDS-PAGE loading buffer (section 2.6.2) added, 
and heated to 100C for five minutes. The whole suspension was loaded 
onto an SDS-palyacrylainide gel and electrophoresis was performed as 
described (section 2.6.2). Following Coomassie Blue staining (section 
2.6.3) the gel was incubated for twenty minutes in Amplify (Amersham) at 
room temperature, with agitation, dried at 80C under vacuum, and exposed to 
X-ray film 
2,6,14.2 Low stringency immun0precipitation from yeast in  vitro spliring 
extracts 
This procedure is based on that described by Lossky et al (1987). 
PAS was swollen in NTN buffer (50mX Tris-HC1pH7.5, 150mM NaCl, 0.1% (v/v) 
NP40) and washed twice with this buffer by resuspension and brief 
centrifugation in the niicrocentrifuge at room temperature. PAS beads (5-
1l packed volume) were then incubated for one hour, with mixing, at room 
temperature with 3-5j.xl of antiserum diluted in lOOj.il NTN buffer or with 
15ig of anti-mG antibody in 100).il of NTN buffer, or with 200-400p1 of 
anti-PRP2 antibodies, affinity purified as described (section 2.6.13). The 
PAS-IgG was sedimented by centrifugation as above and washed three times 
with lml of NTN buffer, as above. Yeast In vitro splicing reactions or 
mock splicing reactions, (without added pre-mRNA) were placed on ice, and an 
equal volume of cold Q buffer (400mM KC1, 2mM magnesium acetate, 20mM 
EDTA, 64mM Tris HCl pH7.5), plus 6mg of yeast total RNA per 10l splicing 
reaction, were added. 	This mixture was added to the PAS-IgG and incubated 
for one to two hours at 4C with agitation. 	The PAS-IgG was sedimented by 
centrifugation for ten seconds at 4C in the microcentrifuge and was then 
washed three times with cold NTN buffer at 4C. The itninunoprecipitate was 
then treated for SDS-PAGE, or RNA extracted from it, as described below. 
To extract RNA from the Immunoprecipitate, the PAS beads were incubated 
with 20.tl of proteinase K solution (50mM Tris-HC1 pH7.5, 03M NaCl, 5mM 
EDTA, 1.5% (w/v) SDS, 2mg/ml proteinase K) for fifteen minutes at 37C with 
agitation and 801.d of 150mM sodium acetate pH5.2, 20jig/ml tRNA added. The 
mixture was extracted twice with phenol-chloroform, and RNA precipitated 
1J 
with ethanol. 	The RNA was then analysed by denaturing polyacrylamide gel 
electrophoresis (section 2.4.9). 
2.6.15 In vitro translation 
101.11 reaction mixtures for in vitro translation contained: 65-70% (v/v) 
rabbit reticulocyte extract (Aniersham, N150: nuclease treated, amino acid 
depleted), lOj.d. L-S-methionine, 227 niX potassium acetate, 2mX magnesium 
acetate, 50.1ni amino acids (except methionine), 0.5-2,ul T7 RNA or control 
RNA (section 2.1.6.3). 	Reactions were incubated at 30C for one hour and 
stopped by freezing. Reticulocyte extract was stored in 50M1  aliquots in 
liquid nitrogen. 
70 
As a first step towards the characterization of PRP2 protein and its 
function, it was decided to raise antibodies to the protein. The approach 
chosen was to construct fusions between E. coil proteins and different 
regions of the ?RP2 protein, and to inject these fusion proteins into 
rabbits. 
Two types of fusion proteins were constructed. 	The first type, which 
was used to raise anti-PRP2 antibodies, were fusions of different regions 
of PRP2 protein to the C-terminus of E. coil -galactosidase. These 
constructs were based on a set of E. coil expression vectors, the pUR 
plasmids (Ruther and Muller-Hill,1982), which contain the whole of the L. 
ccli lacZ gene and its IPTG-inducible promoter, upstream of a polylinker, 
into which the PRP2 gene fragments were cloned. The polylinker is Joined 
to the lacZ gene in a different reading frame In each vector and, knowing 
the sequence of the PRP2 gene CL Beggs, unpublished), It was therefore 
possible to select the appropriate vector, in order to produce an in-frame 
fusion between the lacZ gene and the different PRP2 gene fragments. 
The different fusion constructs are designated pFP2.1 to pFP2.6, in 
chronological order of construction, and are summarised in figure 3.1. 
In general, E. ccli clones containing the desired construct were identified 
by screening transformants with radioactively labelled PRF2 probes, 
followed by restriction mapping of plasmids isolated from positive clones. 
These clones were then tested for production of appropriately sized fusion 
proteins by SDS-P AGE. 
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Figure 3.1 PRP2 fusion constructs 
Top restriction endonuclease map of the PRP2 gene, showing restriction 
sites used in construction of fusion plasmids. Not all II and &U3A 
sites are indicated. 	The BaiLHI site at the 5' end of the gene was 
introduced by cutting at an Allill site and inserting BALLHI linkers (see 
section 4.1.2). The open reading frame is indicated by the arrow marked 
ORF. 
Bottom: the regions of PRP2 protein present in the different fusion proteins 
FP2.1-2.6 are indicated, with the number of amino acids in the PRP2 portion 
of the fusion protein. FP2,1-2.5 are fusions to the C-terminus of E. coli 
8-gaiactosidase; FF2.6 is a fusion to the C-terminus of a 33kD fragment of 
E. coil trpE protein. 
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The first plasmid, pFP2.1 was constructed by M. Lee (Lee et p1, 1986). 
pFP2.2 was constructed as follows (figure 3.2): pY2519+ (Table 2.3) was 
digested with and BSJII linkers were added. The DNA was then 
digested with XbjI and BZIII and a 1.7kb fragment containing the 3' region 
of the PRP2 gene (see figure 3.1) was gel purified. This fragment was 
ligated to pUR288, cut with BaILHI and XI, to create pFP2.2. 
pFP2.3 (figure 3.3) was constructed by using a BAjLHI site, which was 
inserted directly before the ATG start codon of the PRP2 gene (see section 
4.1.2). pBX-PRP2 (section 4.1.2) was digested with BAILHI and Hindlil, and a 
0.6kb fragment from the 5' end of the gene was purified and ligated to 
pUR289, cut with BAzLHI and Hindill. 
pFP2.4 (figure 3.3), containing the whole of the PRP2 gene was 
constructed by ligating a gel purified 3kb BAJI fragment (from pBM-PRP2) 
to pUR289, out with 
pFP2 .5 (figure 3.4), contains a 1.5kb II fragment which encodes the 
central region of the PRP2 gene. 	This fragment was previously cloned Into 
the polylinker region of ]'113mp19, by J.Beggs. 	It was cut out of this 
polylinker with Baj&HI and Hindill, and ligated to pUR291, cut with 	HI 
and Hindlil. 
The second type of PRI'2 fusion protein produced was FP2.6, which 
contains the whole of the PRP2 protein fused to the C-terminus of a 
fragment of the E. coli trpE protein (Dieckmann and Tzagoloff, 1985). The 
vector used in this case, pATH1, contains the trpE gene, under the 
transcriptional control of the indoleacryllc acid (IAA)-inducible tip. operon 
promoter. This vector is part of the pATH series, which have a polylinker 
at the 3' end of a fragment of the trpE gene, fused to the gene In different 
reading frames. pFP2.6 was constructed by ligating a purified 3kb BwILHI 
fragment containing the PRP2 gene (see above, pFP2.4) to pATH1, cut with 
HI. 
E. coll cells carrying the different fusion constructs were Induced for 
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Figure 3.2 Construction of pFP2.2 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: R- E.c.QRI, P-?II, B-J1I, X-XI, S-1I, Bg- g.1II. p- 
1. promoter, o-1 	operator. 
FE 
Figure 3,3 Plasmid maps of pFP2.3, pFP2.4 and pFP2.6 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: P-yjII, B-HI, H-HindIII p -1, promoter, o-lba  
operator. 
Figure 3.4 Construction of pFP2.5 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
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proteins produced ..naiysed by MS-FAGE, with the results shown in figure 
3.5. 	In each track the band indicated by an arrow is the full sized fusion 
protein. 	The more stable fusion proteins are produced in large quantities, 
and are the strongest bands in the track, illustrating the efficient 
expression which can be achieved using these vectors. It Is probable that 
different amounts of fusion proteins are produced In cells containing the 
different constructs because of different susceptibilities of the fusion 
proteins to proteolysis: FF2.2 is less stable than FF2.1, 2.3 and 2.5, and 
the two PRP2 fusions which contain the whole of the PRF2 protein, FF2.4 and 
FF2.6, are much less stable than FF2.2. In the case of FP2.6, large 
amounts of a protein of the same size as the trpE protein are produced 
(lane 1), clearly demonstrating the sensitivity of the FRP2 protein to 
proteolysis, when not protected by $-galactosidase. It is also possible 
that differences in efficiency of translation and/or stability of mRNAs 
coding for the various fusion proteins account for part of the differences 
in quantity of fusion protein produced. 
The apparent molecular weights of the fusion proteins are approximately 
as expected from the lengths of FRP2 coding sequence which are fused to the 
lacZ gene. There are, however, two unexpected results. The first is that 
despite the fact that FF2.2 contains more PRP2 coding sequence than FF2.3 
(219 vs 205 amino acids) the apparent molecular weight of FF2.3 Is slightly 
greater than that of pFP2.2. (These constructions have not been sequenced, 
but are correct according to Southern blotting, using PRF2 probes; not 
shown). There is an in-frame stop codon In the pUR289 sequence, 
immediately downstream of the polylinker, ruling out the possibility that 
the size of FP2.3 is due to translational readthrough Into vector sequences. 
There are two possible explanations of this discrepancy. 	The first is 
simply that pFP2.3 migrates anomalously slowly in SDS-polyacrylamide gels. 
This has been observed for a number of proteins, including 0-galactosidase 
fusion proteins (G. Anderson personal communication). There are no 
obvious sequences in FF2.3 which have been shown to cause such effects In 
other proteins. The second explanation relates to the second unexpected 
result in figure 2: although the expected molecular weight of pFP2.4 is 
approximately 216 kilodaltons, its apparent molecular weight is slightly 
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Figure 3.5 PRP2 fusion proteins 
E. coil strain BXH71-18 carrying ptJR288or pFP2.1 to pFP2.5, and HB1O1 
carrying pFP2.6, were induced for fusion protein synthesis, the cells lysed 
by heating at 100C for 5 minutes in SDS-PAGE sample buffer,and the 
proteins produced analysed by electrophoresis on an 8.5% SDS-polyacrylamlde 
gel. 	The gel was stained with Coomassle blue, following electrophoresis. 
The plasmid carried by the cells is Indicated at the top of each lane. 	In 
each lane the band of full sized fusion protein (or, In lane 7, J3- 
galactosidase) is Indicated by an arrow. 	Lane 11: marker proteins, with 
sizes indicated in kD. 






97 	 - - - 
66 IM 	4dW 
_ _ 
A 40 4W B 
J5 
= 
M 	1 	2 	3 	4 	5 	6 	7 
less than 200kD. 	Using more sensitive western blotting techniques, it has 
not been possible to detect any 3-galactosidase--containlng fusion proteins 
of higher molecular weight in whole cell extracts made from cells carrying 
pFP2.4 (not shown). It is possible that the C-terminal region of PRP2 
protein, which is common to FF2.2 and FP2.4 is extremely susceptible to 
protease degradation in E. coil, and is very rapidly degraded, resulting in 
a lower apparent molecular weight. 
Fusion proteins were purified for for use as antigens by two different 
methods (section 2.6.9). 	The first method, preparative SDS-PAGE, produced 
tens of micrograms of essentially pure, full size fusion proteins. 	The 
second method, urea fractionation resulted in hundreds of micrograms of 
protein, which was mainly -galactosidase fusion protein. Proteins produced 
by the second method are partly native 
Each fusion protein was injected into either two or three rabbits. 
This helped to increase the likelihood of obtaining sera with a high titre 
of antibodies, since the titre varied considerably between different 
rabbits. 	It also helped to identify immunological artefacts peculiar to 
particular animals. 	Injections were continued, at intervals of 3 weeks to 
1 month, until sera which reacted well with PRP2 protein on western blots 
were obtained (see below) whereupon the animals were given one further 
injection and then sacrificed. 	This normally occurred after three or four 
injections. 	However, in the case of FF2.2 seven injections were 
necessary. 
A comparison of the reaction of the different antisera with the PRP2 
protein is shown in figure 3.6. Yeast cell extracts were made by the 
sonication method (section 2.6.5) from two different strains of yeast (see 
below). 	The extracts were analysed by SDS-PAGE followed by Western 
blotting, and the blot probed with the different antisera. 	Each strip of 
the blot contains two tracks the left hand track Is extract derived from 
strain DJY40/pKV49 and the right hand track is from DJY40/pKV-PRP2 
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Figure 3.6 Comparison of antisera raised against different PRP2 fusion 
proteins. 
A Western blot of an 8.5% SDS polyacrylamide gel was cut into strips 
and probed with a 1:1000 dilution of the different antisera, in an equal 
volume of buffer. 	The blot was developed using the alkaline phosphatase 
procedure. Each strip consists of two lanes; the left hand lane contains 
lOpl of extract, made by sonication, from DJY40 cells carrying pKV49; the 
right hand lane contains lOjl of extract from DJY40 cells carrying pKV-
PRP2 (see text). The number of the rabbit from which the antiserum was 
taken is indicated at the top of each strip, as is the fusion protein with 
which each rabbit was injected. 	Lane X: marker proteins, with sizes 
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section 41.2). These differ in that cells carrying pKV-PRP2 produce high 
levels of PRP2 protein, when grown in media which contain galactose as 
carbon source, while cells carrying the parent vector, pKV49, produce normal 
levels of FRP2 protein, from the chromosomal gene. On each strip, as 
expected, the right hand track has a higher signal at the expected size of 
PRP2 protein (approximately lOOkD), which facilitates identification of PRP2 
protein. 
The titre of antibodies against PRP2 protein varies considerably between 
the different sera, although all show some reaction with the protein. 
There also exist smaller differences between different rabbits injected with 
the same fusion protein (cf rabbits 33 and 34). The sera raised against 
fusion proteins 2.3 and 2.5 have a far higher titre of anti-PRP2 antibodies 
than those raised against FF2.1 or FP2.2. This might be due to the fact 
that the former fusion proteins were prepared by the urea fractionation 
procedure, whereas the latter were produced by gel purification. However, 
further attempts to produce antisera to FF2.2, using the urea fractionation 
procedure to prepare the antigen, have not been successful, and as mentioned 
above it took a larger number of injections of FP2,2 than of other fusion 
proteins to obtain a response to PRP2. It is possible that the C-terminal 
region of PRP2 protein is not strongly immunogenic in rabbits. 
All the sera show some reactions with other yeast proteins, such as the 
triplet of bands at approximately 200kd. These bands have been observed 
on western blots using rabbit antisera raised against different (non-PRF2) 
fusions and are partly due to cross-reactions of both the primary and the 
secondary antibodies with these proteins (N. Loesky, G. Anderson, personal 
communication). The smear running ahead of the PRP2 protein in the right 
hand tracks of the strips of the blot probed with sera 54, 55, 138, 139 and 
140, is almost certainly due to breakdown products of the PRP2 protein. 
All the anti-PRP2 antisera have been used to immunoprecipitate the PRF2 
protein from yeast soluble protein extracts. 	An example of such an 
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Figure 3.7 Immunoprecipitat ions with anti-PRP2 antisera. 
Immunoprec ip itat ions with aFP2.1, cFP2.2 and c-peptide serum. 
Immunoprecipitations were performed upon S-labelled yeast soluble 
protein extracts, made by sonication, using 5il of the different antisera 
and the immunoprecipitates analysed by electrophoresis on an 8.5% SDS-
polyacrylamide gel. 	Following electrophoresis, the gel was fluorographed 
and exposed to X-ray film. 
Lanes 1 and 2: immunoprecipitations from extract of KY117/pBX125 cells. 
Lanes 3 to 8: immunoprec ip itat ions from extract of KY117/pBX-PRF2 cells 
(see text). Immunoprec ip itat ions were with preimmune serum from rabbit 34 
(lanes 1 and 3), immune serum from rabbit 134 (aFP2.1; lanes 2 and 7), 
si- v çi' rrbb 	F 	..1, 	cS 
immune serum from rabbit 33 (FP2.2; lane4),'imiune serum from rabbit 122 
(a-peptide serum, see text; lane 6). 	Lane 8 is identical to lane 7 except 
that 10ug of purified FP2.1 was added to the immunoprecipitation at the 
same time as the serum. Lane M: marker proteins, with sizes indicated 
in kD. 
Immunoprecipitations with cFP2.3 and cFP2.5 antisera. 
Immu noprec ip itat ions (using 5)A1 of serum) were performed upon a 20l 
'mock' splicing reaction, (identical to a normal in vitro splicing reaction, 
but with no added pre-mRNA, using splicing extract made from BJ2412 cells). 
The immunoprecipitates were analysed by electrophoresis on an 8,5% SDS-
polyacrylamide gel, followed by western blotting. The blot was probed with 
rabbit 139 serum (aFP2.5) and developed by the alkaline phosphatase 
procedure. 
Lanes 1 and 2: immunoprecipitation from 'mock' splicing reaction with no 
added ATP in incubation prior to immunoprecipitatlon. Lanes 3 and 4: 
immunoprecipitation from mock splicing reaction with 2mM ATP (final 
concentration) added to incubation prior to immunoprecipitation. 
Immunoprecipitations were with serum 55 (aFP2.3; lanes 1 and 3) or serum 
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experiment is shown in figure 3.7A 	Extracts were made from two different 
yeast strains: KY117/pBX125 and KY117/pBX-PRP2. 	The latter carries the 
whole of the PRP2 gene under control of the GALl promoter, on a single copy 
yeast plasmid (section 4.1.2). This strain moderately overproduces the 
PRP2 protein when cells are grown on galactose as carbon source, compared 
to KY117/pBN125 which carries the parent vector. Yeast proteins were 
labelled In vivo with 38S-methionine, and cells were lysed by sonication in 
a buffer containing 1% NP40. The extract was divided into equal aliquots 
and immunoprecipi tat ions, with different antisera were performed, using 
stringent washing procedures (as described in section 2.6.14.1). The 
immunoprecipitates were analysed by SDS-PAGE, followed by fluorography. 
Neither pre-Immune serum, nor immune serum from rabbit 134 (cxFP2.1) 
precipitate detectable amounts of PRP2 protein from KY117/pBX125 extracts 
(figure 3.7A, lanes 1 and 2). However, both 134 (lane 7) and 34 (cxFP2.2; 
lane 5) immune sera precipitate significant amounts of PRP2 protein from 
KY117/pBX-PRP2 extracts. Serum from rabbit 33 (lane 6) is considerably 
less effective than that from rabbit 34 In immunoprecipitatlng PRP2 protein 
despite the relatively small difference between the two sera in detection of 
PRP2 protein on western blots (figure 3.6). This is presumably due to a 
higher titre, In the serum of rabbit 34, of antibodies against epitopes 
revealed in native PRP2 protein. The other antiserum used in this 
experiment was raised against a synthetic peptide from a region close to 
the N-terminus of PRP2 protein. This serum has been shown to 
immunoprecipitate PRP2 protein from yeast extracts (Lee et p1, 1986), but in 
the experiment shown did not detectably immunoprecipitate the protein. 
Figure 5.7B shows immunoprec ipitat ions with sera from rabbits 55 and 
139. In this case, immunoprecipitations were performed upon in vitro 
splicing extracts, made from cells which do not overproduce PRP2 protein. 
The extracts were incubated for 20 minutes under 'mock' splicing conditions 
(identical to those of an in vitro splicing reaction, but with no added pre--
mRNA) in the presence or absence of added ATP (2mM). The reactions were 
then stopped, and imm unoprec ip itat ions performed using low stringency 
washing procedures, (section 2.6.14.2). 	PRP2 protein was detected in the 
ixnmunoprecipitates by Western blotting. PRP2 protein appears as two 
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bands in this experiment, due, presumably, to degradation of the full size 
protein: a similar effect is observed in figure 3,7A, lane 5. Although sera 
55 and 139 appear to react with PRP2 protein on Western blots with 
approximately equal efficiency, serum 139 is considerably more efficient at 
immunoprecipitating PRP2 protein from splicing extracts. It is possible 
that there is a higher titre of antibodies which recognise epitopes present 
in native PRP2 protein in serum 139 than in serum 55. 
Although figures 3.7A and 3.7B are not strictly comparable, due to the 
different extracts and detection methods used, the fact that 55 and 139 
sera detected PRP2 in extracts from cells that do not overproduce PRP2 
protein suggests that they immunoprecipitate PRP2 protein more efficiently 
than 34 or 134 sera. 	This is expected from the stronger reaction of these 
sera with PRP2 protein on Western blots. 	Figure 3.7B also demonstrates 
that the efficiency of precipitation of PRP2 protein is not affected by the 
presence of ATP, in the incubation prior to immunoprecipitation (cf lanes 2 
and 4). 
A number of other labelled proteins are present in the 
immunoprecipitates shown in figure 33A. The amounts of these proteins, 
(of molecular weights 200kD, 58-62kD and 48-52kD), present in the 
immunoprecipitates does not correlate with the amount of FRP2 protein 
immunoprecipitated by the different antisera, and is in general variable 
between experiments. The proteins of molecular weight 200kD are almost 
certainly identical to the proteins of similar molecular weight, which are 
detected on western blots (figure 3.6) and which are known not to be 
related to FRP2 protein. It is probably that the bands observed in figure 
3.7A are proteins which bind IgG non-specifically, probably via hydrophobic 
interactions. 	In pre-immune sera, which contain less IgG than immune 
sera, these bands are reduced. 	Repeated attempts to detect proteins which 
co-imniunoprecipitate with PRP2 protein have failed to identify any such 
proteins. 
In 	figure 	3.7A, lane 	8, 	a 	large excess of 	FP2.1 	was 	added 	to the 
inimunoprecipitation at the same point as the antiserum. This excess of 
fusion 	protein 	would be expected to compete with 	PRP2 	protein 	for the 
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antibody, and thus reduce the intensity of the lOOkD band. In fact, the 
intensity of the lOOkD band is slightly increased In lane B. The failure 
of F?2.1 to compete with PRP2 protein initially led to doubts that the 
lOOkD band observed in immunoprecipitates was the PRP2 protein. The clue 
to understanding this result is the increased precipitation of 52, 112 and 
200kD proteins in this lane; in some experiments the lOOkD band was also 
strongly increased in intensity. In an immunoprecipitation of in vitro 
translated PRP2 protein, (i.e. where the PRP2 protein was the only 315S - 
labelled protein present, section 4,3)In the presence of a -galactosidase-
PRPB fusion protein, a similar effect was observed (not shown), indicating 
that PRP2 protein has a tendency to precipitate more strongly under these 
conditions. Thus, when partially denatured PRP2 fusion proteins are added 
to an immunoprecipitation, two processes compete: (i) competition of the 
fusion protein for anti-PRF2 antibodies and (ii) hydrophobic Interactions 
between the fusion protein and PRP2 protein, followed by immuno-
precipitation of PRP2 protein-fusion protein complexes by antI-n-
galactosidase antibodies. In many cases the latter process is more 
efficient than the former, resulting in Increased immunoprecipitation of 
PRP2 protein in the present of the competing fusion protein. 
Another example of an antigen competition experiment Is shown in figure 
3.7C. Here, the antiserum used was from rabbit 139 and the 
immunoprecipitation performed on splicing extract, using low stringency 
washing procedures (section 2.6.14.2). Competition was performed by 
adding 0-galactosidase (lanes 2 and 5) or FP2.5 (lanes 3 and 6) to the 
incubation of antiserum with PAS, prior to immunoprecipitation. ?RP2 
protein is just visible in lane 1, but due to the background of fusion 
protein and $-galactosidase breakdown products it is not possible to 
observe PRP2 protein In lanes 2 and 3. However, in the immuno-
precipitation supernatants PRP2 protein is clearly visible in lane 6, but 
not in lanes 4 and 5, indicating that FP2.5, but not 0-galactosidase 
competes with PRP2 protein for binding of anti-PRP2 antibodies. It Is not 
clear why the hydrophobic interaction effect is not operative In this 
experiment, but it is possibly due to the fact that PRP2 protein is not 
over-expressed in splicing extract. If PRP2 protein is in a complex with 
other proteins, when it is expressed at a much higher level than the other 
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proteins in the complex, then the excess PRP2 protein will have exposed 
hydrophobic patches on its surface, which will tend to make it stick non-
specifically to hydrophobic patches on the surface of partially denatured 
fusion proteins. Evidence from genetic studies (Last et al,1987) and from 
biochemical fractionation (Lin et al, 1987) suggests that PRP2 protein may 
be part of such a complex. 
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There were two main reasons for creating in vivo and in vitro systems 
for the over-expression of PRP2 protein. The first was illustrated in 
chapter 3: over-expression as a means of identification of the protein. 
The second reason was to obtain an enriched source of PRP2 protein for 
partial purification (see section 4.5). In the course of this work, an 
assay system for PRP2 activity was developed, based on the system of 
Lustig et al (1986). 
The plasmid pJDB2076, which was used to obtain over-expression of PRP2 
protein under the control of its own promoter, contained the whole of the 
PRP2 gene, which was sub-cloned into a high copy number yeast vector, 
pJDB207 (Lee et al, 1984; figure 4.1). A similar construct was used to 
obtain over-expression of PRP2 protein by Last et al (1986). 
An example of the over-expression obtainable using this construct is 
shown in figure 4.2A. DBY747 cells, carrying pJDB207 or pJDB2076 were 
grown on yeast minimal medium, under plasmid selective conditions, and were 
lysed by sonication. The soluble protein extracts were analysed by 
Western blotting, and the blot probed with aFP2.1 serum (rabbit 134), or 
with pre-immune serum from the same rabbit. PRP2 protein was detected 
only in extracts from cells which carried pJDB2076 (figure 4,2A, lane 4). 
It is not possible to estimate accurately the degree of over-expression of 
PRP2 protein in this experiment since it was not detected in the control 
extract. However, the level of expression of PRP2 protein in cells 
carrying pJDB2076 is at least 30-fold higher than the control. 
0









Figure 41 Plsmid map of pJDB2076 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: P-EiII, B-Ht, H-HindIII, BS-g1II. 
Figure 4.2 Over-expression of PRP2 protein in yeast. 
Over-expression of PRP2 protein in yeast using a high copy number 
vector. 
Extracts, made by sonication, of DBY747 cells carrying pJDB207 or 
pJDB2076, were analysed by electrophoresis on an 8.5% SDS-polyacrylamide 
gel, followed by Western blotting. The blot was cut into 2 strips and 
probed with either immune or pre-immune serum from rabbit 134 (aFP2.1) and 
developed using the 125 1-protein A procedure. 
Lanes 1 and 3: extracts from cells carrying pJDB207. 	Lanes 2 and 4: 
extracts from cells carrying pJDB2076. 	Lanes 1 and 2: blot probed with 
1:1000 dilution of preimmune serum from rabbit 134. 	Lanes 3 and 4: blot 
probed with 1:1000 dilution of immune serum from rabbit 134 (aFP2.1). 
Lane M: marker proteins with sizes indication in kD. 
Over-expression of PRP2 protein In yeast under the control of the QALI 
UAS. 
KY117 cells (carrying pBM125 or pBX-PRP2) and DJY40 cells (carrying pKV49 
or pKV-PRP2) were grown on yeast minimal medium, with either glucose or 
raffinose plus galactose as carbon source. 	Extracts of cells, made by 
sonication, were analysed by electrophoresis on an 8.5% SDS-polyacrylamide 
gel, followed by Western blotting. The blot was probed with rabbit 55 
antiserum (cFP2.3) and developed by the alkaline phosphatase procedure. 
Lanes 1 to 4: cells grown with glucose as carbon source. Lanes 5 to 8: 
cells grown with raffinose plus galactose as carbon source. The plasmid 
carried by the cells from which extracts were made is indicated at the top 
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Although extracts from cells carrying pJDB2076 consistently showed 
higher levels of expression of PRP2 protein than control extracts, this 
level was variable, and seemed to decrease with increasing time of storage 
of transforniants on agar plates. 	Furthermore, pJDB207 transformants 
often grew extremely slowly, relative to pJDB207 transformants. 	This 
suggests that high levels of PRP2 protein are inhibitory to growth in 
yeast, and that as a result, cells which have eliminated the plasmid, or in 
which the PRP2 gene on the plasmid was inactivated by recombination, are 
selected during growth in culture. Other laboratories which have used 
high copy number yeast plasmids containing the PRP2 gene have not reported 
similar difficulties, however; the reason for this discrepancy is not known. 
In this laboratory (this work, and X. Lee, J.D. Beggs unpublished), the 
lack of reliable over-expression and growth of pJDB2076 transformants made 
this plasmid unsuitable for further experiments. 
In cells carrying pJDB2076, expression of the plasmld PRP2 gene is 
constitutive, Since it appeared to be the case that such constitutive 
production of high levels of ?RP2 protein is deleterious to cell growth, it 
was decided to use an inducible/repressible expression system. With such 
a system, cells carrying the expression construct can be grown to suitable 
optical density under conditions which repress expression of PRP2 protein, 
(and which, therefore, are not deleterious to growth), and expression then 
induced by a change in growth conditions. 
The yeast AL1 promoter was chosen for controlled expression of the 
PRP2 gene. This promoter controls the transcription of the GALl gene 
according to growth conditions: when cells are grown using glucose as 
carbon source, transcription from the GAT-1 promoter is repressed; when 
galactose is the carbon source, high levels of transcription are induced. 
Raffinose is a neutral carbon source, which neither represses nor induces 
transcription from this promoter. 
81 
Digest with b.LLIII. 
Ligate BAnHH linkers. 





Ligate. with 	HI. 
P I 
GAL 1 .11 




Figure 4.3 Construction of pBM-PRP2 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: R-ERI, P-jII, B-.JiI, H -EftIII, A- Aj1III. 
Pc,iLAkl promoter. 
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Figure 4,4 Plasmid map of pKV-PRP2 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: R-ERI, P -EII, B-HI, Bg-.jII, H-HindIII. 	UASAL- 
Akl upstream activator sequence, 	promoter. 
In order to place the PRP2 gene under control of the GALl promoter, it 
was necessary to separate the PRP2 gene from its own promoter. (Attempts 
to obtain over-expression by placing the PRP2 promoter under control of the 
GALl upstream activator sequence (UAS), on a low copy number plasmid 
(constructed by M. Lossky), did not produce detectably increased amounts of 
PRP2 protein, as assayed by Western blotting; not shown). In order to do 
this the presence of an A1IIII site at the methionine initiator codon of the 
PRPa gene was exploited (figure 4.3). Plasmid pY2016 (Lee et p1, 1984) 
was cut with £tlIII, and overhanging 5' ends filled in with Klenow enzyme. 
m{I linkers were then added, the DNA digested with BAn.HI, and a 3kb DNA 
fragment containing the PRP2 gene purified. 	This fragment was ligated to 
pBM125, cut with 	mII, thus inserting the PRP2 gene downstream of the 
GALl promoter. The BAAHI site inserted at the start of the PRP2 gene was 
utilized in a number of other constructs (e.g. figure 3.1). 
In order to combine the advantages of the GALl induction /repression 
system with those of a very strong promoter, and high plasmid copy number, 
the vector pKV49 was utilized. This plasmid contains the yeast 
phosphoglycerate kinase promoter, under the control of the GALl UAS, and is 
maintained at high copy number. 
In order to insert the PRP2 gene into this plasmid, pBX-PRP2 was cut 
with Baj&HI and the 3kb PRP2 fragment was gel purified. This fragment was 
ligated to pKV49, cut with BSIII, creating pKV-PRP2 (figure 4.4). 
pBM-PRP2. PKV-PRP2, and their respective parent vectors were transformed 
into yeast strains with the appropriate selectable markers. The control 
of expression of PRP2 protein in cells carrying these plasmids was 
examined by Western blotting of protein extracts, produced by sonication 
(figure 4.2B), Cells (KY117 carrying pBX125 or pBX-PRP2, DJY40 carrying 
pKV49 or pKV-PRP2) were grown overnight in yeast minimal medium (YMM) 
plus 2% glucose in order to repress expression of PRP2 protein, or on YXM 
plus 2% raffinose and 2% galactose to induce expression (section 2.6.8), 
Raffinose is present in the latter case as an additional, neutral, carbon 
source, since the yeast strains used grow more slowly on ga1actoe alone 
than on glucose. 
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As figure 4.2B, lanes 2 and 6 indicate, cells carrying pBX-PRP2 over-
express PRP2 protein only when grown on galactose. Cells carrying the 
parent vector pBX125 do not over-express PRP2 protein under either set of 
growth conditions (lanes 1 and 5). pBM-PRP2-carrying cells produce 
approximately ten times as much PRP2 protein when grown on raffinose plus 
galactose than when grown on glucose as carbon source. 
For cells carrying pKV-PRP2 the situation is slightly more complex, since 
PRP2 protein Is over-expressed even when cells are grown on glucose (lane 
4). 	It appears that with this plasmid, glucose repression Is not fully 
operative. 	One possible explanation of this effect is that It is due to 
the high copy number of pKV-PRP2. 	The large number of copies of the .AIg1 
TJAS may titrate out the GAL80 protein, which represses transcription when 
cells are grown on glucose, thereby allowing transcription from the strong 
F_Qj promoter. 
Using a more sensitive detection system, a similar phenomenon was 
observed with pBX-PRP2-carrying cells. Thus, when pBX125 and pBX-?RP2 
were transformed into a temperative sensitive prp2-1 strain (JBY27), and 
the transformants were grown at the restrictive temperative, as expected, 
pBM-PRP2, but not pBM125, was able to complement the temperature sensitive 
growth defect. This complementation occurred when cells were grown on 
either glucose, or on raffinose plus galactose as carbon source (data not 
shown) indicating that there was a small amount of transcription from the 
GAM promoter, even when the cells were grown on glucose. 
When cells carrying pKV-PRP2 are grown on raffinose plus galactose, PRP2 
protein is produced at extremely high levels (100-200 times background 
levels), demonstrating that the Ff& promoter is under the control of the 
.AIL UAS. It was possible to visualize the PRP2 protein by CoomassIe Blue 
staining of a replica of the gel shown in figure 4,2B: a band of PRP2 
protein was only visible in lane 8 (not shown). This experiment Indicates 
that expression of PRP2 protein using the QAL regulation system was both 
efficient and well regulated. These plasmids have therefore been useful 
for a number of different purposes e.g. sections 4.4, 4.5. 
83 
MOMMr-M NMI 	 nFrimWIMMM 064 
As an alternative to yeast, PRP2 protein was expressed in E. coil. 	The 
plasmid expression vector used was pDR540 (Pharmacla), which contains the 
tac promoter, a fusion of the E. coil tr. and 1Z promoters. This 
promoter responds to synthetic lactose analogues such as IPTG in the same 
way as the iQZ promoter. The 3kb BAM.HI fragment from pBX-PRP2, which 
contains the PRP2 gene was sub-cloned into the BAmIHI site, downstream of 
the tac promoter in pDR540, creating pDR-PRP2 (figure 4.5). 
The regulation of expression of PRP2 protein in B. coli cells carrying 
pDR-PRP2 was examined using a similar approach to that used with the yeast 
expression vectors. B. coii cells carrying pDR-PRP2 were grown to mid-log 
phase, and expression from the tac promoter was induced by addition of 
IPTO to the culture (section 2.6,6), After a further brief period of 
growth cells were harvested, resuspended in PBS, lmX PXSF, and lysed by 
sonication. Cellular debris was pelleted by centrifugation, and the 
supernate and pellet fractions subjected to SDS-PAGE followed by Western 
blotting. 	The blot was probed with anti-FP2.3 serum, with the results 
shown in figure 4.6. 	When no IPTG was added to the cells a number of 
strong bands were detected, but no band at approximately lOOkD was visible. 
The strong bands at approximately 8OkD and 60kD are possibly due to 
reaction of the serum with B. roll proteins, which might have been present 
as contaminants in the antigen preparations which were injected into 
rabbits. An alternative explanation is that they are proteins which cross-
react with rabbit antibodies. 
When expression from the tac promoter was induced with IPTG, a band at 
approximately iOOkD was detected in both supernatant and pellet fractions 
(lanes 2 and 6). When the soluble protein extract was subjected to 
immunoprecipitation with serum 54 (aFP2.3), using low stringency washing 
conditions, this band was iminunoprecipitated (lane 7). The protein co-
migrates with authentic PRP2 protein from yeast extract. No such band is 
visible in extracts from IPTG-induced cells which carry pDR540 (data not 
shown). Since the lOOkD protein is only present in cells carrying pDR- 
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Figure 4.5 Plasinid map of pDR-PRP2 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: R-çRI, B-J{I, H-HindIII P - yJ.LII. p-tac promoter, 0- 
tac operator. 
Figure 4,6 Expression of PRP2 protein in E. coli 
E.coli cells (strain BH71-18)carrying pDR-PRP2 were induced for 
expression of PRP2 protein by addition of IPTG, and were iysed by 
sonication. 	Insoluble cell debris was separated by centrifugation. 
Extracts were analysed by electrophoresis on an 8,5% SDS-polyacrylamide gel 
followed by Vesterm blotting. The blot was probed with rabbit 55 serum 
(aFP2.3) and developed by the alkaline phosphatase procedure. 
Lanes 1, 3 and 5: extracts from cells prior to induction with IPTG. 
Lanes 2, 4 and 6: extracts from cells after IPTG induction. 	Lanes 1 and 2: 
181 of resuspended insoluble cell debris. Lanes 3 and 5: 21 of soluble 
cell extract. 	Lanes 4 and 6: lBpl of soluble cell extract. 	Lane 7: 
immunoprecipitate from 3001 of soluble cell extract, from IPTG-induced 
cells, using 5.tl of serum 55 (cFP2.3). 	Lane 8: 1i1 of extract from yeast 
cells carrying pBM-PRP2. 	Lane N: marker proteins, with sizes indicated in 
kD. 
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PRF2, under inducing conditions, it may be concluded that the lOOkD protein 
in lanes 2, 6 and 7 is FRP2 protein. 
It is difficult to compare accurately the relative efficiencies of PRP2 
expression in E. coli and yeast, due to the different methods of extract 
preparation used. Nevertheless, from the concentrations of protein in the 
extracts in lanes 6 and 8, it is clear that expression of PRP2 protein in E. 
li, in this experiment, is at least five times less efficient than in pBX-
PRP2-carrying yeast cells. 
In many experiments, It has been difficult to detect any expression of 
?RP2 protein in E. coil, and in only one case was it possible to 
demonstrate PRP2 protein activity (see section 4.4) in E.cali extracts. 
One possible cause of this problem is that the initiation of translation of 
PRP2 inRNA may be inefficient. There is, however, a sequence which is a 
good match to the Shine and Dalgarno consensus sequence, close to the 
initiation codon of the PRP2 gene in this construct. The cause of the 
problem is most likely to be rapid degradation of PRP2 protein by proteases 
which recognise and degrade foreign proteins. This explanation is 
supported by the relatively low amounts of FF2.4 and FF2.6 produced in L. 
colt in comparison to the other, smaller, PRP2-3-galactosidase fusion 
proteins (section 3.1). Various protease deficient mutant strains of L 
coil have been tested for ability to accumulate PRP2 protein, with no 
significant improvement over the strain used in this experiment (not 
shown). 	It is probable that PRP2 protein is extremely rapidly degraded by 
as yet unidentified B. call proteases. 	Because of the unreliable nature of 
PRP2 expression in B. coil, this system has not been used as a source of 
PRP2 protein for purification experiments. 
The purpose of expression of PRP2 protein in vitro was to determine 
whether It interacts directly with spliceosomes, using an experimental 
design similar to that used by Chang et al (1988). This involves addition 










Figure 4,7 Plasmid map of pSPT-PRP2 
Open boxes: PRP2 coding sequences. 	Closed boxes: vector genes. 
Restriction sites: P-EII, B-HI ) H-HiridIII, P.-SP6 promoter, P-T-7-T7 
promoter. 1CS-multiple cloning site. 
non-denaturing electrophoresis to determine whether 	S- labelled PR?2 
protein co-migrates with spliceosomes. 
In order to express PRP2 protein by in vitro translation, a plasmid 
designed for transcription of the PRP2 gene in vitro was constructed. 
This plasmid, pSPT-?RP2 (figure 4.7), contains the whole of the PRP2 gene 
inserted downstream of the bacteriophage 17 promoter. It was constructed 
by inserting the 3kb BZLMJiI fragment from pB-PRP2 (section 4.1.2), which 
contains the whole of the PRP2 gene, into the B=HI site in the polylinker 
of pS?T18. 
pSPT-?R?2 was linearized by digestion with SAII and was transcribed in. 
vitro (as described in section 2.4.23, with the exception that the UTP 
concentration in the transcription reaction was 0.5mX, and no 2P-labelled 
UT? was present). The RNA made was examined by agarose gel 
electrophoresis and by denaturing polyacrylamide gel electrophoresis, and 
was mainly full length (3kb; data not shown). Different sized aliquots of 
the in vitro transcription reaction were used to programme an in vitro 
translation reaction (section 2.6.15), which contained 5S-methionine, and 
the products of the translation reaction were examined by SDS-PAGE, 
followed by autoradiography (figure 4.8). 
In the absence of added RNA, there are no protein bands in the lOOkD 
region of the gel (lane 1). There is, however, a band at approximately 
27kD and a large smear at the bottom of the gel which is haemoglobin, 
produced from residual haemoglobin mRNA in the rabbit reticulocyte extract. 
Lane 2 is a reaction to which 1 il of a control RNA substrate (see section 
2.1.6.3) was added. Large amounts of a protein of the expected molecular 
weight, 26kD, were made, indicating that the rabbit reticulocyte extract was 
capable of accurately translating exogenous RNA. When progressively 
larger aliquots of the pSPT- PRP2- programmed in vitro transcription reaction 
were added to the in vitro translation extract (lanes 3 to 5), increasing 
amounts of a lOOkD protein were made, plus various smaller proteins. The 
lOOkD protein was efficiently immunoprecipitated by anti-PRP2 antibodies, 
confirming that it was PRP2 protein (data not shown). The origin of the 
smaller proteins is unclear, although they are derived from the PRP2 gene 
Figure 4,8 In vitro translation of PRP2 protein. 
In vitro translations were performed as described in section 2.6.15, and 
the proteins produced analysed by electrophoresis on an 8.5% SDS-
polyacrylamide gel. 	Following 	electrophoresis, the gel was 
fluorographed. 	Each sample is 8)11 of an in vitro translation reaction, 
programmed with the RNA indicated at the top of the lane. Lane K: marker 
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since they are also precipitated by anti-PRP2 antibodies, albeit with a 
lesser efficiency than the full sized protein (data not shown). These 
proteins might arise due to (a) prematurely terminated substrate RNA or (b) 
premature termination of translation. Of these alternatives, (b) appears 
to be the most likely since the RNA used as substrate was mainly full 
length (not shown) While in some experiments the ratio of full sized 
PRP2 protein to smaller fragments was higher than in the experiment shown, 
it was not possible to Increase this proportion reproducibly by altering i& 
vitro translation conditions (concentrations of Mg 2 and K, presence of 
yeast tRNA) which might affect the frequency of premature translation 
termination. 
A preliminary step towards the objective of determining whether 
labelled PRP2 protein co-migrates with spliceosomes on non-denaturing gels 
was to show that the in vitro translated protein has PRP2 activity (section 
4,4). 	However, it was not possible to demonstrate any PRP2 activity In in. 
vitro translation reactions programmed by PR22mRNA (not shown). 	The 
reason for this is uncertain: it might be due simply to a limitation of the 
assay system (section 4.4), which Is that -only small volumes of protein 
extract (which must therefore be concentrated) can be added to in vitro 
splicing reactions. 	Attempts to concentrate in vitro translated PRP2 
protein did not succeed in demonstrating PRP2 activity. 	An alternative 
possibility is that the activity of PRP2 protein in splicing may be 
dependent on post-translational modifications. Because it was not 
possible to demonstrate that in vitro translated PRP2 protein was active in 
pre-mRNA splicing, the investigation of whether 31-S_labelled PRP2 protein 
is associated with spliceosomes was not pursued. 
An assay for PRP2 protein activity was developed as part of pilot 
studies for purification of the protein. The assay system exploits the 
fact that the activity of splicing extracts made from temperature sensitive 
prp2 strains is Itself temperature sensitive (Lustig et p1,1986). It is 
possible to show that the temperature sensitivity of such extracts is due 
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Figure 4.9 Assay system for FRP2 protein activity in pre-mRNA splicing. 
A: Complementation of heat inactivated prp2 splicing extracts with 
different protein extracts. 
Wild type and prp2 splicing extracts (made from strains BJ2412 and 
JBY27 respectively) were heated for different periods of time at 32C, prior 
to in vitro splicing. 	RNA was purified from a 10l in vitro splicing 
reaction and analysed by electrophoresis on a 12% acrylamide, 8M urea gel. 
The pre-mRNA used in this experiment was made by in vitro transcription of 
pSPRP51A2, cut with 
Splicing extracts were heated for 0 (lanes 1 and 3) or 60 (lanes 2 and 
4 to 8) minutes at 32C, prior to commencement of the splicing reaction. 
Lanes 1 and 2: splicing reactions performed with extract made from wild 
type (BJ2412) cells. 	Lanes 3 to 8: splicing reactions performed with 
extract from prp2 (JBY27) cells. 	Following heating, but prior to 
commencement of the reaction, lj.tl of the following was added: dH20 (lanes 2 
and 4); a 1:5 dilution of extract from cells carrying pBX125 (lane 5); a 1:5 
dilution of extract from cells carrying pBM-PRP2 (lane 6); a 1:15 dilution 
of extract from cells carrying pBX125 (lane 7); a 1:15 dilution of extract 
from cells carrying pBM-PRP2 (lane 8). P-pre-mRNA, IVS.E2-lariat 
Intermediate, IVS-lariat product. Exon 1 and spliced mRNA are not visible 
in this gel due to the background of degraded pre-mRNA. 
B. Splicing activity of complementing extract from cells carrying pBX-
PRP2. 
Prp2-4 splicing extract (made from strain DJY39) was heated for 
different periods of time at 32C, prior to in vitro splicing. 	RNA was 
purified from a lOj.d in vitro splicing reaction and analysed by 
elctrophoresis on a 6% acrylamide, 8X urea gel. The pre-mRNA used in this 
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to the temperature sensitive p14?2 protein see below) and that splicing 
activity can be restored by addition to the heated extracts of wild type 
PRP2 protein. (This is referred to as in vitro complementation). Such 
heat inactivated extracts therefore provide an assay system for the 
activity of PRP2 protein. 
An experiment demonstrating that heat inactivation of prp2 extracts was 
due to the heat inactivation of prp2 protein is shown in figure 4,9A. Wild 
type and prp2 extracts were incubated at 32C for 1 hour (section 2.5,3) 
and small amounts of complementing extracts were added, prior to the 
commencement of in vitro splicing. Lanes 1 and 2 show that the activity 
(as measured by the production of lariat containing RNAs) of splicing 
extract made from a wild type strain of yeast (BJ2412) was not temperature 
sensitive. The activity of prp2-1 splicing extract was destroyed by a one 
hour incubation at 32C (lanes 3 and 4) but was restored by adding 1il of 
a 1:5 dilution of extract from cells carrying pBX-PRP2 (lane 6). 
(The sources of PRP2 protein used in this experiment were extracts, made 
by the procedure for preparation of splicing extracts, from KY117 cells 
carrying either pBM125 or pBX-PRP2, and grown on raffinose plus galactose 
as carbon sources. These extracts were used in all experiments involving 
complementation of heat inactivated prp2 splicing extract). 
Addition of an equal amount of extract from cells carrying pBX125 
complemented the heat inactivated prp2 splicing extract only weakly (lane 
5). 	At a 1:15 dilution the pBX-PRP2 extract was still able to complement 
the prp2 extract (lane 8), while pBM125 extract did not (lane 7). 	The 
fact that an extract which contained elevated levels of PRP2 protein 
(section 4.1.2) was able to complement the heat inactivated prp2 splicing 
extract at higher dilutions than control extract, is strong evidence that 
the temperature sensitivity of the splicing extract is due to the 
temperature sensitive prp2 protein. In some experiments, however, a 
process of non-specific heat inactivation of prp2 extracts occurred, and it 
was therefore necessary to determine whether non-specific heat Inactivation 
occurred in each such experiment, by demonstrating full restoration of 
activity by small amounts of extracts from cells carrying pBM-PRP2. 
Figure 4.9B demonstrates that the complementing extract did not itself 
possess any splicing activity. The temperature sensitive prp2 splicing 
extract used in this experiment is made from a prp2-4 strain of yeast. 
Splicing extracts made from strains carrying this prp2 allele have very 
similar properties to prp2-1 extracts. Prp2.4 extracts were incubated at 
32C for 1 hour, and small amounts of complementing extracts were added 
prior to in vitro splicing. As lanes 1 to 3 show, the activity of the 
prp2-4 splicing extract was temperature sensitive, and could be restored by 
addition of 11 of a 1:10 dilution of extract from cells carrying pBX-PRP2. 
Lane 5 shows that ljil of pBX-PRP2 extract has no splicing activity in the 
absence of prp2.4 splicing extract. The restoration of activity to heat 
inactivated prp2 splicing extracts by pBX-PRP2 extract must therefore be 
due to PRP2 protein. 
In the experiment shown in figure 4.9B, lane 4, the complementing 
extract was added to the heat inactivated splicing extract after the 
commencement of the splicing reaction i.e. after the early stages of 
splicing complex formation have occurred (Lin et p1, 1987; Cheng and 
Abelson, 1987). Since the PRP2 protein was able to complement the prp2 
extract under these conditions, It is clear that PRP2 protein does not need 
to be present at the initial stages of splicing complex formation, in order 
to perform its function, In agreement with the findings of Cheng and 
Abelson (1987). 
A pilot study for the purification of PR?2 protein Is shown in figure 
4.10. A 1L culture of DJY40 cells, carrying pKV-PR?2, was grown on yeast 
minimal medium with raffinose plus galactose as carbon source, in order to 
Induce expression of PRP2 protein (section 4.1,2). The cells were harvested 
by centrifugation (5000rpm, for 10 minutes in a Sorvall GS-3 rotor), and 
their cell walls partially digested with lyticase in order to weaken them. 
They were then lysed by sonication (section 2.6.5). This method of lysis 
was chosen in order to maximize extraction of PRP2 protein from the cells 
while minimizing the extraction of other proteins. Partial spheroplasting 
Figure 4.10 Partial purification of PRP2 protein. 
Samples of different fractions from the partial purifgication of PRP2 
protein were analysed by electrophoresis on 2 15% SDS -polyacrylamlde gels. 
The gels were stained with Coomassie Blue (A), or western blotted, probed 
with serum 139 (aFP2.5) and developed by the alkaline phosphatase procedure 
(B). 	The quantities given are for A: in B the quantities were 50% of those 
in A. 
Lane 1: unfractlonated extract of DJY40 cells carrying pKV-PRP2, 1% of 
total. 	Lane 2: supernatant of 35,000rpm centrifugation, 1% of total. 	Lane 
supernatant of 50% ammonium sulphate precipitation, 1% of total. Lane 
pellet of 50% ammonium sulphate precipitation, 1% of total. 	Lane 5: 
flowthrough fraction from heparin agarose column, 1% of total. Lanes 6 to 
19: heparin agarose column fractions, 5% of total. 	Lane 6; fraction 2. 
Lane 7: fraction 4. 	Lane 8: fraction 6. 	Lane 9: fraction 8. 	Lane 10: 
fraction 10. 	Lane 11: fraction 12. 	Lane 12: fraction 14. Lane 13: 
fraction 16 Lane 14: fraction 18. Lane 15: fraction 20. 	Lane 16: 
fraction 22. 	Lane 17: fraction 24. 	Lane 18: fraction 26. Lane 19: 
fraction 28. Lane X: marker proteins, with sizes Indicated in kD. 
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of the cells was found to increase the yield of protein upon sonication 
(not shown). However, breaking the cells with a Dounce homogenizer, while 
further increasing the total protein yield did not increase the yield of 
PRP2 protein. 
Cell debris was removed by centrifugation at 17,000rpm for 30 minutes 
at 4C and the extract subjected to a further centrifugation at 38,000rpm 
for 1 hour at 4C, in order to remove fragments of chromatin and ribosomes. 
The extract was analysed by SDS-PAGE and contained proteins in the range 
15kD to greater than 200kD (figure 4.10A, lane 1). Some low molecular 
weight proteins, which were possibly ribosomal proteins or chromatin-
associated proteins, were removed by high speed centrifugation (lane 2). 
PRP2 protein remained in the supernatant after centrifugation (figure 4,10B 
lane 2). 
Ammonium sulphate was then added to the high speed supernate, to 50% 
saturation, and the protein precipitate recovered by centrifugation (section 
2.5.2). Both pellet and precipitate were dialysed against buffer A (20mM 
HEPES pH 7.9, 0.5mM EDTA, 0.5mM DTT, 10% (v/v) glycerol), to remove 
ammonium sulphate. As can be seen (figure 4.10A, lanes 3 and 4), this 
step selectively removes a number of proteins, particularly low molecular 
weight proteins. PRP2 protein is precipitated essentially quantitatively 
in this step (figure 4.10B, lanes 3 and 4). 
The ammonium sulphate precipitate was loaded onto a imi heparin-agarose 
column, which was pre-equilibrated with buffer A. The flow through 
fraction from the column was collected and the column washed with 5 
column-volumes of buffer A. Proteins were eluted with a 50-800mM sodium 
chloride gradient (3ml) in buffer A, and lOOjd fractions collected. 
Samples of some of these fractions were analysed by SDS-PAGE (figure 4.10A, 
lanes 5-19). Although much of the protein in the ammonium sulphate 
precipitate bound to the heparin agarose, a number of prominent protein 
bands were found in the heparin agarose flow-through fraction (figure 
4.10A, lane 5). PRP2 protein bound to the column, and only a small 
proportion was found In the flow through fraction (figure 4.10B, lane 5). 
Elution of proteins from the column with a salt gradient fractionated the 
EEO 
proteins efficiently (figure 4.10A, lanes 6-19). 	The PRP2 protein peak was 
found In fractions 10 to 16 which corresponds to a salt concentration range 
of approximately 300-480 mM. 
There Is a prominent doublet of protein bands in the 97-100kD range in 
the crude extract and ammonium sulphate precipitate which clearly 
fractionate differently on the heparin agarose column, the higher molecular 
weight protein eluting at lower salt concentrations. 	The upper band of 
the doublet is one of the major proteins in the crude extract. 	It migrates 
in this gel at 97kD, which Is faster than Its normal migration rate of 
approximately 102kB, while PRP2 protein migrates faster than the 97kD 
marker (figure 4.10B). Such small differences in electrophoretic mobility 
have been observed for PRP2 protein, in other experiments (not shown). 
The lower band of the doublet is not generally detected In crude yeast 
extracts. However, such a band was visible in extracts of pKV-PRP2-
carrying cells, but only when such cells had been grown on raffinose plus 
galactose as carbon source (not shown). This suggests that the lower band 
of the doublet is PRP2 protein. The suggestion is apparently supported by 
the coincidence of position of the peak of this protein with the peak of 
PRP2 protein. Although the Intensity of the bands in lane 10 to 16 in 
figures 4.10A and B is not precisely parallel, in both cases there is a 
sharp difference In intensity of the bands between lanes 9 and 10, at the 
start of the peaks, and between lanes 15 and 16, at the end of the peaks. 
If it Is the case that the lower band of the doublet Is the PRP2 protein, 
then it Is clear that substantial purification has been achieved (cf lanes 1 
and 11): in lanes 11 and 12 this band is the strongest band in the lane. 
Fractions 10 and 12 were found to contain PRP2 activity (not shown), but 
since quantitative assays of PRP2 protein activity were not performed, it is 
not possible to accurately determine the degree of purification of PRP2 
protein. 
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As mentioned in Chapter 1, two of the ERE gene products, PRP4 protein 
and PRP8 protein have been shown to be associated with snRNPs (Lossky &t 
&L 1987, Banroques and Abelson, 1989, Peterson-Bjorn et al 1989). It was 
therefore of interest to determine whether PRP2 protein was also associated 
with yeast snRNPs. 
An experimental design similar to that used for PRP4 and PRP8 
proteins was employed for this purpose: a yeast snRffP preparation (derived 
from splicing extract by two consecutive 35% ammonium sulphate 
precipitations; section 2.5.2) was incubated under 'mock' splicing conditions 
(identical to conditions for RNA splicing, but with no pre-mRNA added), in 
the presence or absence of 2mM ATP. Immunoprecipitations, with different 
antisera, were then performed, using low stringency washing conditions 
(section 2.6.14.2) and RNA extracted from the immunoprecipitates was 
analysed by denaturing polyacrylamide gel electrophoresis, followed by 
Northern blotting (section 2.4.21). The blot was then probed with 
oligonucleotides complementary to yeast Ui, U2, U4, US and tJ6 RNAs, in 
order to determine if U snRNAs co-precipitated with PRP2 protein. 
The results of such an experiment are shown in figure 5.1. Anti-m3G 
antibodies immunoprecipitated all 5 U snRNPs from the snRNP preparation 
(lane 2). Serum 58 (aPRP8) precipitated US snRNP, and this did not depend 
upon whether ATP was present or absent during the incubation of the snRNP 
preparation, prior to immunoprecipitation (lanes 3 and 4). Affinity 
purified anti-PRP2 antibodies did not iminunoprecipitate any snRffPs, under 
either conditions (lanes 5 and 6), suggesting that the PRP2 protein is not 
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Figure 5.1 Inmunoprecipitation of snRNFs 
A partially purified snRNP preparation was incubated under 'mock 
splicing' conditions in the presence or absence of ATP, for 20 minutes, and 
then subjected to immunoprecipitation. RNA was purified from the 
immunoprecipitates and analysed by electrophoresis on a 6% acrylamide, 811 
urea gel. 	The gel was Northern blotted and the blot probed with 2P- 
labelled oligonucleotides, complementary to the U snRNPs, 
In lanes 3 and 5, no added ATP was present during incubations prior to 
iiumunoprecipitation; in lanes 4 and 6, 2m11 ATP was present during the 
incubation. Lane 1: total yeast RNA, 9g. 	Immunoprecipitat ions were 
performed with anti-m3G antibodies (3l; lane 2) serum 58 (3il; lanes 3 and 
4) or anti-PRP2 antibodies (300.tl, affinity purified from a mixture of 
serum 55 and 139; lanes 5 and 6). 	Lane 7: supernate (equivalent of 10i1 
mock' splicing reaction) from immunoprecipitation in lane 5. 	Lane 11: 
markers with sizes indicated in nucleotides. The snRNA species Ui, 2, 4, 5 
and 6 are indicated at the left hand side. 
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stably associated with an snRNP. 	Lane 7 demonstrates that all the U 
snRNPs were present in the supernate from the Immunoprecipitatlon in lane 
6, and were not degraded. Since the snRNP preparation used in this 
experiment does not display an ATP-dependent assoclatiation of U5 and U4/6 
snRNPs (Lossky et al, 1987; Konarska and Sharp, 1987) it appears that it 
differs from unfractionated splicing extract in some aspects of its 
response to AT?. The possibility therefore remains that PRP2 protein is 
associated with snRNPs in the presence of AT?. However, a number of other 
attempts, using whole splicing extract, to detect association between PRP2 
protein and snRNPs, in the presence and absence of AT?, have failed to 
detect any such association. 	(In some of these experiments association of 
US snRNP and U4/6 snRNP was detected). 	A further possibility, that PRP2 
protein is very weakly, or transiently associated with snRNPs (other than 
in spliceosomes), cannot be ruled out. 
In order to Investigate the Interaction of PRP2 protein with 
spliceosomes, a similar approach to that In section 5.1 was used, starting 
from In vitro splicing reactions, rather than from a snRNP preparation. 
An experiment of this type is shown In figure 5.2A. 	In vitro 
splicing reactions, using wild type (RP51A) or branchpolnt deletion mutant 
(RP51A3B) pre-mRNAs were incubated for 20 minutes and then subjected to 
Immunoprecipitation (section 2,6.14.2). Lanes 1 to 3 show that 
Intermediates and products of the splicing reaction were formed only when 
AT? was present and when the pre-mRNA contained a functional UACUAAC 
sequence. 	As expected, anti-m3G antibodies co-precipitate precursor, 
Intermediates and products of the splicing reaction. 	When these reactions 
were immunoprecipitated with affinity purified anti-PRP2 antibodies, co-
precipitation of significant levels of 32P-labelled RNA species occured only 
from a standard splicing reaction (lane 7), and not when the pre-mRNA 
lacks a branchpolnt sequence (lane 9), or when ATP is absent from the 
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Figure 5.2 Co-precipitation of RNA with PRP2-specific antibodies. 
A. Co-precipitation of RP51A RNA. 	RP51A and RP51A TACTAAC deletion 
mutant (63B) pre-mRNA5 (made by in vitro transcription of pSPRP1A and 
PSPRF51A3B, cut with flI) were incubated in in vitro splicing reactions 
(using extract made from BJ2412 cells) for 20 minutes, the reactions 
stopped and immunoprecipitatioris performed. RNA was analysed by 
electrophoresis on a 67. acrylamide, 8M urea gel. The identities of the 
intermediates and products of the reactions were based on size, AT? 
dependence and kinetics of appearance (not shown). 
Lanes 1 to 3: RNA extracted from 1 il of unfractionated splicing 
reactions, performed with RP51A pre-mRNA in the presence (lane 1) or the 
absence (lane 2) of ATP, or with R?51A3B pre-mRNA (lane 3). 	Lanes 4 to 
9: RNA extracted from linmunoprecipitates from 9 il of splicing reactions; 
lanes 4 to 7, from reaction 1; lane 8, from reaction 2; lane 9, from 
reaction 3. Immunoprecipi tat ions were with anti-m3G antibodies (3jl; lane 
4), protein A-Sepharose control (without IgG; lane 5), preimmune IgG (0.5il; 
lane 6) or anti-PRP2 antibodies (affinity purified from serum 139, 300l; 
lanes 7 to 9). Lane N: markers with sizes indicated in nucleotides. 
IVS .E2- lariat intermediate, IVS- lariat intron product, P-pre-mRNA, m- mRNA, 
El-exon 1. 
The upper, stronger pair of bands in the lariat region of the gel are the 
full size [VS and IVS.E2 species: the lower, fainter band Is a degradation 
product of the IVS. 
B. 	Co-precipitation of actin RNA. Actin pre-mRNA (made by in vitro 
transcription of pSPTact/alu cut with BJiI) was Incubated In an in vitro 
splicing reaction for 20 minutes, the reaction stopped and 
immunoprecipitations performed. RNA was analysed by electrophoresis on a 
6% acrylamide, 8N urea gel. 	Lane 1: RNA extracted from 1 pl of the 
splicing reaction. Lanes 2,3: RNA extracted from Immunopreclpitates from 
9jil of the splicing reaction. 	Immunoprecipitations were with protein A- 
sepharose alone (lane 2), or anti-PRP2 antibodies (affinity purified from 
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splicing reaction (lane 8), 	This co-precipitation was dependent upon 
anti-PRF2 antibodies, and did not occur when there were no antibodies (lane 
5), or preiminune antibodies (lane 6), bound to the protein A-sepharose. 
Since spliceosomes form only under standard splicing conditions, it may be 
concluded that the observed co -precipitation of 32P-labelled RNA in lane 7 
is due to co-precipitation of spliceosomes, and not of non-specific RNA-
protein complexes. Examination of the pattern of co-precipitated RNA 
species confirms this conclusion: anti-PRF2 antibodies co-precipitated only 
precursor and Intermediate species, which, by definition, occur only in 
spliceosomes. 	A similar pattern of co-precipitation with anti-PRP2 
antibodies was observed using an actin pre-mRNA (figure 5.2B, lane 3). 	In 
this case, co-precipitation of exon 1 was detected only after a long 
exposure of the gel (not shown), Further experiments (not shown), 
demonstrate that anti-FRP2 antibodies purified from rabbit 55 serum 
(aFF2.3) also precipitate spliceosomes, and specifically co-precipitate the 
species X with high efficiency (see below). 
These observations indicate that PRP2 protein associates with 
spliceosomes prior to step 1 of the splicing reaction and is present 
throughout step 1. It is not clear, however, whether FRF2 protein 
dissociates from the spliceosome before step 2 of the reaction or 
immediately after completion of this step. 
An Interesting feature of the pattern of RNA co-precipitation with 
anti-PRP2 antibodies, is the presence of the species X, at levels 
approximately tenfold above those expected from its levels in the 
unfractionated RNA (lane 1). 	The RNA X is produced during SF6 
transcription of the substrate RNA . 	(In these experiments the full length 
substrate RNA was not gel purified). By its size, X would be expected to 
terminate between the UACUAAC sequence and the 3' splice site. 	If this is 
true, the results of Rymond and Rosbash (1985) predict that X should 
undergo step 1, but not step 2, of the splicing reaction 
X was gel purified and used as the substrate of a splicing reaction 
(figure 5.3). Lanes 3 and 4 demonstrate that X undergoes step 1 of the 
splicing reaction, generating exon 1 and a species which runs slightly 
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Figure 5.3 In vitro spli:ing of purified species X 
Full lenSth RP1A pre-mRNA 'made by in vitro transcription of pSPRP51A, cut 
with jHI), and species X were purified from a denaturing polyacrylamide 
el (section 2.4.9) and used as substrates for in vitro splicing. RNA was 
purified from a 10jtl in vitro splicing reaction and analysed by 
electrophoresis on a 6% acrylamide, 8M urea gel. 	IVS.E2-lariat 
intermediate, IVS-lariat intron product, P-pre-mRNA, m-iuRNA, El-exon 1. 
Lanes 1 and 2: duplicate reactions, with full length pre-mR1IA as substrate. 
Lanes 3 and 4: duplicate reactions, with X as substrate. 	IVS.E2-lariat 
intermediate, IVS-lariat intron product, P-pre-mRNA, m-mRNA, El-exon 1. 
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ahead of the full sized lariat product species as would be expected for a 
lariat RNA with a shortened 3' tail, This experiment therefore confirms 
that the 3' end of the species X lies between the UACUAAC sequence and the 
3' splice site. 
In figure 5.2B, lane 3 a similar effect to that in figure 5,2A is 
observed, with actin pre-mRNA: a species X', the 3' end of which maps 
between the UACUAAC sequence and the 3' splice site is precipitated at 
approximately ten times the expected levels. This result suggests that 
the phenomenon of preferential co-precipitation of RNA species terminating 
between the UACUAAC sequence and the 3' splice site, is a general one, and 
is not restricted to RP51A pre-mRNA. 
In order to investigate this effect in more detail, two 
deoxyol igonuc leot ides (A and C, corresponding exactly to oligonucleotides A 
and C used by Rymond et al, 1987; figure 5.4), which are complementary to 
sequences in the region of the RP51A transcript between the tJACUAAC 
sequence and the 3' splice site, were hybridized to the RP51A transcript. 
The transcripts were then cleaved with E. coli RNase H and used as 
substrates for in vitro splicing (figure 5.5). The splicing reactions were 
incubated for 20 minutes, and immunoprec ip itat ions performed with affinity 
purified anti-PRP2 antibodies. 
In agreement with the results of Rymond et al (1987), oligo C-cleaved 
transcripts (lane 2) efficiently undergo step 1 of the reaction (cf figure 
5.3, lanes 3 and 4), while oligo A-cleaved substrates do not (lane 3). The 
3' end of X lies between the oligo C cleavage site and that of oligo A, at 
32-35 nucleotides downstream of the IJACUAAC sequence. 
Lanes 4 to 9 show immunoprec ipitat ions performed upon these 
reactions. Species X (lanes 4 and 7) and oligo A-cleaved substrate (lanes 
6 and 9) were preferentially co-precipitated by anti-PRP2 antibodies. 
Oligo C-cleaved transcripts, in contrast, are co-precipitated with the same 
efficiency as full length transcripts (lanes 5 and 8). These data show 
that preferential co-precipitation of pre-mRNA5 only occurs when the pre-





Figure 5.4 Sequence from UACUAAC to 3 splice site of the RP51A gene (from 
Teem and Rosbash 1983). 
Regions of hybridization of oligonucleotides A and C and approximate 
position of 3' ends of species X (see figure 5.5) are indicated. 
Figure 5.5 Preferential co-precipitation of transcripts terminating between 
the UACUAAC sequence and the 3' splice site of the RP51A pre-mRNA. 
RP51A pre-mRNA (made by in vitro transcription of pSPRP51A cut with 
DAaD was cleaved with oligonucleotide A or C plus RNase H (section 2.4,22) 
and used as substrate for in vitro splicing. 	After 20 minutes of 
incubation, the reactions were stopped and immunoprecipitations performed 
with anti-PRP2 antibodies (affinity purified from serum 139, 300ul). RNA 
was analysed by electrophoresis on a % acrylamide, 8X urea gel. 
Lanes 1 to 3: RNA from 1 jl of unfractionated reactions using full 
length pre-mRNA (lane 1), oligo C cleaved pre-mRNA (lane 2), or oligo A-
cleaved pre-mRNA (lane 3). 	Lanes 4 to 6: RNA extracted from anti-PRP2 
immunoprecipitations, from 9 j.l of reactions in lanes 1 to 3, respectively. 
Lanes 7 to 9: long exposure of lanes 4 to 6. 	Lane M: markers, with sizes 
Indicated in nucleotides. 	IVS.E2-lariat intermediate, IVS-lariat intron 
product, P-pre-mRNA, iu-mRNA, El-exon 1, PIA-oligo A-cleaved pre-mRNA, P/C-
oligo C-cleaved pre-mRNA. 
Total lmmunoprecipitatiofls 
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The increased sensitivity of detection of co-precipitation available 
with oligo A-cleaved transcripts was utilized to determine whether heat 
inactivated prp2 protein associates with spliceosomal complexes. Ryniond 
et al (1987) demonstrated that complexes I and III form on oligo A-cleaved 
pre-mRNA. Splicing extract made from a 12rp2-1 strain was inactivated by 
heating for 1 hour at 32C (see section 4.4), and used for in vitro splicing 
reactions with both full length RP51A pre-niRNA, and oligo A-cleaved pre-
inRNA, The splicing reactions were incubated for 20 minutes, and 
immunoprecipltations performed with affinity purified anti-PRP2 antibodies. 
Lanes 1 to 3 demonstrate that the extract was efficiently heat 
inactivated, but was capable of being complemented by a small amount of 
pBM-PRP2 extract i.e. the heat inactivation was prp2-speciflc(section 4.4). 
A similar set of reactions was performed with the same batch of heat 
inactivated extract, using oligo A-cleaved substrate (lanes 4-6) and 
immunoprecipitations were performed upon these reactions (lanes 7-10). 
When prp2-1 protein was heat inactivated (lane 5) no co-precipitation of 
substrate RNA was observed (lane 9). When the prp2 deficiency was 
complemented with wild type PRP2 protein, however, (lanes 6 and 10) co-
precipitation of substrate RNA was restored. 
In a separate experiment (figure 5.7), prp2-1 (lanes 1 and 2) and prp2-4 
(lanes 3 and 4) splicing extracts were heat inactivated and subjected to 
immunoprecipitation with serum 139 (the heat inactivation of the prp2-1 
extract is not presented; the heat inactivation of the prp2-4 extract is 
shown In figure 4.9B), As lanes 2 and 4 demonstrate, heat inactivated 
prp2 proteins are immunoprecipitated, after heat Inactivation, by anti-PRP2 
serum. It is therefore clear that the failure to co-precipitate 
spliceosomes from heat inactivated prp2 extracts, with anti-PRP2 antibodies 
Is not due to failure to immunoprecipitate the heat inactivated prp2 
protein. 
These results provide further evidence that co-precipitation of substrate 
RNA is dependent upon PRP2 protein, and demonstrate that heat Inactivation 
M. 
Figure 5.6 .  l]nmunoprecipitation of spliceosomal complexes from heat 
inactivated prp2-1 splicing extract. 
RP51A pre-mRffA (made by in vitro transcription of pSPRP51A cut with DjdaD, 
or RP51A pre-mRNA cleaved with oligonucleotide A plus RNase H (section 
2.4.22) was used as substrate for in vitro splicing, with prp2-1 splicing 
extracts (made from strain DJY85). 	After 20 minutes of incubation the 
reactions were stopped and immunoprecipitat ions performed with anti-PRP2 
antibodies (affinity purified from serum 139, 400l). RNA was analysed by 
electrophoresis on a 6% acrylamide, BX urea gel. 
Lanes 1 to 6: RNA extracted from 1.&1 of unfractionated reactions. 
Lanes 1 to 3: reactions with full length RP51A substrate, performed with 
untreated prp2-1 extract (lane 1), heat treated prp2-1 extract (lane 2), or 
heat treated prp2-1 extract complemented with wild type PRP2 protein 
(section 4.4; lane 3). 	Lanes 4 to 6 are as lanes 1 to 3, but using oligo 
A-truncated RP51A pre-mRNA. Lane 7: protein A-Sepharose control 
inimunoprecipitation from 9jil of reaction in lane 4. 	Lanes 8-10: anti-PRP2 
iinmunopreclpitations from 9il of reactions in lanes 4-6 respectively. 	)t: 
markers with sizes Indicated in nucleotides. 	IVS,E2-lariat intermediate, 
IVS-lariat iritron product, P-pre-mRNA, m-mRNA, El-exon 1, P/A-oligo A-
cleaved pre-mRNA. 
The origin of the band at approximately 370 nucleotides In lanes 8 and 10 
is uncertain: while generally present In such experiments Its intensity is 
variable. 
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Figure 5.7 Immunoprecipitation of heat-inactivated prp2 proteins. 
Splicing extracts from prp2-1 cells (strain JBY27) or prp2-4 cells 
strain DJY39) were heat inactivated (section 4.4) and used for in vitro 
splicing. 	Immunoprecipitations were performed, upon 20l splicing 
reactions, using 2il of serum 139 (aFP2.5) using low stringency washing 
conditions. The immunoprecipitates were analysed by electrophoresis on an 
8.5% SDS-polyacrylamide gel, followed by Western blotting. The blot was 
probed with rabbit 139 serum (aFP2.5) and developed by the alkaline 
phosphatase procedure. 
Prp2-1 (lanes 1 and 2) or prp2-4 (lanes 3 and 4) splicing extracts were 
heat treated for 0 (lanes 1 and 3) or 60 (lanes 2 and 4) minutes at 32C. 
N: marker proteins, with sizes indicated in kD. 
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of prp2-1 protein prevents its interaction with spliceosomal complexes. 
Similar results have been obtained with extracts made from prp2-4 yeast 
strains (not shown). 
To investigate which specific spliceosomal complexes PRP2 Interacts 
with, different spliceosomal complexes formed on RP51A substrate RNA were 
fractionated by non-denaturing gel electrophoresis. 	A typical time course 
of appearance of the different complexes Is shown in figure 5.8A. 	After 
three minutes of incubation, two complexes, labelled 2 and 3 are present, 
while after twenty minutes a further complex, 1 is visible. 	These 
complexes were electroeluted (section 2,55) and 10% of the P-labelled RNA 
analysed by denaturing gel electrophoresis (figure 5.8B). 	Complexes 3 and 
2 contain bnly pre-mRNA (lanes 2,3). 	Complex 1 contains mainly pre-mRNA 
plus a small amount of Intermediates and lariat product, while after 20 
minutes complex 2' contains the majority of intermediates, plus some pre-
mRNA (lanes 4 and 5). It Is possible that in addition to active 
spilceosomes, this band contains some residual complex 2, since complexes 2 
and 2' co-migrate In the non-denaturing gel. The ratio of X to full length 
pre-mRNA is greatest in complex 1, suggesting that X is trapped in this 
complex, its progress to complex 2' possibly being retarded due to the lack 
of a sufficient length of RNA 3' to the TJACUAAC sequence (see Chapter 6) 
Anti-PR?2 immunoprecipitations were performed on the remaining 90% of 
the material eluted from the non-denaturing gel, (figure 5.8B, lanes 6-9). 
While there is no detectable immunopreclpitation from complexes 2 and 3, 
strong co-precipitation of pre-mRNA is observed from complex 1, and weaker 
co-precipitation from complex 2'. It is therefore likely that the majority 
of pre-mRNA and species X co-precipitated from whole splicing reactions 
comes from complex 1. For reasons which are not clear, co-precipitation 
of splicing intermediates in elution experiments Is relatively Inefficient. 
However, since intermediates are precipitated from whole splicing reactions, 
PRP2 protein must be associated with this complex. These observations 
indicate that the point of initial interaction of PRP2 protein with 
spliceosomal complexes is the transition from complex 2 to complex 1. 
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Figure 5.8 Kinetics of interaction of PRP2 protein with spliceosomes. 
kinetics of splicing complex formation. 	20jil in vitro splicing 
reactions using RP51A pre-mRNA (made by in vitro transcription of pSPRP51A 
cut with 	I) were incubated for the times indicated and then quenched on 
ice and fractionated by non-denaturing gel electrophoresis (section 2,5,4) 
for 8 hours at 120V. 
Elution and imniunoprecipitation of splicing complexes from a non-
denaturing gel. 	Bands 3, 2, 1 and 2' were eluted from the gel shown In 
figure 5.8A, and 10% of the eluted RNA was purified (lanes 2 to 5 
respectively). The remaining 90% was Immunoprecipitated with anti-PRP2 
antibodies (affinity purified from serum 139, 300.&l; lanes 6 to 9, 
respectively). RNA was analysed by electrophoresis on a 67. acrylamide, 8M 
urea gel. 	Lane 1: RNA extracted from 1 jil of the unfractlonated 20 minute 
sample of the splicing reaction. Lanes 1 to 5 are a 24 hour exposure; 
lanes 6 to 10 are a 1 week exposure. X: markers, with sizes indicated in 
nucleotides. 	IVS.E2-lariat intermediate, IVS-lariat intron product, P-pre- 
mRNA, m-mRNA, El-exon 1. 
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A method of partially disrupting spliceoeomes was used to investigate 
the localisation of PRP2 protein, relative to pre-mRNA, in spliceosomes. 
The experimental design (figure 5.9) exploits the fact that the central 
region of the RP51A intron is available, in spliceosomes, for hybridization 
with oligonucleotides (Rymond and Rosbash, 1986). Since yeast splicing 
extracts contain an endogenous RNase H activity, adding to a splicing 
reaction an oligonucleotide complementary to a central region of the intron 
results in cleavage of the pre-mRNA into two fragments. The cleaved 
spliceosomes are then subjected to immunoprecipitation under standard 
conditions. 
An experiment of this type is shown in figure 5.10. 	In vitro splicing 
reactions were incubated for 15 minutes under standard conditions, and for 
a further 4 minutes in the presence of oligonucleotide E. As lanes 3 and 
4 demonstrate, addition of oligonucleotide E efficiently cleaves the pre-
mRNA to give the two major species indicated. These species were 
identified on the basis of their size, and further cleavage with 
oligonucleotide C (lane 11). In agreement with the findings of Rymond and 
Rosbash (1986), after cleavage, the 5' portion of the molecule is present in 
much larger amounts than the 3' portion, due presumably to degradation of 
the 3' portion of the molecule by endogenous 5' to 3' exonucleases (Rymond 
and Rosbash, 1986). The small discrepancy between the sizes of the 5' 
portions of wild type and 63B RNA is due to a minor difference in sequence, 
Introduced during the construction of the A3B deletion (Pikielny et al., 
1983). 
The cleaved spliceosomes were subjected to immunoprecipitatlon with 
anti-m3G or anti-PRP2 antibodies (lanes 6 and 7). Anti niG antibodies co-
precipitated both the 5' and 3' portions of the pre-niRNA plus residual 
uncleaved pre-niRNA and exon 1 (lane 6). Despite the degradation of most 
of the population of 3' portions of pre-mRNA there therefore exists a 
certain quantity of 3' portions associated with snRN?s. In contrast to the 
result with anti-mG antibodies, anti-PRP2 antibodies co-precipitated only 
the 5' portion of the pre-mRNA (lane 7), and this precipitation was 
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Figure 5.9 Procedure for cleavage of RNA and immunoprecipitation of 
splicing complexes. 
The oligonucleotide used, E, hybridizes to the RP51A intron sequence 
between 90 and 110 nucleotides downstream of the 5 splice site. The large 
dot indicates the position of the TACTAAC sequence and the shaded circles 
indicate complexes which protect these regions of the RNA (Rymond and 
Rosbash, 1966). 	Separate complexes are drawn at each site for reasons of 
clarity. 
Figure 5.10 Immunoprecipitation of cleaved spliceosomes 
In vitro splicing reactions using RP51A or RP51A3B pre-nIRNA (made by 
In vitro transcription of pSPRP51A or pSPRP51A3B cut with DdaD were 
incubated for 15 minutes under standard conditions and then for a further 4 
minutes with oligonucleotide E (0.2nmol). 	The reactions were stopped 
and immunoprecipitations performed, using low stringency washing 
conditions. RNA was analysed by electrophoresis on a 6% acrylamide, 81( 
urea gel. 
Lane 1: RNA from 1 il of reaction using full length RP51A pre-mRNA, 
sample taken prior to addition of oligo E. 	Lane 2: as lane 1, from 
reaction using A3B pre-niRNA. 	Lanes 3 and 4: RNA from 1 il of reactions 
in lanes 1 and 2, respectively, samples taken after incubation with 
oligonucleotide E. 	Lanes 5 to 7: RNA extracted from immunoprecipitates 
from 9 ,ui of reaction in lane 3. 	Immunoprecipitations were with protein 
A-Sepharose (lane 5), anti-mG antibodies (3)j.l; lane 6), or anti-PRP2 
antibodies (affinity purified from serum 139, 300l; lane 7). 	Lane 8: RNA 
extracted from anti-PRP2 immunoprecipitate, from 9 il of reaction in lane 4. 
Lane 9: RNA from supernate from immunoprecipitation in lane 7 (equivalent 
of 1 il of splicing reaction). 	Lane 10: RNA extracted from anti-mG 
immunoprecipitate from supernate (9jil splicing-reaction-equivalent) shown 
in lane 9. Lane 11: same RNA as in lane 3, but purified and then cleaved 
with oligonucleotide C plus E. coli RNase H (section 2.4.24). 	M: markers, 
with sizes indicated in nucleotides. 	IVS.E2-lariat intermediate, IVS-lariat 
intron product, P-pre-n1RNA, m-mRNA, El-exon 1. 	The arrow on the right 
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dependent upon spliceosome formation, since it did not occur when the 63B 
pre-mRNA was used as substrate (lane 8). 	Anti-PRP2 antibodies did not 
immunoprecipitate exon 1. 	The control experiment presented in lane 9 
shows that the supernatant from the immunoprecipitation In lane 7 contained 
the same amount of 3' portions of pre-mRNA as the starting material (lane 
3), and these were still co-precipitable by anti-maG antibodies (lane 10). 
The fact that anti-PRP2 antibodies co-precipitated only the 5' half of the 
pre-mRNA provides evidence that PRP2 protein Is associated, in 
spllceosomal complexes with this portion of the RP51A transcript. 
Given that in this experiment the 3' half of the pre-mRNA 
was more or less quantitatively degraded by an endogenous nuclease 
activity failure to detect immunoprecipitation of this molecule 
by antibodies against PRP2 protein must make this conclusion 
tentative. 
This thesis describes experiments aimed at understanding the 
involvement of the PRP2 protein in pre-mRNA splicing in Saccharomyces 
The most important reason for choosing this organism for the study of 
pre-mRNA splicing was the availability of well characterised splicing 
mutants strains, including prp2. This allowed the cloning of the PRP2 
gene, in this laboratory (Lee et p1, 1984) and by others (Last et al, 1984). 
This, in turn, facilitated an immunological approach to understanding the 
Involvement of the PRF2 protein In RNA splicing, since it allowed the 
construction of 3-ga1actosidase fusion proteins, for raising antisera to 
PRP2 protein, in rabbits. The availability of prp2 strains of E, 
cerevislae also allowed the development of an assay system for the activity 
of PRP2 protein In RNA splicing. 
The first part of this work involved the generation and characterisation 
of antibodies to PRP2 protein. The general approach taken was to 
construct fusions between E. roll proteins and different regions of PRP2 
protein, and to use these fusion proteins to raise antisera against PRF2 
protein. In all, five different fusion proteins were constructed of which 
three (FF2.2, FF2.3 and FF2.5) were used to raise antisera against PRP2 
protein. Together, these fusion proteins contain regions covering the 
whole of PRF2 protein, with only small regions of overlap (figure 3.1). 
Injection of each of the fusion proteins into rabbits resulted in the 
production of antisera which specifically recognised PRP2 protein, both on 
Western blots and under immunoprecipitation conditions. However, the 
different antisera had widely different strengths of reaction with PRP2 
protein; antisera raised against FF2.2 produced weak responses compared to 
the antisera against FF2.3 and FF2.5. It is possible that the C-terminal 
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region of FF.P2 protein, present in FF22 is at poor immunogen, in rabbits. 
Antibodies raised against FF2.3 and FF2.5 were used to attempt to detect a 
metazoan homologue of FRP2 protein, by probing western blots of HeLa cell 
extracts; no HeLa proteins were specifically recognised by the anti-FRP2 
antisera in such experiments (data not presented). 
The second major part of the work was over-expression of FRP2 protein 
in various systems, development of an assay system for FRP2 protein 
activity in pre-niRNA splicing, (based on the work of Lustig et al 1986), 
and partial purification of the protein. Initial studies of overexpression 
of PRP2 protein used a high copy number yeast plasmid (pJDB2076), which 
expressed PRP2 protein constitutively (section 4.1.1). It was found, 
however, that this plasmid caused growth problems in cells which carried 
it, and this appeared to be due to the high constitutive levels of PRP2 
protein in these cells. Because expression of PRF2 protein, using this 
piasmid, was not reliable, two further plasmids, in which expression of 
PRF2 protein was under the control of the yeast QAL1 upstream activator 
sequence, were constructed. These constructions, one based on a low copy 
number vector and the other on a high copy number vector, allowed 
expression of FRP2 protein to be regulated by the carbon source upon which 
the cells were grown. The low copy number construct, pBX-PRF2, gave an 
approximately 10-fold increased level of expression of FRF2 protein under 
Inducing conditions. The high copy number construct, pKV-PRF2, which also 
contained a strong promoter (the yeast ?IK promoter) gave a 100 to 200-
fold increased level of expression under inducing conditions, although 
expression of PRP2 protein was not fully repressed under conditions (growth 
on glucose as carbon source) designed to repress transcription from the EQL 
promoter. Nevertheless, cells carrying pKV-FRP2 facilitated identification 
of the PRP2 protein, and were a useful enriched source of FRP2 protein, for 
partial purification. 
PRP2 protein was expressed in F. coli using an expression vector, 
pDR540, which contains the tac promoter. However, in contrast to the 
high expression of 0-gaiactosidase-FRP2 fusion proteins (section 3.1), the 
expression of full-size FRP2 protein was considerably lower than in yeast 
cells containing pBX-FRP2, under inducing conditions, and was furthermore 
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not consistent, from experiment to experiment. 	The cause of this problem 
was probably rapid degradation of PRP2 protein. Because of this problem, 
E. coil cells carrying pDR-PRP2 were not, used as a source of PRP2 protein 
for other studies. 
PRP2 protein was also expressed by in vitro transcription followed by in. 
vitro translation (section 4.3). For the purpose of these studies the FRP2 
gene was subcloned Into pSPT18, a vector containing a bacteriophage T7 
promoter. PRP2 niRNA was produced by in vitro transcription using T7 
polymerase, and this RNA was translated in a rabbit reticulocyte extract. 
Full sized PRP2 protein was produced In these experiments, but did not show 
any detectable activity in RNA splicing. 
An assay system for FRP2 protein activity in RNA splicing was 
developed, based upon the work of Lustig et al (1986). This system 
depends upon the inactivation of splicing extracts from prp2 strains of 
yeast, by heating. The experiments shown in section 4,4 demonstrate that 
the splicing activity of the system depended strongly upon the amount of 
PRP2 protein present, with very low background activity in the absence of 
added wild type PRP2 protein. 
The PRP2 protein was partially purified from extracts of yeast cells 
carrying pKV-PRP2. The purification procedure, which consisted of 
sequential steps of centrifugation, ammonium sulphate precipitation and 
heparin agarose columnfractionatlon, resulted in considerable purification 
of the protein, which retained activity in RNA splicing. Other 
experiments, using anti-PRP2 antibodies for immunoaffInity purification, 
resulted in purification of small amounts of PRF2 protein. However, the 
purified PRP2 protein was not active In RNA splicing, due, presumably, to 
the harsh conditions necessary to efficiently elute the protein from the 
antibody column (data not presented). 
The third major part of the work consists of experiments to investigate 
the Interaction of PRP2 protein with splicing factors and with 
spliceosomes. It has been shown (Lin et p1, 1987; Cheng and Abelson, 
1987) that PRP2 protein is not required for the early steps in spliceosome 
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assembly, and it was suggested that it is a factor 'extrinsic' to the 
spliceosome. Prior to the experiments presented in Chapter 5 of this 
thesis, no direct physical association of PRP2 with either spliceosomes or 
with other spicing factors had been demonstrated although it appears to be 
functionally associated with another factor, b-, (Lin et al 1987). Two other 
EKE gene products, PRP4 and PRP8 proteins, have been shown to be associated 
with snRNPs (Lossky et p1, 1987; Banroques and Abelson, 1989; Peterson-
Bjorn et p1, 1989), and it was therefore of interest to determine whether 
PRP2 protein was also associated with snRNPs. 
The approach taken to investigating PRP2 protein interactions with 
snRNPs and spliceosomes was to use affinity purified anti-PRP2 antibodies 
to immunoprecipitate PRP2 protein, and to determine whether any snRHPs or 
spliceosomes were co-precipitated. Using this technique it was not 
possible to detect any Interactions between PRP2 protein and yeast snRNPs. 
It Is possible that such Interactions are very weak, or transient and 
require more sensitive techniques to detect them. This result is 
consistent with evidence (section 5.2.3) suggesting that PRP2 protein does 
not associate with splicing complexes until all the U snRNPs are probably 
already bound. It is also consistent with the results of Cheng and 
Abelson (1967), who found that in heat inactivated prp2 splicing extracts, 
spliceosomal complexes formed which contained all the U snRNPs, although 
heat Inactivation of a snRNP-associated prp2 protein might not necessarily 
prevent its Interaction with spliceosomes. 
It has, however, been possible, using anti-PRP2 antibodies, to detect cc-
precipitation of pre-rnRNA and splicing intermediates from in vitro splicing 
reactions. This co-precipitation occurs only under conditions in which 
spliceosomal complexes can be formed, indicating that PRP2 protein 
interacts with pre-mRNA only during RNA splicing. It was also shown 
(section 5.2.2) that heat inactivated prp2 protein does not associate with 
spilceosomes. This result independently confirms that the co-precipitation 
of pre-mRNA observed with anti-PRP2 antibodies Is dependent upon PRP2 
protein. These observations and direct co-precipitation of gel-purified 
spliceosomes are the first demonstration that PRP2 protein Interacts 
directly with spliceosomes rather than acting Indirectly in splicing by, for 
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example, covalently modifying splicing factors, prior to their assembly into 
spl iceosomes, 
Anti-PRP2 antibodies co-precipitate pre-mRNA and splicing intermediates, 
but not products, from an in vitro splicing reaction. This result 
indicates that PRP2 proteinfirst associates with the spliceosome prior to 
step 1 of the splicing reaction and is present throughout step 1. It is 
difficult to determine at which point it dissociates from the spliceosome: 
the lack of co-precipitation of splicing products may indicate that it 
leaves before step 2, or immediately upon completion of this step. Post-
splicing complexes, which contain lariat intron product, complexed with 
snRNPs have been detected (Konarska and Sharp, 187); the mRNA remains in 
an ribonucleoprotein complex which does riot contain snRPs . The PRP2 
protein does not appear to associate with either complex, although it is 
possible that PP2 protein does associate with them, but that the epitopes 
which ere bound by anti-PRP2 antibodies are not accessible, in these 
complexes. 	This possibility can, in general, not be excluded wherever 
anti-PRP2 antibodies fail to co-precipitate RNA. 	It would be desirable to 
confirm such results using an independent technique for demonstrating the 
presence of PRP2 protein in spliceosomes. 
The experiments demonstrating co-precipitation of RP51A pre-mRNA and 
splicing intermediates with anti-PRP2 antibodies also revealed that a 
species (X, in figure 5.2) was preferentially co-precipitated. The 3' end 
of this species, and of a similar species in actin pre-mRNA, map between 
the UACUAAC sequence and the 3' splice site. In both RP51A and actin 
genes, there is a sequence in this region which is very T rich (13/19 
nucleotides in actin, 12/15 nucleotides in RP51A). It is likely that 
during in vitro transcription, the bacteriophage polymerase pauses or 
terminates in this region, due to the limiting amounts of UTP in the 
transcription reaction (section 2.4.23). 
It ws shown that X was capable of undergoing step 1 of the splicing 
reaction. More detailed analysis of this region in RP51A pre-mRNA 
revealed that transcripts with less than approximately 32 nucleotides 3' to 
the UACUAAC sequence are preferentially co-precipitated. This figure is 
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close to the minimum of 29 nucleotides which was reported to be required 
for step 1 of the splicing reaction to occur (Rymond et al, 1987). 
The preferential co-precipitation of these transcripts with PRP2 protein 
is explained by the results of the investigation of which specific splicing 
complexes PR?2 protein Is associated with. In the experiment shown in 
section 5.2.3, four complexes (1, 2, 2' and 3) were observed which, based on 
(a) the relative electrophoretic mobilities of the complexes, (b) the 
kinetics of their appearance and (c) the RNA species associated with them 
appear to correspond to the complexes Al, A2-1, A2-2 and B observed by 
Cheng and Abelson (1987). However, In the absence of data on the snRNP 
composition of the complexes such comparisons must be approached with 
caution, due to the different gel systems and substrates employed. The 
species X appeared to accumulate in complex 1, and anti-PRP2 antibodies co-
precipitated pre-mRA predominantly from this complex. Although they 
observed a slightly different pattern of complex formation, Rymond et al 
(1987) also found that oligo A-cleaved pre-mRNA was trapped in the most 
slowly migrating complex. Thus, the relatively Inefficient co-
precipitation of full length transcripts is explained by the fact that the 
RNA in complex 1 is a small proportion of the total RNA In the in vitro 
splicing reaction. This is because pre-mRA is present in this complex 
for a very short time, the complex being rapidly converted to the active 
spliceosome. Species like X, by contrast, which have less than 32 
nucleotides 3' to the tJACUAAC sequence are trapped In this complex and 
therefore efficiently co-precipitated by anti-PRP2 antibodies. 
The results presented in section 5.2.3 define the initial point of 
interaction of PRP2 protein with spliceosomal complexes to be the 
transition from complex 2 to complex 1. While slightly different patterns 
of complex formation have been seen in other experiments, in no case has 
PRP2 protein been observed to associate with the fastest migrating (and 
first appearing) complex on the gel. As noted above, it is possible that 
PRP2 protein is associated with these complexes, but PRP2 epitopes are not 
available for antobody binding in these particular complexes. However, 
since it has been shown (Cheng and Abelson, 1987) that such early 
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complexes can form in the absence of active PRP2 protein, this possibility 
is considered unlikely. 
By using an oligonucleotide plus endogenous RNase H to cleave the pre-
mRNA in the intron it has been possible to separate a fragment of 
spliceosomes containing the 5' splice sitefrom a fragment containing the 
UACtJAAG box and 3' splice site. Following cleavage of pre-mRNA in i. 
vitro splicing extracts, degradation of a substantial fraction of the 
population of 3' portions of the molecule occurs, with the result that there 
is an excess of free 5' portions. 	A fraction of both portions is m3G- 
precipitable. 	The 3' portions are clearly not all physically associated 
with 5' portions since anti-PRP2 antibodies do not co-precipitate detectable 
quantities of the 3' portion, while they strongly co-precipitate the 5' 
portion. In contrast to this result, when spliceosomes formed on poly A-
containing pre-mRNA are purified by inimunoprecipltatlon with antibodies to 
yeast poly A-binding protein, and are then cleaved by a similar procedure, 
the two fragments of the pre-mRNA appear to remain associated (not 
presented). This difference is possibly due to the fact that the 
immunoprecipitations involve long incubations in buffers containing high 
salt and EDTA concentrations, in the presence of excess competitor RNA. 
Rymond and Rosbash (198) showed that the association between the two 
fragments of the cleaved spliceosome was disrupted under non-denaturing gel 
electrophoresis conditions similar to the immunoprecipitation conditions 
used here. 
The results of experiment presented in section 5.2.4 show that the 5' 
portion of spliceosomal complexes co-precipitate with PRP2 protein 
indicating that, at least in complex 1, PRP2 protein is associated with this 
region of the spliceosome. An additional weaker association of PRP2 
protein with a subcomplex attached to the 3' portion of the cleaved RNA 
cannot be excluded, as certain interactions may be disrupted upon cleavage 
and dissociation of the spliceosome. Although it as not possible to 
clearly identify the cleaved lariat intermediate species, the lack of 
co=precipitation of exon 1 might suggest that (subject to the same 
reservation) that PRP2 protein is associated with the intron. It is 
106 
tempting to speculate that the PRP2 protein is associated with complexes at 
the 5' splice site. 
The current state of knowledge regarding the Involvement of PRP2 protein 
In RNA splicing may be summarised as follows. 	PRP2 protein is a factor 
required for RNA splicing in S. cerevisiae. 	It is not associated with any 
snRNP and is not required for the early stages of spliceosome formation. 
It binds to spliceosomal complexes, possibly in association with the b, 
factor, at a specific stage of spliceosome assembly, the transition from 
complex 2 to complex 1. 	In complex 1, at least, It is associated with 
the region of the pre-mRNA containing the 5' splice site. 	PRP2 protein is 
present thoughout step 1 of the splicing reaction, and leaves the 
spliceosome at some point subsequent to completion of this step, possibly 
when splicing complexes dissociate upon completion of step 2. 
Given this information, it is possible to speculate upon the function of 
the PRP2 protein in pre-mRNA splicing. The facts that PRP2 protein is not 
associated with any snRNP, that it is not required for the early stages of 
splicing complex formation and only enters the spliceosome when all the U 
snRNPs are probably already present, suggest that PRP2 protein does not 
have a major structural role In the spliceosonie, but may rather be closely 
connected to the catalytic functions of splicing complexes. Its possible 
association with the 5' splice site suggests that it is involved in step 1 
of the splicing reaction, and the presence of the zinc finger structure in 
the protein suggests that it may bind directly to the pre-mRNA. One 
possibility is that PRP2 protein is the endonuclease responsible for 5' 
splice site cleavage, In step 1 of the splicingreaction. The nuclease 
activities in group I and group II RNA splicing have been shown to reside 
in RNA molecules (Cech and Bass, 1986), and it is often assumed that, given 
the apparent similarities In mechanism between group I, group II and pre-
mRNA splicing, that this will also be the case In the latter. Thus it Is 
expected that the catalytic activity will reside in one of the U snRNA 
species, with the associated proteins playing a role similar to the 
maturases of groups I. This is, however, only a supposition and it is 
possible that the catalytic activities in pre-niRNA splicing have been taken 
over by proteins, such as PRP2 protein. 
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A second possibility is that PRP2 protein is responsible for 5' splice 
site selection, or the exact positioning of the catalytic apparatus relative 
to the 5' splice site. It has been shown that there exist proteins in 
mammalian systems which enhance the correct binding of Ui snRNP to the 5' 
splice site (Mayeda et al, 1986; Zapp and Berget, 1989). Other possible 
functions for ?RP2 protein Include bringing the 5' splice site and 
branchpoint sequences together, during step 1 of the reaction. 
With regard to future investigations of the function of PRP2 protein, 
there are a number of important questions which remain to be answered. 
Firstly, it is of interest to know whether ?RP2 protein directly contacts 
the pre-mRNA. This could be answered by UV-crosslinking studies, although 
such studies have so far failed to observe any such direct interaction (B. 
Whittaker, personal communication). If such studies did detect binding of 
PRP2 protein to RNA, they could be followed up by mapping of the binding 
site by Ti RNase digestion of pre-mRNA in spliceosomes, followed by 
inimunoprecipitation with anti-PR?2 antibodies. It would also be of 
interest to determine whether AT? is required for ?RP2 binding to 
spliceosomes. This could be Investigated by allowing splicing complexes 
to form in heat inactivated prp2 extracts, depleting the extracts of AT? 
using glucose and hexokinase and then adding ?R?2 protein in the presence 
and absence of fresh AT?, followed by immunoprecipitation using anti-PRP2 
antibodies. AT? binding to ?RP2 protein could be examined using radio-
labelled ATP analogues which contain groups which make covalent cross links 
to proteins, when irradiated with UV light. 
Other studies might focus on the interactions of PRP2 protein with other 
splicing factors. This might be approached by isolating and 
characterizing trans-acting suppressors of prp2 mutants. Such studies have 
been Initiated (D. Jamieson, personal communication). 
An alternative possible approach to the identification of yeast proteins 
which bind to PR?2 protein, would be to use immobilised PRP2--
galactosidase fusion proteins, if these can be obtained in a native form, as 
affinity columns for S-labelled yeast proteins. This approach is more 
direct than the method of co-precipitation used in section 3.3, and would 
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Allow Analysis of which region of FRP2 protein interacts with such 
proteins. 
A different method for analysis of the function of PRP2 protein would be 
site directed mutagenesis of the protein. Such a mutation, of an amino 
acid which is a crucial part of the putative zinc finger structure, has been 
generated, and fails to complement the prp2 defect in viva (E.Whittaker, 
G.Anderson and J.Beggs, personal communication). 
Finally, the technique of cleavage of spliceosomes into two portions, 
followed by co-precipitation of the 5' portion with anti-PRP2 antibodies, 
allows the Investigation of general aspects of spllceosome architecture. 
In particular, it would be of interest to determine which snRNPs are co-
precipitated with the 5' portion of the RNA in such experiments. 
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